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8PREFACE
TRIPs provides minimum worldwide standards for IP protection. Its article
27(3)(b) is revolutionary in that it provides, for the first time in an international
treaty, for the patenting of life forms. Traditionally, patents have been available for
industrial/mechanical inventions only.
Article 27(3)(b) of TRIPs nevertheless offers some flexibility in that member
states may exclude from patentability certain life forms e.g. plants and animals.
Certain inventions may also be excluded from patentability in order to protect
morality, protect human, animal or plant health or protect the environment as per
article 27(2) of TRIPs.  However, there must be IP protection for plant varieties
i.e. either by patents or an effective sui generis system.
What does this portend for Africa? Traditionally, African rural farmers have
saved, exchanged and reused seeds for generations. The free exchange of seed
among farmers has been the basis of maintaining biodiversity as well as food
security. This exchange is based on cooperation and reciprocity and also involves
exchange of ideas or knowledge of how to work the seed. It is a culture of free
access to agro-biodiversity for food and agriculture. Biological resources are seen
as a “common heritage of mankind” and indeed not a preserve of private rights.
Powerful MNCs, in the life-sciences industry (mainly pharmaceuticals, chemicals,
agro-chemical and seed corporations), based in developed countries, particularly
USA have driven this expansion of patentable subject matter to now include life
forms.
The thesis will show that modern biotechnology R&D is in the hands of these
commercial interests. In the industrialized countries, biotechnology R&D is
stimulated by IPRs, particularly patents which assures the MNCs of return of
research costs and profits. The thesis will show some of the main issues that arise
as a result of IPRs in agricultural biotechnology, which have implications on the
right to food in Africa.
In addition, one of the major challenges in assessing the relevance or
appropriateness of modern agricultural biotechnology in solving food insecurity in
Africa is the role of IPRs and its impact on the acquisition, development and
diffusion of biotechnology.
The thesis will highlight the implications of TRIPs on the right to food in Africa. It
shows that with a strengthened IPRs regime under TRIPs, the individual right to
food (and food security) is threatened with violation worsening an already
desperate situation.
9RESEARCH METHODOLOGY
This thesis is mainly based on research work carried out at the library of the
Raoul Wallenberg Institute. It is also based on relevant and useful information
found on the Internet.
In addition, I made study visits, conducted interviews and collected data at the
following institutions, all based in Nairobi, Kenya:
African Biotechnology Stakeholders Forum (ABSF); African Centre for
Technology Studies (ACTS); Biotechnology Trust Africa (BTA); International
Livestock Research Institute (ILRI); Kenya Agricultural Research Institute
(KARI) – National Biotechnology Centre; Kenya Industrial Property Institute
(KIPI); Kenya Plant Health Inspectorate Service (KEPHIS); National Council
for Science and Technology; The Rockefeller Foundation, Africa Regional Office;
the library of the United Nations Environment Programme (UNEP); and World
Vision International.
THESIS OUTLINE
Chapter one studies the historical roots of the human rights and IPRs regimes and
analyses the interaction between these two systems. It highlights the similarities
and differences and the potential tensions or conflicts and considers the balance of
rights attempted under both rubrics.
Chapter two looks at TRIPs with a human rights eye. In this light a human rights
approach and analysis of TRIPs is made. It particularly focuses on the right to
food (and food security) analysing what this right means in international law. It
also looks at the state obligations that the right imposes and also identifies what
constitutes a violation of the right to food.
Chapter three looks at the origins of TRIPs and the role of Africa in its adoption.
It also highlights its relevant IP provisions for food and agriculture.
Chapter four looks at the implications of TRIPs on the right to food. In this light, a
study of other relevant international and regional agreements is made to assess the
impact of TRIPs.
Chapter five tries to reconcile the implications and issues raised in the previous
chapter. It provides a brief status of food security in Africa. As TRIPs is a binding
treaty, it also looks at strategies and the flexibility options African countries can
employ under it so as to remain TRIPs compliant but yet not compromise human
rights, among other interests.
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1 HUMAN RIGHTS AND
INTELLECTUAL PROPERTY
RIGHTS
1.1 History of Intellectual Property1
At inception, IPRs were intended to foster the technological and industrial
progress of the state granting the patent. The major function of IPRs especially the
patent regime, was economic self-sufficiency. The rights of inventors were only
the corollary of the monopoly conditions deemed appropriate for such
exploitation, while the rights of foreign inventors were completely disregarded.
The law thus did not protect the property right of the original inventor as such, but
permitted the importer of the invention to exercise rights similar to those of the
original inventor. Under these conditions, the objective of the patent law was not
to promote the position of the inventor.
The different subject areas of IPRs originate in different places and at different
times.2 Some state that the origins of IP date back to Aristotle in 4th century B.C.
while others to 9th century China.3 However, the Venetians are credited with the
first properly developed patent law in 1474 and their model spread to other
European states.4 In England, the Statute of Monopolies of 1623 swept away all
monopolies except those made by the “true and first inventor” of a “method of
                                                
1 IP refers to the creations of the human mind, the human “intellect.” It is a generic term that
refers to intangible objects and probably came into regular use during the 20th century. This
is because it was customary to refer to industrial and IPRs. The term “industrial” was used
to cover technology-based subject areas like patents, designs and trademarks. “IP” was
used to refer to copyright. The modern convention is to use “IP” to refer to both industrial
and IP. See Peter Drahos. Intellectual Property and Human Rights. 1999. IPQ. No. 3. Sweet
& Maxwell. p. 350
2 IPRs are those rights derived from human intellectual creativity. These rights protect the
interests of the inventors by giving them property rights over their creativity/inventions. IP
law is today divided into two branches: Industrial Property Law and Copyrights Law. There
are different forms of industrial property rights e.g. plant breeder’s rights, patents, petty
patents/utility models, geographical indications, trademarks, undisclosed information/trade
secrets, industrial designs. Each industrial property right has different requirements and
grants different rights.
3 Chapman Audrey.  Approaching Intellectual Property as a Human Right: Obligations
Related to Article 15(1)(C) of the International Covenant on Economic, Social and
Cultural Rights. Committee of Economic, Social and Cultural Rights. 24th Session. Nov-Dec
2000. E/C.12/2000/12. p. 4
4 Peter Drahos, op cit., p. 350
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manufacture.”5 Modern copyright law began in England with the 1709 Statute of
Anne.6
In 1791, France recognized the rights of inventors because in the context of the
1791 law it provided a right of representation to authors, it was argued that “the
property of the work which is born of the writer’s thought is the most sacred, the
most legitimate, the most unassailable and the most personal of all properties.”7
The US Constitution of 1787 justifies the legislative authority granted to the
Congress in IP matters on grounds of public interest by stating that “The
Congress shall have power…to promote the progress of science and useful arts,
by securing for limited times to authors and inventors the exclusive right to their
respective writings and discoveries.”8 In 1790 the US enacted a patent law.9
It is notable that during the first half of the 19th century when some states in
Europe were adopting patent laws, there arose an anti-patent movement in other
quarters. Britain, Germany, the Netherlands and Switzerland saw the patent
system experience its greatest challenge.10 In Switzerland, its legislature rejected
proposals in 1849, 1851, and 1854 and twice in 1863 to adopt patent laws on
the ground that the “economists of greatest competence” had declared the
principle of patent protection to be “pernicious and indefensible.”11 Anti-patent
movement saw patents as unfair and giving rise to anti-competitive behaviour in
the marketplace.
Nevertheless, the anti-patent movement did not stifle the march by patent
advocates. The second part of the 19th century therefore saw the proliferation in
Europe of national IP systems. IP was developed on a national basis, with
considerable diversity in the nature of protection. Outside Europe, IP grew along
colonial paths, for instance the British colonies in Africa, Asia and the self-
governing colonies of Australia and Canada, enacted copyright and patent laws,
which were identical to those in England.12
This period is dominated by the principle of territoriality, the principle that IPRs
do not extend beyond the territory of the sovereign, which has granted the rights
                                                
5 ibid
6 Audrey Chapman, op cit., p. 4. This statute was to encourage its citizens to bring in foreign
technology for the benefit of the national economy.
7 See paper by the Secretariat of the WTO. Protection of Intellectual Property under the
TRIPS Agreement. Committee on Economic, Social and Cultural Rights. 24th session.
November 2000. United Nations. Geneva. p. 1
8 ibid
9 ibid
10 Frederick Abbot, Thomas Cottier and Francis Gurry. International Intellectual Property
Systems: Commentary and Materials. Part One. 1999. Kluwer Law International. Hague. p.7
11 ibid. Then Geigy Chemical Company of Basel Switzerland likened patent monopoly to
robbery; today the same company (Ciba-Geigy) is a major crusader for patents for the
corporate sector. How times change!
12 Peter Drahos, op cit., p. 352
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in the first place.13 This meant that an IP law passed by country A did not apply in
country B. This principle showed the interrelationship between state sovereignty,
property rights and territory. As a result IPRs owners faced a problem, due to the
free copying of their creations in other countries. This inevitably led to the
expansion of IP protection to the international sphere.
1.1.1 The international period
During the 19th century, states began to take a greater interest in the possibility of
international co-operation in IP. The development of national IP systems and
international trade raised awareness of the need for international protection.
The UK in response to the free riding problem passed the 1838 and 1844 Acts
that protected works first published outside the UK.14 These Acts introduced the
principle of reciprocity, which meant that foreign works would only gain
protection in the UK if the relevant state agreed to protect UK works. The 1844
Act saw a considerable number of bilateral agreements concluded between the
UK and other European states.15
However, there were some states that remained isolationist, notably the USA.
The 1790 US Copyright Act only granted copyright protection to citizens and
residents of the USA. This form of national protectionism prevailed for a long
time.
Nevertheless, like copyright, other branches of industrial property law also
became the subject of bilateral agreements and by 1883 there were 69
international agreements mostly dealing with trademarks.16 They introduced the
principle of national treatment, which principle was based on the reciprocity
principle developed in the UK. States realized that if they did not discriminate
between nationals and foreigners in the regulation of IPRs, neither would other
states. Thus in this way states could secure protection for the works of their
authors in foreign jurisdictions.
The adoption of various bilateral agreements in IP in the 19th century was
important in that it contributed to the recognition that an international framework
was needed. These agreements also provided a framework of principles that the
international regime could work with, although the level of protection was not
satisfactory.
Following an international exhibition of inventions held in Vienna, Austria in 1873,
developments towards international protection of inventions stepped up. This led,
                                                
13 ibid
14 ibid
15 ibid
16 ibid
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in 1883, to the adoption of the Paris Convention for the Protection of Industrial
Property (Paris Convention).
Then, industrial property rights were developed as a way to reward creativity and
promote innovation during the Industrial Revolution and thus were limited to
industrial/mechanical inventions. These rights stimulated human intellectual
creativity for the benefit of the public and promoted trade in goods and services.
Later, in 1886, the Berne Convention for the Protection of Literary and Artistic
Works (Berne Convention) was also adopted. These conventions ushered in an
era of international cooperation in international IP property regimes.
These conventions were the first international agreements on IP, mainly drawing
membership from European states. Later, after the Second World War and the
emergence of states from the colonial period, their membership increased, largely
drawn from the developing countries. Over the years, the conventions have also
gone through a series of amendments to keep up with technological
advancements.
As more international IP agreements were adopted, in 1967, an international
agreement established WIPO to administer them.17 Member states agreed on
basic principles, the most important being, the principle of national treatment18 but
states still retained a lot of discretion on the standards of IP within their
jurisdiction. There was thus no harmonisation of IP standards across states.
1.1.2 The global period
With the increasing interdependence of national economies, a need for an
effective international legal system to regulate IP matters was identified,
particularly one that ensured a harmonisation of IP standards among states.
Up to this time, despite the existence of international IP agreements administered
by WIPO, there was still a lot of free riding or copying of works and inventions
that was tolerated. The only enforcement mechanism under the various
international IP treaties was an appeal to the ICJ and most states entered
reservations on such clauses.19
                                                
17 International secretariats were established for both the Paris and Berne Conventions.
These then merged to form a “United International Bureau for the Protection of Intellectual
Property”. WIPO superseded this institution and is now responsible for the promotion of IP
worldwide. It administers several IP treaties and also acts as a secretariat for the negotiation
of treaties that establish new norms in IP. It also conducts extensive training and technical
assistance programs for developing countries.
18 This principle effectively means that the IP protection offered by a state to its nationals is
equally offered to a foreigner within that state’s jurisdiction.
19 Peter Drahos, op cit., p. 355
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For the USA however, the lack of effective enforcement machinery for IPRs
under WIPO was detrimental to key industries of the national economy, such as
film and pharmaceuticals.20 For US pharmaceutical companies for instance, IP
was an investment issue. They wanted to locate their production anywhere in the
world safe in the knowledge that their IP would be protected. With intensive
lobbying these industries succeeded in linking IP to trade. The immediate
advantages of such an approach were firstly, if IP standards were made part of an
international trade agreement, it would give those standards a truly global
coverage. Secondly, IP would now fall under the enforcement mechanism that
states had developed for settling trade disputes.
Beginning in 1984, the US amended its 1974 Trade Act several times providing
for a bilateral enforcement mechanism against countries that did not have
adequate and effective levels of IP enforcement.21 It included IP in the “section
301” trade process, such that if countries failed to act on IP they would face trade
sanctions from the USA.22
In addition, under the initiative of the USA (particularly its business community),
IP was included as a negotiating issue at the Ministerial Meeting at Punta del Este
during the launch of the Uruguay Round of Multilateral Trade Negotiations held
under GATT.23
In April 15, 1994 the Uruguay Round concluded with the signing in Marrakesh,
Morocco of the Final Act Embodying the Results of the Multilateral Trade
Negotiations. This Final Act contains the Agreement Establishing the WTO and
several annexed agreements. TRIPs is found in Annex 1C of the WTO
Agreement.24 TRIPs came into force on 1 January 1995, although it gives its
members transitional periods to bring themselves into compliance with its rules,
which differ according to their stage of development.25
After TRIPs was adopted, other international IP treaties have since been
concluded under the aegis of WIPO. In 1996, the WIPO Performances and
Phonograms Treaty and the WIPO Copyright Treaty were concluded to deal
with the new technological developments in the digital area.
                                                
20 ibid
21 ibid
22 ibid
23 ibid
24 TRIPs is the most comprehensive multilateral agreement that sets out detailed minimum
standards for the protection and enforcement of IP. It is known either as a Paris-plus or
Berne-plus agreement because its standards incorporate those of the Paris and Berne
Conventions in their most recent form and also includes standards on certain matters where
the pre-existing conventions are silent or are seen as being adequate. However, Article 6bis
of the Berne Convention on author’s moral rights was not incorporated into TRIPs.
25 Developed countries had until 1January 1996 to comply with TRIPs, developing countries
had until 1 January 2000 while least developed countries have until 1 January 2006.
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Current international IP law is modelled on western IP tradition rooted in the idea
that IPRs are positive rights created by the state for the benefit of its citizens.26
Although WIPO identifies that IP legal regimes firstly, give statutory expression to
the moral and economic rights of creators in their creations and define the rights of
the public to access to such creations and secondly, that they provide incentives
and rewards to inventors and creators and thereby stimulate economic and social
development;27states have used IP laws as a means to improve their country’s
competitive economic advantage.28 This has become increasingly dominant in this
globalisation era. As this thesis will show, TRIPs favours major economic
interests, particularly the large MNCs, to the detriment of protecting public access
and benefits in the home country and promoting development in developing
countries, 29Africa included.
The economic importance of IP has grown with the increasing role of information
and knowledge-based industries. A causal link has been created between IP and
investment.30 There is a progressive re-conceptualisation of IP as an investor’s
right rather than a creator’s right. A historical analysis on the emergence of IP
reveals that they have always been used by states to secure market place
objectives, both domestic and international. IPRs are still viewed as an economic
tool facilitating trade and investment. The linkage between IP and trade is made
even clearer by the adoption of TRIPs.
1.2 History of Human Rights
Some basic ideas critical to the development of what we define as human rights
today can be traced to various world religions and philosophies. In the holy
books of Christianity, Islam, Judaism, Hinduism, Buddhism, Confucianism, there
is a call for the more humane treatment of fellow human beings. In the Middle
Ages in Europe various social contracts bore the same ideas.31 The concept of
Human Rights was also further developed during the time of the Enlightenment
                                                
26 ibid
27 World Intellectual Property Organization. Intellectual Property Reading Material. WIPO
Publication. No. 476 (E). Geneva. 1995. p. 5
28 Audrey Chapman, op cit., p.5
29 ibid
30 Under the OECD, the Multilateral Agreement on Investment (MAI) Negotiating text
defines investment to include every kind of asset including IPRs. See Peter Drahos, op cit.,
p. 357.
31 For example, the Ceasar Hadrians basic laws for Roman law, the 1215 Magna Carta
Libertatum in England, the 1282 Erik Klippings Håndfaestning in Denmark, the 1356 Joyeuse
Entrée in Brussels, the 1579 Union of Utrecht in the Netherlands, 1689 Bill of Rights in
England. See Gudmundur Alfredsson et al. International Human Rights Monitoring
Mechanisms. 2001. Kluwer Law International. Hague. p. 19
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setting down the basis of rights derived from Natural Law, iura naturalia, and
the recognition of the right of all humans to freedom and dignity.32
From the 16th century onwards, prominent philosophers and jurists later
developed the notion of natural rights, as another source of law i.e. the Law of
Nature. Hugo Grotius (regarded as the father of modern international law),
Samuel von Pufendorf, John Locke, Jean Jacques Rousseau, and Charles de
Montesquieu, all based their work on the notion that above positive law existed
another source of law, the Law of Nature.33 This natural law had roots in human
reason and could be discovered without any knowledge of the positive law.
Rousseau observed that the sovereigns derived their powers from this source and
were thus also to obey and respect it while Montesquieu developed the concept
of separation of powers.
A cornerstone in human rights law is the principle of the equal dignity and worth
of every human being.34 It is a principle primarily derived from religion.35 These
religious, moral or ethical basic notions of human value from natural law were later
transformed into positive law, at the national and international levels.
The 1776 American Declaration of Independence, the 1781 Bill of Rights of the
American Constitution, the 1789 French Declaration des Droits de l’Homme et
du Citoyen (Declaration of the Rights of Man and of the Citizen) and the 1793
Declaration are all based on the notion that all human beings have equal status
and have certain inalienable rights.
Human rights during the 18th and 19th centuries were related to the freedom of the
individual and the need for citizens to be protected from infringements on these
freedoms by state power. The principle of equality pressed for the need of the
government to strive to improve the living conditions for the wider population.
Therefore, many constitutions drafted at this time, contained provisions in the
areas of “social and economic” and not just the “classic” freedoms.36
The general right of property was recognized by the liberal traditions of France
and the USA. The French Revolution (which resulted in the 1789 Declaration) is
                                                
32 ibid
33 ibid, p. 20
34 The Preamble of the UDHR recognizes the “inherent dignity and equal and inalienable
rights of all members of the human family” and “in the dignity and worth of the human
person and in the equal rights of men and women.”
35 This is derived from e.g. Christianity or Judaism where it is recorded in Genesis 1: 26 &27
(NIV) that “Then God said, Let us make man in our own image, in our likeness…So God
created man in his own image, in the image of God he created him; male and female he
created them.” Thus, God created man in his own image. If man is then created in the image
of God he has dignity and worth. Therefore every man (and woman) has equal dignity and
worth.
36 Alfredsson, G. et al. op cit., p. 22. For example, the Norwegian Constitution of 1814, the
Mexican Constitution of 1917, the Constitution of the Soviet Union of 1918.
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said to have explicitly manifested the idea of IPRs as natural rights37 – as opposed
to positive rights (granted by the state), hence providing a human rights approach
to IPRs.38
The 1789 Declaration included “property” among the “natural and imprescriptible
rights of man.”39 The freedom of communication and the press that the 1789
Declaration proclaimed was made concrete once printers no longer had to obtain
the privilege of printing from the King.40 However, it is observed that in actual fact
the French Revolution was much more about the liberation of information than the
creation of property rights in information.41
In the 19th century, as international law began to develop elements of human rights
also began to emerge. Notable were such areas as the protection of the rights of
minorities,42 the prohibition of slave trade43, protection of persons in armed
conflict44 and in labour standards.45
1.2.1 The United Nations
A Conference of International Organisations saw the birth of the United Nations
in June 26th 1945 in San Francisco, USA. The signing of the Charter of the UN
was a significant step in bringing human rights more firmly within the sphere of
international law. The UN Charter establishes the promotion and protection of
human rights as one of the main objectives of the organization.46
The atrocities committed during the Second World War – where the Nazi regime
in Germany founded a power base based on terror and gross violations of the
rights of persons residing within its jurisdiction – spurred the creation of the UN,
an organization that would work to “save succeeding generations from the
                                                
37 In the modern context, the notion of a “natural right” might often be replaced by an appeal
to a sense of equity and fairness. It is seen as fair that, for example, an inventor would draw
some benefit from others using the fruits of his or her creative efforts for economic gain.
38 See paper prepared by the Secretariat of the WTO. Protection of Intellectual Property
under the TRIPS Agreement. Committee on Economic, Social and Cultural Rights. 24th
session. November 2000. United Nations. Geneva. p. 1
39 ibid
40 ibid
41 Peter Drahos, op cit., p. 351
42 e.g. 1648 Treaties of Munster and Osnabruck, 1878 Treaty of Berlin. From 1919, the League
of Nations also wanted to include in its general peace settlement and machinery obligations
in regard to the protection of minorities.
43 e.g. 1926 Slavery Convention
44 e.g. 1899 and 1907 Hague Conventions
45 e.g. 1906 Berne Convention aimed at protecting women from being subjected to night time
work. In 1919, the International Labour Organization (ILO) was founded with a constitutional
document that puts an emphasis on human rights and social justice.
46 See Article 1 and also articles 55 and 56 of the Charter. Human rights are also mentioned in
the preamble, articles 8, 13, 62, 67, 68, 73 and 76 of the Charter.
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scourge of war”, “reaffirm faith in fundamental human rights,” “establish conditions
under which justice…can be maintained,” and “promote social progress and
better standards of life in larger freedom.”47
The atrocities committed during the Second World War also emphasized the
need for international protection of human rights. There was a need for violations
of human rights by persons representing state power (e.g. Hitler in Nazi Germany)
to be seen as a breach of international law, a breach of a duty towards the
international community. Only then would the international community step into
the state’s sphere (or what is now known as the domestic jurisdiction of a state)
and suggest measures to ensure conformity with international law obligations, of
which human rights now formed a part.
In 1948, under the aegis of the UN, the General Assembly adopted the Universal
Declaration of Human Rights (UDHR).48 The UDHR formed the basis for the
development of international human rights treaties containing a wide spectrum of
rights, from the right to life, liberty, food to the right to be protected from various
forms of discrimination, and the right have a say and share in a country’s
economic, social and cultural development.49
The concept of human rights is broad, covering most aspects of human
existence.50 Therefore, for ease of reference several schemes have been used to
classify the rights, either as basic human rights; or four freedoms; or 1st, 2nd, 3rd
generation rights; or individual or collective rights; or civil and political versus
economic, social and cultural rights.
Human rights could also be classified according to the various treaties dealing with
a specific issue, either as subjects in need of protection i.e. minorities, indigenous
                                                
47 Preamble of the UN Charter. The formation of the UN in 1945 was a collaborated effort of
the Allies of the second world war namely USA, UK, France, USSR and China who became
the five permanent members of the Security Council. During the war, the Allies in the
Atlantic Charter of 1.1.42 stated, that “complete victory over their enemies is essential to
defend life, liberty, independence and religious freedom, and to preserve human rights and
justice in their own lands as well as in other lands…” See Åshild Samnoy, The Origins of the
Universal Declaration of Human Rights in G. Alfredsson and A. Eide (eds). The Universal
Declaration of Human Rights. 1999. Kluwer Law International. Hague. p. 3
48 Adopted by the General Assembly of the UN by Resolution 217 (III) of 10th December 1948
49 UDHR together with the 1966 International Covenant on Civil and Political Rights (ICCPR)
and the 1966 International Covenant on Economic, Social and Cultural Rights (ICESCR)
comprise the International Bill of Human Rights. Examples of other international human
rights treaties are the 1948 Convention on the Prohibition and Punishment of the Crime of
Genocide, the 1965 Convention on the Elimination of Racial Discrimination, 1979 Convention
on the Elimination on Discrimination Against Women, 1989 Convention on the Rights of the
Child etc.
50 One of the main sources of inspiration and broad approach to human rights was the “four
freedoms” address in 1941 by US President Franklin Delano Roosevelt, where in his State of
the Union address he stated that everyone is entitled to freedom of speech, freedom of faith,
freedom from want and freedom from fear.
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peoples, refugees, women, children, migrant workers etc, or according to the
elimination of specific forms of discrimination e.g. race, religion etc, or according
to an elaboration on certain rights e.g. genocide, torture, treatment of prisoners,
or on a regional or geographical view point e.g. African, American or European
etc.
Whatever the classification “all human rights are universal, indivisible and
interdependent and interrelated. The international community must treat human
rights globally in a fair and equal manner, on the same footing, and with the same
emphasis.”51
Human rights norms differ from other rights in international law in several key
respects. Human rights originated from a perceived need to protect the individual
against the abuse of power by the state and therefore the primary purpose of
human rights is to govern the relationship between the individual and the state,
whereas other areas of international law govern the relationship between states.
From the preamble of the UDHR, it can be deciphered that human rights form the
foundation of freedom, justice and peace in the world. Human rights promote
social progress and better standards of living. They also foster friendly relations
between states. However, as part of international law, human rights are to be
implemented in a national context; human rights gives rise to duties, the
responsibility of which falls on states. By agreeing to be bound by human rights
norms, states have agreed to govern in a manner consistent with those norms.
States are the ones to be held accountable in case of failure or non-performance
of those duties resulting in human rights violations. Human rights norms therefore
serve as a guide for national legislation and policies.
Other characteristics of human rights are that they are inherent in all human beings
by virtue of their humanity alone; are inalienable within qualified legal boundaries;
are equally applicable to all; and are fundamental to life, dignity and other
important human values.
1.3 The link between Human Rights and
Intellectual Property Rights
The historical link between human rights and IPRs is thin. Nevertheless, the
relevant provisions are article 27 of UDHR52 and article 15 of ICESCR53. An
                                                
51 Paragraph 5 of the Vienna Declaration and Programme of Action adopted at the 1993
World Conference on Human Rights held in Vienna, Austria. A/CONF.157/24
52 It states: “1. Everyone has the right freely to participate in the life of the community, to
enjoy the arts and to share in scientific advancement and its benefits. 2. Everyone has the
right to the protection of the moral and material interests resulting from any scientific,
literary or artistic production of which he is the author.”  (emphasis mine)
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analysis of article 27(2) UDHR and article 15(1)(c) ICESCR reveals an individual
human right in IP, although not explicitly worded as such.54 To this extent
therefore one can say that the drafters recognized IPRs as human rights.55
Also, IPRs affect other human rights either positively or negatively. In particular,
TRIPs has created tensions with human rights. This tension principally revolves
around balancing the IPRs of inventors/creators with that of the public.
1.4 Balance of rights under Human Rights Law
Article 27 UDHR and Article 15 ICESCR reflect a balance of rights and identify
a need to strike a balance between the protection of the rights of authors and
creators and that of the public. Four components are identified: the right to
culture, the right to benefit from scientific advancement, IP and freedom of
scientific and creative activity.56
There is a link between the right of everyone to benefit from the protection of the
moral and material interests resulting from any scientific, literary or artistic
production of which he is the author (private interest) with the right to participate
in cultural life and to enjoy the benefits of scientific progress and its applications
(public interest). The right of the author or creator (private interest) and the rights
of the wider society (public interest) are seen as complimentary.
These provisions recognize that the rights of authors and creators are not just
good in themselves but are understood as essential preconditions for cultural
freedom and participation and scientific progress. As material progress is often
the result of scientific progress, it thus implies that everyone must have access to
                                                                                                                           
53 It builds on and closely resembles article 27 of UDHR. It states: “1. The State Parties to
the present Covenant recognize the right of everyone: (a) To take part in cultural life; (b) To
enjoy the benefits of scientific progress and its applications; (c) To benefit from the
protection of the moral and material interests resulting from any scientific, literary or
artistic production of which he is the author…”(emphasis mine)
54It was felt by the drafters that there was no need to include a specific reference to property
in Article 27 UDHR due to the existence of the right to property in Article 17 UDHR.
However, the right to property was omitted in ICESCR. See Audrey Chapman, op cit., p. 8-9
and Peter Drahos, op cit., p. 358-371
55 Very little attention has been paid to analyse IP as a human right. A notable exception is
indigenous peoples who have called for the recognition of their knowledge as a human right
(See Article 29 UN Draft Declaration on the Rights of Indigenous Peoples,
E/CN.4/Sub.2/1993/29). More effort has been made to adopt a human rights approach to IP
than to recognize IP as a human right. Whether, IPRs are viewed as human rights today is
also problematic because of the fact that firstly, they are granted by the state rather than
recognized by the state. Secondly, IPRs exist for a limited period of time and are territorial as
opposed to human rights that are perpetual, inalienable and universal. Thirdly, IPRs have
differing characteristics and hence not all fit into the category of protecting the human
dignity and worth of its creators. See Audrey Chapman, op cit., p. 9 and Peter Drahos, op
cit., p. 365-367
56 Ragnar Adalsteinsson and Pall Thorhallson in G. Alfredsson and A. Eide (eds.). The
Universal Declaration of Human Rights. 1999. Kluwer Law International. Hague. p. 591-595
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these scientific results and must not be restricted to a few. In order to avoid
conflicts between the human rights guaranteed by these provisions e.g. IPRs and
cultural rights, there is a need to strike the right balance in their promotion and
protection.57
1.5 Balance of rights under Intellectual Property
Law
The balance between private and public interests identified by Articles 27 UDHR
and 15 ICESCR is familiar to IP law.
Under IP law, states grant limited rights over creations or inventions as a means of
providing incentive for innovation eventually ensuring that the public has access to
those creations or inventions. Thus, for example, under patent law, a state grants
an inventor a patent for a limited period of time in return for the inventor’s
disclosure of the invention in his patent application.
During the period of protection, the inventor (now patent holder) has classic
property rights e.g. he can exclude others from making, using or selling his
patented product. He can also use this time to recoup research and investment
costs incurred in the development of his invention and/or otherwise commercially
exploit his invention. After the time of protection expires, the invention falls into
the public domain and is now freely accessible by all.
Therefore, in the long term there is no conflict but a mutually supportive
relationship between the interests of promoting creativity and innovation (private
interest) and maximising access of the new invention to the wider society (public
interest). However, during the period of protection, there is potential for conflict
between the rights of the patent holder and the public because patents are
exclusive rights. The public would not have access to the protected works or
inventions, except with the authorization of the patent holder.
The challenge therefore is for national and international IP laws to strike the right
balance between the human rights of authors, creators and inventors (private
                                                
57 ibid, p. 593. When judging a states’ fulfilment of these rights, it is relevant to consider the
following (a) measures taken to ensure the application of scientific progress for the benefit
of everyone; (b) measures taken to promote the diffusion of information on scientific
progress; and (c) measures taken to prevent the use of scientific and technical progress for
purposes which are contrary to the enjoyment of all human rights. It is observed that the
1993 World Conference on Human Rights held in Vienna, Austria reaffirmed the right of
everyone to enjoy the benefits of scientific progress and its applications but noted that
certain advances, notably in the biomedical and life sciences as well as information
technology, may have potentially adverse consequences on human rights and called for
international cooperation to ensure that human rights are fully respected in light of these
scientific advances. See the Vienna Declaration and Programme of Action adopted on
25.06.93 at A/Conf.157/23.
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interest) and the promotion of access to protected works or inventions for the
public good (public interest). An emphasis of either one of the interests would tilt
the optimal balance that is to be achieved. In the TRIPs regime, the required
balance between the private and public interests is proving difficult to attain.
It is my view that IPRs are instrumental rights in the sense that their grant and
exercise should promote and protect all human rights. Human rights should guide
the development of IPRs and thus IPRs would be of service to all humanity.
Determining whether the standards set in TRIPs promote and protect human
rights is the focus of the next chapter.
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2    TRIPs AND HUMAN RIGHTS
2.1 Introduction
There are potential links between TRIPs and human rights.
The overall objectives of WTO as reflected in the preamble of the WTO
Agreement (of which TRIPs is part) are that member countries’ trade and
economic relations “should be conducted with a view to raising standards of
living, ensuring full employment…while allowing for the optimal use of the world’s
resources in accordance with the objective of sustainable development, seeking
both to protect and preserve the environment and to enhance the means for doing
so in a manner consistent with their respective needs and concerns at different
levels of economic development.”58
It also recognizes the “need for positive efforts designed to ensure that developing
countries, and especially the least developed among them, secure a share in the
growth in international trade commensurate with the needs of their economic
development.”59
Article 7 of TRIPs spells out the objectives of the agreement by stating that “the
protection and enforcement of IPRs should contribute to the promotion of
technological innovation and to the transfer and dissemination of technology, to
the mutual advantage of producers and users of technological knowledge and in a
manner conducive to social and economic welfare, and to a balance of rights and
obligations.”
These objectives thus recognize a need for a balance between “mutual advantage
of producers and users of technological knowledge” and “a balance of rights and
obligations.” This also corresponds to the attempted balance of rights and
tensions inherent between articles 15(1)(a) and 15(1)(b) of ICESCR, which
recognize “the right of everyone to take part in cultural life” and “to enjoy the
benefits of scientific progress and its applications” and article 15(1)© of ICESCR
“the right of everyone to the protection of the moral and material interests resulting
from any scientific, literary or artistic production of which he is the author.”
The above stated objectives lay an emphasis in promoting social and economic
welfare. TRIPs can also be seen to give effect to IPRs, as a human right, at the
international level as indicated in its preamble that IPRs are private rights.
                                                
58 See document of the Secretariat of the WTO to the Committee on Economic, Social and
Cultural Rights. Day of General Discussion, op cit., p. 2
59 ibid
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TRIPs also seems to promote values deemed essential for the realization of
human rights such as the prohibition of discrimination on the basis of nationality in
IPRs which values are resonant in international human rights law.60
TRIPs could also be seen to promote the rule of law at the national and
international levels by the observance of due process and the peaceful settlement
of disputes through its dispute resolution mechanism.61
TRIPs also encourages international cooperation by requiring member-developed
countries to facilitate technology transfer to member least developed countries
and to provide, on request, technical and financial cooperation to both member
developing and least developing countries.62 International cooperation is also
encouraged in international human rights law especially as pertaining to the
implementation of economic, social and cultural rights.63
2.2 Seeking the right balance
An objective of IP protection is to promote long-term public interest by means of
providing exclusive rights to right holders for a limited period of time. After the
expiration of the term of protection, protected works and inventions fall into the
public domain and anyone is free to use them without the prior authorization of the
right holder. In the long term therefore, there is no conflict but rather a mutually
supportive relation between the interests of rights holders and those of the public
by promoting creativity and innovation and maximising access.
However, during the term of protection there is potential for conflict between
those two interests, which can also mirror the marked differences between the
interests of right holders and users. The challenge is therefore to find the optimal
balance between the competing interests with a view to maximizing the public
good while meeting the human rights of authors and inventors.
TRIPs has attempted to achieve this balance in a number of ways: by determining
the definition of protectable subject matter, the scope of rights, permissible
limitations and the term of protection.64 As TRIPs is a minimum rights agreement it
leaves a fair amount of leeway to member states to implement its provisions within
                                                
60 See Article 3-5 of TRIPs on “National Treatment” and “Most-Favoured-Nation Treatment”
clauses.
61 See Part III of TRIPs
62 See Article 66(2), 67, 69 of TRIPs.
63 See Article 2 of ICESCR
64 See Report of the Secretary General. Intellectual Property Rights and Human Rights.
Economic and Social Council. UN Doc. E/CN.4/Sub.2/2001/12. p. 7-9 and also Report of the
Secretariat of WTO, op cit., p. 4-7
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their own legal system and practise and fine-tune the balance in light of domestic
public policy considerations.65
Finding a link between the standards of TRIPs and human rights is not the same
as saying that TRIPs takes a human rights approach to IP protection; the primary
question is whether TRIPs strikes a balance that is consistent with a human rights
approach.66
There are actual or potential conflicts inherent in the implementation of TRIPs that
have been identified.
On 17 August, 2000, the UN Sub-Commission for the Protection and Promotion
of Human Rights, adopted a resolution unanimously on “Intellectual Property
Rights and Human Rights” noting, inter alia, that:
“There are actual or potential conflicts that exist between the
implementation of TRIPS and the realization of economic, social and
cultural rights in relation to, inter alia, impediments to the transfer of
technology to developing countries, the consequences for the enjoyment of the
right to food of plant variety rights and the patenting of genetically modified
organisms, “biopiracy” and the reduction of communities’ (especially indigenous
communities’) control over their own genetic and natural resources and cultural
values, and restrictions on access to patented pharmaceuticals and the
implications for the enjoyment of the right to health.”67(emphasis mine)
The resolution “affirms that the right to protection of the moral and material
interests resulting from any scientific, literary or artistic production of which one is
author is, in accordance with article 27(2) of UDHR and article 15(1)© of
ICESCR, a human right, subject to limitations in the public
interest.”68(emphasis mine)
It further “declares, however, that since the implementation of the TRIPS
Agreement does not adequately reflect the fundamental nature and
indivisibility of all human rights, including the right of everyone to enjoy the
benefits of scientific progress and its applications, the right to health, the right to
food and the right to self-determination, there are apparent conflicts between
the intellectual property rights regime embodied in the TRIPS
Agreement, on the one hand, and international human rights law, on the
other.”69 (emphasis mine)
                                                
65 See Article 1(1) and Article 8 of TRIPs
66 See Report of the High Commissioner for Human Rights, op cit., p. 7-11
67Economic and Social Council. Intellectual Property Rights and Human Rights. Sub-
Commission on Human Rights Resolution 2000/7. E/CN.4/SUB.2/RES/2000/7
68 ibid, paragraph 1
69 ibid, paragraph 2
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There exists a conflict between the “private” interests of IPRs holders,
championed by TRIPs, and the “social” or “public” concerns found in
international human rights law. TRIPs is seen to tilt the balance inherent in IP law
away from the public interest and in favour of IPRs holders.
The resolution further “reminds all governments of the primacy of human rights
obligations over economic policies and agreements; and requests them to take
international human rights obligations and principles fully into account in national,
regional and international economic policy formulation and also further requests
governments and intergovernmental organizations to integrate in their national laws
and policies provisions that are in accordance with international human rights
obligations and principles that protect the social function of intellectual
property.”70
The resolution is said to mark the beginning of what promises to be a closer
monitoring of WTO by the UN human rights system.71 It is historic, in that it has
reaffirmed the primacy of human rights over other state obligations that states may
have.
It is against this backdrop that this thesis will look at the implications of TRIPs on
the right to food in Africa.
2.3 The Right to Food in International law72
Article 25 of UDHR73 and article 11 of ICESCR74 are the more authoritative
international human rights provisions on the right to food.75 The right to food is a
                                                
70 ibid, paragraph 4, 5, 6
71 See Someshwar Singh. TRIPS regime at odds with human rights law, says UN body at
http://www.twnside.org.sg/title/odds.htm
72 Historically (and purely on ideological reasons) human rights have been split into, civil
and political rights on the one hand and economic, social and cultural rights on the other.
These rights have also been treated differently, with civil and political rights being
emphasised more than the others. In this dichotomy, the right to food is a core social right.
Nevertheless, whatever the classification “all human rights are universal, indivisible and
interdependent and interrelated. The international community must treat human rights
globally in a fair and equal manner, on the same footing, and with the same emphasis.”
See Paragraph 5 of the Vienna Declaration and Programme of Action adopted at the 1993
World Conference on Human Rights. A/CONF.157/24.
73 It states in part “Everyone has the right to a standard of living adequate for the health and
well-being of himself and his family, including food, clothing, housing and medical care and
necessary social services…”
74 It states in part “The State Parties…recognize the right of everyone to an adequate
standard of living for himself and his family, including adequate food…The State Parties will
take appropriate steps to ensure the realization of this right, recognizing to this effect the
essential importance of international cooperation based on free consent…”
75 The right to food is also found in: Article 12 of Convention on the Elimination of
Discrimination Against Women, Article 24 of Convention on the Rights of the Child, Article
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basic human right as well as a basic human need. It is a component of the right to
an adequate standard of living. It is also closely linked to the right to life.76 The
right to adequate food77 is “realized when every man, woman and child, alone
or in community with others, have physical and economic access at all times to
adequate food or means for its procurement. States have a core obligation to take
the necessary action to mitigate and alleviate hunger.”78
It is noted that the concept of “adequacy” is particularly significant because the
notion of sustainability is intrinsically linked to the notion of adequate food or food
security, implying food being accessible for both present and future generations;
however the precise meaning of “adequacy” is to a large extent determined by
prevailing social, economic, cultural, climatic, ecological and other conditions
while “sustainability” incorporates the notion of long-term availability and
accessibility.”79
The right to adequate food is “indivisibly linked to the inherent dignity of the
human person and is indispensable for the fulfilment of other human rights
enshrined in the International Bill of Human Rights… it is inseparable from social
justice, requiring the adoption of appropriate economic, environmental and social
policies, at both the national and international levels, oriented to the eradication of
poverty and the fulfilment of all human rights for all.”80
The core content of the right to adequate food “implies the availability of food in a
quantity and quality sufficient to satisfy the dietary needs of individuals, free from
adverse substances, and acceptable within a given culture; (and also) the
accessibility of such food in such ways that are sustainable and that do not
interfere with the enjoyment of other human rights.”81
                                                                                                                           
2 of Convention on the Prohibition and Punishment of the Crime of Genocide; Article 21 of
African Charter on Human and Peoples Rights, Article 12 of San Salvador Protocol to
American Convention on Human Rights including in the 1948 Geneva Conventions I, III, IV
and the 1977 Additional Protocols and the Statute of the International Criminal Court Part 2,
Art. 6-8.
76 The Human Rights Committee, a treaty body established under the ICCPR, in its General
Comment No. 6 (1982) on the Right to Life has stated that “the expression “inherent right to
life” cannot properly be understood in a restrictive manner, and the protection of this right
requires that States adopt positive measures…to reduce infant mortality, increase life
expectancy, especially in adopting measures to eliminate malnutrition and epidemics.”
77 General Comment No. 12 (1999). Right to adequate food. Report of the Committee on
Economic, Social and Cultural Rights. UN Doc. E/2000/22. Paragraph 6, p. 102-110.
78Freedom from hunger is fundamental. States have an obligation to ensure as a minimum
that people do not starve.
79 General Comment No. 12, op cit., paragraph 6
80 ibid, paragraph 4
81 The term “dietary needs” refers to those needs which are necessary for physical and
mental growth and physical activity; “free from adverse substances” requires certain
measures such as food safety, hygiene and environmental protection, “cultural or consumer
acceptability” requires the need to take into account values attached to food and food
consumption e.g. religious beliefs etc; “availability” implies either a possibility to feed
oneself from productive land or the existence of a well-functioning food distribution system.
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2.3.1 Food Security
All the 189 members states of the UN attending the World Millennium Summit
held at the UN headquarters in New York, USA in September 2000 adopted the
UN Millennium Declaration.82 One of the UN Millennium goals is the eradication
of extreme poverty and hunger, a goal that is to be achieved by reducing by half
the number of people who live on less than a dollar a day and those that suffer
hunger by 2015.83
More specifically, the World Food Summit held in Rome, Italy in 1996 laid the
foundations for diverse paths to achieve food security, at the individual,
household, national, regional and international levels.84 This summit reaffirmed “the
right of everyone to have access to safe and nutritious food, consistent with the
right to adequate food and the fundamental right of everyone to be free from
hunger.”85
Food security exists when “all people, at all times, have physical and economic
access to sufficient, safe and nutritious food to meet their dietary needs and food
preferences for an active and healthy life.”86
The summit noted that while food supplies have increased substantially,
constraints on access to food and continuing inadequacy of household and
national incomes to purchase food, instability of supply and demand, as well as
natural and man-made disasters, have prevented basic food needs from being
fulfilled.
                                                                                                                           
“Accessibility” consists of both economic and physical accessibility with vulnerable
groups such as indigenous peoples (who may not have access to their ancestral lands)
needing special attention or programmes. See General Comment No. 12, paragraph 8.
82 See the text at http://www.un.org/millennium/declaration/ares552e.htm.
83 See the text at http://www.un.org/millenniumgoals/index.html
84 The representatives of 185 nations and the EC pledged their political will and commitment
to achieve food security for all and eradicate hunger in all countries, with an immediate view
to reduce the number of undernourished people by half no later than 2015. The summit
adopted the “Rome Declaration on World Food Security” which comprises a set of
observations about food security and also an Action Plan i.e. “World Food Summit Plan of
Action”. The Action Plan is a set of 7commitments made by countries attending the Summit
to ensure food security. The Rome Declaration is not a legally binding document. See
http://www.fao.org/worldfoodsummit and text at
http://www.fao.org/docrep/003/w3613e/w3613e00.htm
85 Rome Declaration on World Food Security, FAO 1996.
86 Paragraph 1 World Food Summit Plan of Action. It should be noted that “food security”
and the “right to food” are conceptually different. The right to food is an individual human
right while food security is the condition through which this right can be realized. Food
security is not, in itself, the right to food, but rather a state, which if attained, permits the
individual to enjoy that right. See Asbjorn Eide and Wenche Barth Eide in G. Alfredsson
and A. Eide (eds). The Universal Declaration of Human Rights. 1999. Kluwer Law
International. Hague. p. 540-541
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The summit also noted that the problems of hunger and food insecurity have
global dimensions and are likely to persist, and even increase dramatically in some
regions, unless urgent, determined and concerted action is taken, given the
anticipated increase in the world’s population and the stress on natural resources.
According to FAO’s latest estimates, “there were 840 million undernourished
people in the world in 1998-2000; 799 million in developing countries, 30 million
in countries in transition and 11 million in developed market economies. More
than half of the undernourished (508 million people; 60 percent of the total) live in
Asia and the Pacific, while Sub-Saharan Africa accounts for almost a quarter
(196 million people; 23 percent of the total). Sub-Saharan Africa has the highest
prevalence of undernourishment, at 33 percent of the population.”87
In June 2002, FAO organized a follow up to the 1996 summit dubbed ”World
Food Summit: Five Years Later.”88 This summit acknowledged that the problem
of food insecurity had increased particularly in developing countries. It
unanimously adopted a declaration reaffirming the call to the international
community to reduce the number of undernourished people by half by 2015, a
goal made in the 1996 summit.89
The 2002 summit reaffirmed the right of everyone to have access to safe and
nutritious food and reaffirmed the commitments made in the 1996 Rome
Declaration and Plan of Action. It was also acknowledged that success would
require political will, resources, technology and fairer trade practices. An urgent
need to reinforce efforts of all concerned parties was recognized whereby a call
for an international alliance to accelerate action to reduce world hunger was made
so as to meet the 1996 food security objectives.
Notably, the 2002 summit noted the importance of the International Treaty on
Plant Genetic Resources for Food and Agriculture in achieving food security.
Hunger is a cause and an effect of extreme poverty. Accelerated progress in
poverty eradication is critical to improve access to food. At the 1996 and 2002
summits, states made a commitment to implement policies aimed at eradicating
poverty and inequality and improving physical and economic access by all, at all
times, to sufficient, nutritionally adequate and safe food.
Trade, inter alia, was seen as a key element in achieving food security. States
made a commitment to strive to ensure that food, agricultural trade and overall
                                                
87 FAO’s “The State of Food and Agriculture, 2002”. See text at
http://www.fao.org/DOCREP/MEETING/005/Y7462e/Y7462e00.HTM.
88 179 countries and the EU attended the summit. See
http://www.fao.org/worldfoodsummit/english/index.html.
89 See text of Declaration at
http://www.fao.org/DOCREP/MEETING/005/Y7106E/Y7106E09/Y7106E09.htm#TopOfPage
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trade policies are conducive to fostering food security for all through a fair and
market-oriented world trade system. In this light, the 2002 Summit noted the
outcomes of the 4th Ministerial Conference of the WTO held in November 2001
in Doha, Qatar.
It was also noted, inter alia, that food should not be used as a tool for political
and economic pressure. The importance of international cooperation and
solidarity as well as the necessity to refrain from unilateral measures not in
accordance with international law and the Charter of the UN that endangers food
security, was also recognized.
The fundamental role of farmers, fishers, foresters, indigenous peoples and their
communities, and all other people involved in the food sector, and of their
organisations was acknowledged in attaining food security, supported by effective
research and extension.
It was observed that 70% of the world’s poor people live in rural areas and
depend almost entirely on agriculture and rural development. Measures were
called to increase agricultural productivity, food production and distribution,
within the framework of sustainable management of natural resources, with the
need to revitalize rural agricultural productivity.
FAO together with CGIAR and other international research institutes were called
upon to advance agricultural research and research in new technologies, including
biotechnology; such research to be conducted in a safe manner and adapted to
local conditions so as to help improve agricultural productivity. A commitment
was made to study, share and facilitate the responsible use of biotechnology so as
to address development needs.
The 2002 summit also recognized that developing countries were facing
challenges in making better use of benefits in research and technology and also in
responding to the challenges and opportunities of globalisation in the field of
agriculture and food security. In a spirit of cooperation and solidarity, a pledge
was made to strengthen FAO’s work, within its mandate, to enable developing
countries cope with the challenges and reap the benefits of globalisation and also
have access to the necessary scientific and technical knowledge related to the
new technologies that address poverty and hunger reduction.
2.3.2 State Obligations
Under international law, human rights obligations are primarily held by states.
Article 2 of ICESCR is the key provision, according to which a state shall take
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steps “to the maximum of its available resources, with a view to achieving
progressively” the full realization of the right to food. 90
States are thus obliged, regardless of the level of economic development, to
ensure for everyone under its jurisdiction access to the minimum essential food
which is sufficient, nutritionally adequate and safe, to ensure their freedom from
hunger.91 The concept of progressive realization constitutes a recognition that full
realization of the right to food will generally not be able to be achieved in a short
period of time but it imposes an obligation to move as expeditiously as possible
towards the realization of this right.
However, it should be noted that state obligations are intended to supplement
personal efforts whenever needed.92 The individual is expected whenever possible
through his or her own efforts and by use of his own resources, to find ways to
ensure the satisfaction of his or her own needs, individually or in association with
others.93
The right to adequate food, like any other human right, imposes three types of
state obligations: the obligation to respect, to protect, and to fulfil. In turn, the
obligation to fulfil incorporates both an obligation to facilitate and an obligation
to provide94.
2.3.2.1 Obligation to respect
At the primary level, the state must respect existing access to adequate food and
must not take measures that result in preventing such access.95 The state must
respect the individual’s freedom and space to be able by their own means to
produce their own food or to use their own resources to obtain food on the
market.
In this regard, collective or group rights are particularly important. The resources
belonging to indigenous peoples such as claims to lands must be respected if such
                                                
90 See General Comment No. 3 (1990). Nature of State Obligations under Article 2(1). Report
of the Committee on Economic, Social and Cultural Rights. UN Doc. E/1991/23. p. 83-87.
Also, state obligations for economic, social and cultural rights have been elaborated by a
group of experts, convened by the International Commission of Jurists, in Limburg,
Netherlands in June 1986. The outcome of the meeting, the so-called Limburg Principles
offer a guide on state obligations under ICESCR. See The Limburg Principles on the
Implementation of the ICESCR at UN Doc E/CN.4/1987/17
91 See General Comment No. 12, op cit., paragraph 14
92 See Asbjorn Eide. The Right to an Adequate Standard of Living Including the Right to
Food. A. Eide et al. (eds.). Economic, Social and Cultural Rights. 2nd ed. 2001. Kluwer Law
International. Hague. p. 138-140
93 Furthermore, the realization of individual economic, social and cultural rights will usually
take place within the context of a household as the smallest economic unit.
94 See General Comment No. 12, op cit., p. 23-25
95 ibid, paragraph 15
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peoples are to meet their basic needs.96 Similarly, respect of the rights of peoples
to exercise permanent sovereignty over their natural resources may be essential
for them to be able, through their own collective efforts, to satisfy their needs.
Hence, the state should take steps to recognize and register the land rights of
indigenous peoples and land tenure of small-scale farmers whose title is uncertain.
2.3.2.2 Obligation to protect
At the secondary level, measures are required by the state to ensure that
corporations or individuals do not deprive individuals of their access to adequate
food.97 The state should protect its citizens, against third parties, by the
preservation of existing rights or resources.
As a protector, the state should prevent the encroachment on the land of
indigenous peoples or other vulnerable groups by more aggressive third parties
such as more powerful economic interests like MNCs.98 The state should also
protect its citizens against fraud, against unethical behaviour in trade and
contractual relations and, against the marketing and dumping of hazardous or
dangerous products that threatens the individual’s right to food.
The state should also protect rural farmers from the corporate patenting of genetic
material of seeds and the subsequent attempts to prevent farmers to sell or reuse
seeds with the same genetic structure (seeds that may have been developed as
hybrids and used for long periods of time by these very communities) if they have
not been purchased from, or royalties paid to, the corporate holder of the patent.
It has been said that perhaps, the protective function of the state is the most
important aspect of state obligations.99 There is a need for the state to establish a
buffer, which makes it possible for those on the borderline of poverty to
overcome a crisis and be able to ensure an adequate standard of living through
their own means. The obligation to protect would also require the state to ensure
that food on the market is safe and healthy and also to ensure food availability and
regulation of food prices and subsidies.
                                                
96 The lack of recognition of the collective land rights of indigenous peoples has been a
major cause of their impoverization in many parts of the world. It is becoming increasingly
recognized both at the national and international level that their land rights must be
respected and protected.
97 General Comment No. 12, paragraph 15
98 The state in carrying out this obligation could also by law require the protection of land
for groups of people who have a close connexion to the land e.g. indigenous peoples or
require by law that land can be owned only by the tiller of the land especially when
agriculture is the major basis of income. This may be even more important in the realization
of the right to food for these people. Asbjorn Eide, op cit., p. 143
99 See Asbjorn Eide, Economic, Social and Cultural Rights as Human Rights in, A. Eide et al.
(eds). Economic, Social and Cultural Rights.  2nd ed. 2001. Kluwer Law International.
Hague. p. 24
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2.3.2.3 Obligation to fulfil
At the tertiary level, the state has the obligation to fulfil the right to adequate food.
This could be by facilitating the same or by direct provision.
Facilitation would mean that the state must pro-actively engage in activities
intended to strengthen people’s access to and use of resources and means to
ensure their livelihood, including food security. It could require the state to take
measures to improve methods of production, conservation and distribution of
food by making full use of technical and scientific knowledge, by disseminating
knowledge of the principles of nutrition and by developing or reforming agrarian
systems in such a way as to achieve the most efficient development and utilization
of natural resources.100
Whenever an individual or group is unable, for reasons beyond their control, to
enjoy the right to adequate food by the means at their disposal, the state has an
obligation to fulfil that right directly. This could consist of the direct provision of
food or resources, which can be used for food e.g. direct food aid or social
security when no other possibility exists.
However, in practice, the ability of developing countries to directly provide food
aid or other resources for food to their citizens is severely curtailed or is made
increasingly difficult or impossible due to a variety of factors such as the lack of
domestic financial resources due to the servicing of international debts, economic
policies imposed by international financial institutions i.e. the IMF and World
Bank e.g. structural adjustment programmes etc.
2.3.3 What constitutes a violation of the right to food?
Violations of the minimum core obligation of the right to food occur when a state
fails to ensure the satisfaction, at the very least, the minimum essential level
required to be free from hunger.101 This is irrespective of the availability of
resources in the country concerned or other factors.
In order to determine which state acts or omissions amount to a violation of the
right to food, it is important to distinguish the inability from the unwillingness of
a state party to comply.102
                                                
100 Article 11(2) of ICESCR
101 See General Comment 12, op cit., paragraph 17. In addition, The Maastricht Guidelines on
Violations of Economic, Social and Cultural Rights, though not legally binding, are relevant
in determining violations of economic, social and cultural rights at the national, regional and
international levels. See Asbjorn Eide and Wenche Barth Eide, op cit., p. 537-539
102 A state cannot use the “progressive realization” provision in article 2 of ICESCR as a
pretext for non-compliance nor can a state use its own differences in social, religious and/or
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In addition, discrimination in access to food, as well as to means and entitlements
for its procurement, on the grounds of race, colour, sex, language, age, religion,
political or other opinion, national or social origin, property, birth or other status
with the purpose or effect of nullifying or impairing the equal enjoyment or
exercise of the right to food also constitutes a violation.103
Violations of the right to food can occur through the direct action of states or
other entities insufficiently regulated by states. This can be done either through: the
repeal of laws necessary for the continued enjoyment of the right to food; denial
of access to food to particular individuals or groups; adoption of laws that are
manifestly incompatible with pre-existing legal obligations relating to the right to
food; failure to regulate the activities of individuals or groups so as to prevent
them from violating the right to food of others; failure of the state to take into
account its international legal obligations regarding the right to food when entering
into agreements with other states or with international organizations.104
It is observed that gross violations of the right to food of individuals and groups in
Africa have occurred and/or are threatened with violation through the direct
action of African states or other entities such as MNCs insufficiently regulated by
African states. In this thesis, I will show that, the adoption of  TRIPs, with many
African countries being party to it, is to a large extent in direct conflict with the
right to food.
2.4  A Human rights approach to TRIPs
A human rights approach to TRIPs would require that the private/public balance
be struck with the primary purpose of promoting and protecting all human rights.
A human rights approach is centrally based on protecting and nurturing human
dignity and the common good. The rights of creators and inventors are therefore
not absolute but conditional on contributing to the common good and welfare of
the society. Therefore, vesting creators, authors and inventors with full and
unrestricted monopoly IP rights is not in consonant with a human rights approach.
                                                                                                                           
cultural background. If a state argues resource constraints that make it impossible to
provide access to food for those who are unable by themselves to secure such access, the
state has to show that every effort has been made to use all resources at its disposal in an
effort to satisfy, as a matter of priority, those minimum obligations. If a state claims that it is
unable to carry out its obligations for reasons beyond its control, it has to prove that this is
the case and that it unsuccessfully sought to obtain international support to ensure the
availability and accessibility of the necessary food. In addition, the choices made by a state
would need to be assessed in order to determine a violation e.g. what part of its resources
are allocated to the realization of the right to food vis-à-vis other purposes? See General
Comment 12, paragraph 17 and Asbjorn Eide, op cit., p. 25-28
103 General Comment No. 12, paragraph 18
104 ibid, paragraph 19.
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TRIPs although identifying the need to balance rights with obligations does not
give guidance as to how that is to be done. However, the comparable provisions
under human rights law i.e. rights under article 27 UDHR and article 15 ICESCR
(provide some way of achieving the balance) and together with other human rights
will be best served, taking into account their indivisible, interdependent and
interrelated nature.105 Thus, whatever balance is struck it should not work to the
detriment of other rights guaranteed in the ICESCR.106 This is also consistent with
the Vienna Declaration and Programme of Action adopted by the UN
Conference on Human Rights held in Vienna, Austria, which declares, “human
rights are the first responsibility of Governments.”107In TRIPs, the various links
with human rights e.g. the promotion of health, nutrition, environment and
development are generally expressed in terms of exceptions to the rule rather than
the guiding principles themselves, and are also made subject to the provisions of
the agreement. A human rights approach would place the promotion and
protection of all human rights at the heart of the aims of IP protection rather than
as only exceptions.108
A human rights approach would establish a different standard for the evaluation or
grant of IP by including human rights safeguards. IP should be consistent with the
realization of other human rights, particularly those guaranteed in ICESCR. For
instance, such an IP regime would facilitate and promote cultural participation and
scientific progress and also do so in a manner that will broadly benefit members of
society both on an individual and collective level.
TRIPs only recognizes individual rights by stating in its preamble that IPRs are
private rights. By emphasizing IPRs as private rights, TRIPs ignores the creativity
and innovation of groups and communities. A human rights approach would
recognize that, although not in all cases, an author, artist, inventor or creator could
be a group or a community as well as an individual.
                                                
105 For instance, Article 15 ICESCR should be read together with Article 5 ICESCR, which
states, “nothing in the present covenant may be interpreted as implying for any state, group
or person any right to engage in any activity or to perform any act aimed at the destruction
of any of the rights or freedoms recognized herein, or at their limitation to a greater extent
than is provided for in the present covenant.” See also the Report of the Secretary General,
op cit., p. 8
106 It is observed that TRIPs, like any international treaty does take away a degree of
autonomy from states. But it has a significant departure, in that it requires member states to
provide patent protection to cover all forms of technology. This could have an impact on a
states ability to decide on development strategies.
107 Article 1Vienna Declaration and Programme of Action. Document: A/CONF.157/23
108 See Report of the High Commissioner for Human Rights, op cit., p. 8. Human rights are
promoted by commercial aims e.g. the right to development.  On the other hand, IPRs are an
incentive for creativity and innovation and are human rights. Thus, the balance is struck
when IPRs are not overemphasized, as TRIPs does, at the expense of other guaranteed
human rights. As observed earlier, all human rights are “universal, indivisible and
interdependent and interrelated. The international community must treat human rights
globally in a fair and equal manner, on the same footing, and with the same emphasis.”
Human rights are also promoted by commercial aims e.g. the right to development.
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Strengthened IPRs under TRIPs particularly patents could impede or block the
creativity and innovation of other individuals or groups to the extent that they
would not have access to products or processes under IP protection or such
access would be under restrictive terms and conditions set by the patent holder.
As a result, TRIPs is seen as impeding scientific and cultural progress. A human
rights approach would recognize that IP products or processes with an intrinsic
value are an expression of human dignity, creativity and cultural values and not
just an economic commodity and therefore ultimately the public good would
outweigh private rights.
TRIPs also focuses on forms and levels of protection that have developed in
industrialized countries. For instance, patents on modern biotechnological
inventions are most relevant to inventors in these countries. A human rights
approach would recognize the need to protect TK and technology of local
communities and indigenous peoples. The emphasis on modern technology or the
“formal” sector and not other forms of technology or the “informal” sector
suggests an imbalance within TRIPs that would have an impact on the enjoyment
of human rights.
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3 THE TRIPs REGIME
3.1 Introduction
IP protection, till recently viewed as a subject of a few specialists, has gained a
prominent place on the current international economic agenda.109 The factors that
have contributed to this change and which also explain the new and vigorous
attitude of innovating firms and industrialized countries towards the availability and
enforcement of IPRs worldwide are: a substantial increase in R&D costs,
problems of appropriating the results of innovative activities (particularly new
technologies), and the globalisation of the economy.110 The renewed interest in IP
issues has triggered unilateral actions111 as well as multilateral negotiations.112
It is observed that today’s technological advances are intertwined with another
phenomenon, globalisation, together creating the network age.113 In the Industrial
Age, raw materials and labour were key resources but today intellectual
“commodities” like knowledge, scientific discoveries, and creative works are the
central asset in this information or knowledge-based economy; IPRs have
become one of the most important assets of knowledge-based economies.114 For
instance, it is estimated that today more than a quarter of the exports of the USA,
the world’s largest producer of IP, rely on IP.115
It must be stated that technological advances and globalisation (and its new rules)
are mutually reinforcing.116 The world has witnessed in the later part of the 20th
century, the integration of world markets driven by trade liberalization and
privatisation and the strengthening of IPRs. These changes have set off a race to
lay claim to knowledge, changing technology’s path. New advances in information
and communication technology have also reinforced and accelerated the process.
                                                
109 Transnational Corporations and Management Division. Department of Economic and
Social Development. Intellectual Property Rights and Foreign Direct Investment. United
Nations. New York. 1993. p.1
110 ibid
111 For example under the US Trade and Tariffs Act
112 Either within WIPO or the Uruguay Round of Multilateral Trade Negotiations
113 The network age is characterised by the global information society and is a major
historical shift i.e. from the Industrial Age, which is rapidly unifying world markets. UNDP
Human Development Report 2001. 2001. Oxford University Press. New York. p. 27
114 ibid
115 Audrey Chapman, op cit., p. 1.This is in direct contrast with the past: in 1947, IP
comprised just under 10% of all US exports, in 1986, 37% and in 1994, it was over 50%. See
Vandana Shiva. Protect or Plunder? Understanding Intellectual Property Rights. 2001.
Zed Books. London and New York. p. 19
116 UNDP Human Development Report 2001.  p. 30-31
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Globalisation propels technological progress with the competition and incentives
of the global marketplace and the world’s financial and scientific resources while
on the other hand, the global marketplace is technology based with technology
being a major factor in market competition.117 This new age is giving rise to global
networks in many fields, an important new force in shaping the path and spread of
technology. Hence, technology may be globalising communities, but globalisation
is also shaping the path of new technologies. It is observed that the high-tech
manufacturing sector has been the fastest-growing area of world trade and
accounts for one-fifth of the total.118
3.2 Origins of TRIPs
In the eighth Round of the Multilateral Trade Negotiations under GATT, which
began in 1986 at Punta del Este, Uruguay, developed countries pressed and
succeeded in incorporating IPRs, inter alia, in the package of new rules and
procedures to conduct international trade.119
The conclusion of these negotiations introduced the most comprehensive
multilateral agreement that sets out minimum worldwide standards for the
protection and enforcement of IPRs i.e. TRIPs. TRIPs is one of the agreements
annexed to the Final Act embodying the results of the Uruguay Round of
Multilateral Trade Negotiations under GATT; it is contained in Annex 1C of the
Agreement establishing the WTO. It was adopted in April 1994 and came into
force on 1 January 1995.
The introduction of IP issues in the agenda of the Uruguay Round of Multilateral
Trade Negotiations was principally an initiative of the USA. The USA first raised
IP protection under GATT to clamp down on trade in counterfeit goods and
parallel imports.120 The need to discuss IPRs in these negotiations arose so as to
reduce distortions in international trade and the increase in trade in counterfeit
goods.121
This issue first emerged in the 1970’s and early 1980’s when the world went into
a severe recession and the USA experienced a dramatic shift in its balance of
                                                
117 ibid
118 UNDP Human Development Report 2001. p. 31
119 GATT was created in 1947 and provided the basic rules of the multilateral trading system
from 1.1.48 until WTO Agreement entered into force on 1.1.95. Its contracting parties met in
sessions known as Rounds. The main aim of the Rounds was to reduce tariffs and other
barriers or obstacles to trade so as to enable free international trade. The Uruguay Round
included new topics on the agenda for negotiation: such as inter alia, TRIPs.
120 Rohini Acharya. Intellectual Property, Biotechnology and Trade: The Impact of the
Uruguay Round on Biodiversity. African Centre for Technology Studies (ACTS). ACTS
Press. Biopolicy International Series No. 4. Nairobi, Kenya. p. 7
121 ibid, p. 7-8
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trade.122 A worsening balance of trade led the USA to examine structural changes
to boost its competitiveness in world trade and the examination revealed that the
USA was losing its technological lead over other industrialized countries, notably
Japan and also newly industrializing countries (NICs), notably east Asian
countries, mostly due to liberal technology transfer and generally lax import
policies.123
At this time, US industries mainly in the computer software and microelectronics,
entertainment, pharmaceuticals, chemicals, and agro-chemical sectors claimed
they were suffering heavy losses from the absence of adequate protection of their
IPRs abroad.124 They were concerned about the loss of commercial opportunities
abroad – brought about by the failure of foreign countries to recognize their IPRs
based on US IP law which was different from or non-existent in those countries –
and thus a loss to the US economy.125 In 1987, a survey by the US International
Trade Commission (ITC) confirmed, on the basis of public hearings held and
questionnaires administered, that firms in the US were loosing some US$ 43-61
billion annually, owing to lack of IP protection abroad.126
The non-recognition of IPRs granted in the USA meant that NICs would be in a
position to imitate new technologies.127 The result was the production and export
of “counterfeit” goods from NICs, which are cheaper than the IP protected
counterparts from the industrialized countries.128 The NICs while closing their
markets to exports from the US would gain access to the US market as a result
of the liberal trade practices in the US.129 The increasing competitiveness of the
NICs threatened the supremacy of US business as a result of increasing imitation
                                                
122 ibid. It is estimated that in the 1980’s, the trade deficit of the US was $150 billion. See
Vandana Shiva, op cit., p. 19
123 ibid
124 Adede, A. O. The Political Economy of the TRIPS Agreement: Origins and History of
Negotiations. 2001.African Centre for Technology Studies (ACTS). Biopolicy International
Series No. 24. Nairobi, Kenya. p. 2
125 Vandana Shiva, op cit., p. 19 and Rohini Acharya, op cit., p. 8
126 Adede, op cit., p. 2 and Vandana Shiva, op cit., p. 19
127 In the 1980s, counterfeiting (and copyrights piracy) increased in the developing countries
because of the desire of these countries to catch up in the industrialization process and also
to have access to printed educational material, which they needed. The situation was
accelerated by various factors, namely: the advent of copy-prone electronic-based
technologies and products; the growing competitiveness of NICs in the manufacturing
sector; the increasing globalisation of the marketplace; and the growing perception of IP by
the enterprises of the developed countries as a strategic asset. There was thus a tension
between the quest for tighter protection of IPRs for the promotion of creativity being
pursued by the industrialized owners of the property and the policy of maximization of social
welfare arising from an impeded diffusion of that creativity, being pursued by developing
countries, through more relaxed IPRs protection. See Adede, op cit., p. 4
128 Rohini Acharya, op cit., p. 8
129 ibid
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of IP protected goods.130 Thus, to reverse this trend, a need to counter such
unfair trade practices of NICs was identified.131
At the multilateral level, the enforcement of IP protection under WIPO was very
weak or non-existent. During the Uruguay Multilateral Trade Negotiations, the
USA pointed out the failure of conferences in 1980-1984 to revise the Paris
Convention to address these issues, and therefore preferred the GATT forum for
negotiating effective enforcement of IPRs at the international level.132 The USA
stated that the GATT forum provided for effective enforcement of agreements
and for dispute settlement mechanisms, which were practically lacking in the
WIPO administered conventions. The USA continued with its efforts to
introduce, in the GATT forum the protection of IPRs to address the problem of
counterfeit products and later of copyrights piracy, which had been increasing in
the developing countries in the 1980s.133
At the Uruguay Negotiations, the debate on inclusion of IPRs under GATT pitted
developed and developing countries against each other mainly due to different
priorities faced by these two groups of countries.134 Developed countries
favoured the IPRs debate under GATT so as to clamp down on trade in
counterfeit goods which was undermining their own industrial production while
developing countries were concerned about the implications of this for technology
transfer and technological development of their countries.135
Developing countries saw the concern being raised by the developed countries,
particularly the USA as being expressed on behalf of US industries. They saw all
efforts towards the establishment of an effective regime for the protection of IPRs
as aimed at furthering the interests of western-based industries and not those of
                                                
130 ibid and also Vandana Shiva, op cit., p. 19
131 Rohini Acharya, op cit., p. 9. The US began to use its domestic law i.e. US Trade Act -
section 301 unilaterally to enforce trade sanctions against states that deny adequate and
effective protection of IPRs. Under this law, the US Trade Representative is authorized to
identify foreign countries that deny adequate and effective protection of IPRs. “A priority
watch list” of specific countries whose action exhibited this unfair trade practice, mostly
developing countries, was made for further investigation.
132 See Adede, op cit., p. 3 and Rohini Acharya, op cit., p. 10
133 It is observed that US business was the main driving force behind the insistence by the
US government to include IPRs in the GATT forum, notably through the Intellectual
Property Committee (IPC) of USA, and also industry associations of Japan (Keidanren) and
Europe (UNICE). IPC is a coalition of 13 major US corporations i.e. Bristol Myers, Dupont,
General Electric, General Motors, Hewlett Packard, IBM, Johnson and Johnson, Merck,
Monsanto, Pfizer, Rockwell and Warner. See Vandana Shiva, op cit., p. 94-98.
134 Rohini Acharya, op cit., p. 10
135 ibid. Developing countries saw the establishment of an international IPRs system under
GATT as likely to be detrimental to their economic growth and development. Developed
countries are largely the ones who develop new technologies and therefore, developing
countries saw the introduction of IPRs under a trade forum such as GATT, as a barrier for
them to gain access to these new technologies or be able to develop imitations of their own.
See Rohini Acharya, op cit., p. 10
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developing countries. Indeed, the US pharmaceutical industry, was already
leading in the effort to link the protection of IPRs to trade.136
Developing countries thus resisted the idea of making the issue of IPRs protection
a subject for discussion under the Multilateral Trade Negotiations because of such
strong industry influence and specific agenda. They considered IP an issue
exclusively within the competence of WIPO. The EC also did not, at least at the
beginning, endorse the link between IP to the negotiations under the GATT
forum. However, later together with the USA, they attempted to introduce an
Anti-Counterfeit Code (ACC) at the Tokyo Round of Negotiations but the code
was never adopted.137
The USA did succeed in including the protection of IPRs in the agenda of the
Multilateral Trade Negotiations, even beyond the question of counterfeiting and
piracy, to include substantive minimum IP protection standards to be adopted by
all negotiating countries.138 However, the inclusion of IPRs in the negotiations did
not mean that developing countries had abandoned their reluctance to IPRs issues
being discussed under the GATT forum.139
3.2.1 Towards a clarification on TRIPs
One of the arguments advanced towards the inclusion of IPRs within the GATT
forum, and not WIPO was that: “Under the GATT forum developing countries
may have the opportunity to use a bargaining power and secure trade-offs in
negotiating favourable terms on issues such as textiles and clothing, agriculture,
tropical products and safeguards, as part of the package that included IPRs. The
consideration of such trade issues clearly went beyond the limited discussion on
whether or not to establish high standards for the protection of IPRs, as would be
in the case of negotiations within the framework of WIPO.”140 Thus, the Uruguay
                                                
136 In 1984, Edmund T. Pratt, Chairman of the Pfizer Corporation initiated the process by
saying: “We must also work to get more broadly based economic organizations, such as the
OECD and the GATT, to develop intellectual property rules, because intellectual property
protection is essential for the continued development of international trade and
investment.” See Adede, op cit., p. 3
137 ibid, p. 4
138 Rohini Acharya, op cit., p. 10-11 and Adede, op cit., p. 4. It is observed that TRIPs
“featured almost as a footnote on a crowded agenda and it was uncertain whether that
contentious item would survive the end of the Round.” But the Trade Ministers at the
negotiations, borrowing from the language used in another item on the proposed agenda
(Trade-related Economic Measures) and coined the expression “Trade-related Aspects of
Intellectual Property Rights” and included it on the agenda of the Uruguay Round of
Multilateral Trade Negotiations.
139 Adede, op cit., p. 4 and Rohini Acharya, op cit., p. 10. It should be noted that developing
countries were willing to examine the issue of trade in counterfeit goods and negotiate a
multilateral framework to regulate it. Some developing countries had laws to control the
production of counterfeit goods, what they were against is to discuss IPRs under GATT
instead of WIPO.
140 Adede, op cit., p. 5
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Round of Multilateral Negotiations was seen as providing a unique opportunity for
developing countries to achieve tangible gains by expanding the scope of issues
for discussion.
This argument on possible useful trade-offs in the results of the negotiations
encouraged developing countries to assess more closely the positive and negative
elements associated with their continued rejection of the inclusion of IPRs in the
Uruguay Round. A further consideration of the possible package-deal helped
some developing countries warm up to the idea of inclusion of TRIPs on the
Uruguay Round agenda. But they still adopted a restrictive approach because
firstly, they wanted WIPO to remain as the only organisation with the competence
over substantive standard setting for IPRs; secondly, they wanted to limit the
negotiations under the mandate to counterfeit and strictly trade related issues;
thirdly, they stressed the importance of transfer of technology and development
policies as a quid pro quo for IP protection.141
With intensive lobbying and discussions, the actual agreement to take TRIPs up
for discussion began in 1989 by the Trade Negotiating Committee (TNC).142 It
thus took three years between the decision to include TRIPs in the Uruguay
Round in 1986 and the actual agreement to take it up for discussion in 1989.
The discussion on TRIPs began with a number of legal texts prepared, first in
March 1990 by members of the EC.143 The submission of a complete text by the
EC was an important phase of the negotiations, bearing in mind the earlier doubts.
The USA, Switzerland and Japan, also submitted drafts all of which borrowed
substantially from the EC text.144
Later, in addition to the above drafts, a group of twelve developing countries
agreed to participate in the actual negotiations on TRIPs by producing their own
detailed proposal.145 By presenting their proposal, the developing countries
wanted to signal first, their determination to emphasize the part dealing with trade
in counterfeit goods while minimizing the part relating to substantive standards on
IPRs; second, they wanted to highlight the importance of the public policy
objectives underlying national IPR systems, the necessity of recognizing those
objectives at the international level and the need to specify some basic principles
                                                
141 ibid
142 In 1988, during the Ministerial Meeting held in Montreal, Canada the trade ministers
failed to agree on the commencement of negotiations of, inter alia, TRIPs. They then
decided that the TNC should meet in Geneva in April 1999 to continue discussions and
agree upon the remaining areas and review the entire package. The pressure was to be
applied upon the so-called “big” developing countries to abandon their resistance. See ibid,
p. 6-7.
143 Adede, op cit., p. 8.
144 ibid
145 ibid. These countries were: Argentina, Brazil, Chile, China, Colombia, Cuba, Egypt, India,
Nigeria, Peru, Tanzania and Uruguay and later joined by Pakistan and Zimbabwe.
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e.g. national treatment, which could subsequently elucidate the application of any
standards established in TRIPs; third, they insisted on the need to respect and
safeguard national legal systems and traditions on IPRs in view of the diverse
needs and levels of development of states participating in the IPR negotiations.146
Successive revisions of the composite text occurred as a result of further
negotiations.147 The Ministerial Meeting held in Brussels in December 1990,
produced tangible results leading to the tabling of the Draft Final Act in December
1991.148 This Final Act contained close to the complete TRIPs agreement.
3.2.2 Africa’s participation towards TRIPs
As noted above, developing countries generally considered the management and
control of IPRs as a key element in development policy. They saw strengthened
IPRs under GATT as an obstacle to the transfer of technology, which they
needed for their industrialization process as the engine for their development. As
latecomers to the industrialization process, developing countries in order to catch
up showed an unwillingness to strengthen the protection of IPRs because their
technological capacities were still weak; their budding enterprises could not take
full advantage of the incentive provided by stronger IP protection. Hence, the
benefits gained from such protection would be outweighed by the disadvantages
of not being able to access or acquire and adapt foreign technology without
reference to the inventor or creator.
In contrast, developed countries saw the existence of an effective IPRs protection
system as the best tool against imitation and piracy which had resulted in their
industries loss of royalties, but also as a necessary prerequisite to establish a
competitive edge in foreign markets as well as an engine for driving investment in
R&D and technology transfer.
These opposing views should be kept in mind as we look at three major factors
that influenced Africa (and other developing countries) undertake negotiations
towards TRIPs.
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Firstly, as noted earlier, was the expectation of gains in other trade areas as
trade-offs to TRIPs.149 Once the package was presented to include possibilities
for improved market access and gains in agriculture, textile and clothing, tropical
products, and safeguards as trade-offs (to which they had a competitive
advantage over the developed countries) the success of the Uruguay Round was
more or less assured. It does appear that compromises were reached to achieve
progress towards a desired goal.
Secondly, the African negotiators recognized the benefits of a multilateral system
for the resolution of disputes in IP based on credible procedures and mechanisms
that would have reasonable prospects and hence sought protection against
unilateralism.150 A multilateral framework was seen as a lesser evil than a bilateral
one because, firstly, it discouraged the unilateral use of trade sanctions by
developed states for extracting concessions on IP areas; secondly, it ensured that
trade conflicts relating to IP issues would be handled objectively and effectively;
thirdly, due to political and economic reasons, such as the fear that a failure of
negotiations could lead to unilateralism on the part of the EU and Japan.151
Thirdly, the African negotiators saw the possibilities for benefits from improved
market access in general and from market-based policies for attracting foreign
direct investments (FDI).152 It was also viewed that TRIPs should also not only
reflect the interests of IPRs owners but also users and of net importing countries
and thus it was important to agree on conditions on access of technologies from
their IPR owners.153 Thus, issues such as compulsory licensing, parallel importing,
exhaustion, control of anti-competitive practices, transitional arrangements and
test data protection were seen important so as to achieve a balanced protection
of interests. All of this was set to establish market-based economic policies so as
to attract FDI.
3.2.3 TRIPs as adopted
For notable reasons, TRIPs has revolutionised the IP protection system.
First, it imposes a minimum IPRs standard for all WTO members.154 This
standard is derived from the laws of industrialized countries, applying the form
and level of protection of the industrialized world to all WTO members. Although
TRIPs has attempted to harmonise national IP standards, these standards are far
                                                
149 Adede, op cit., p. 11-12
150 For example, under the US Trade Act – Section 301 procedure. Adede, op cit., p. 12-13
151 ibid
152 Adede, op cit., p. 13-14. It is observed that the relationship between IPRs and FDIs is
widely disputed. For a comprehensive analysis on the subject, see Intellectual Property
Rights and Foreign Direct Investment at Note 103, Supra.
153 Adede, op cit., p. 14
154 See Article 1of TRIPs
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too high for many developing countries, including those in Africa.155 WTO
members must ensure that their laws meet the minimum standards laid down but
they can introduce stringer laws if they so wish.156 However, not all members
comply with the provisions of the agreement at the same time.157
Second, TRIPs provides for an effective IP protection enforcement mechanism
through the integrated dispute settlement system. 158A serious threat in this system
is that if a country does not fulfil its IPRs obligations under it, trade sanctions can
be imposed against it. TRIPs also includes for the first time in any area of
international law “rules on domestic enforcement procedures and remedies.”159
Third, TRIPs has expanded the scope of IP by extending the scope of
protectable subject matter.160 Also, TRIPs allows for the first time, the patenting
of life forms and processes e.g. microorganisms, microbiological processes and
plant varieties under article 27(3)(b).
Fourthly, TRIPs has also strengthened the level of IP protection and thereby
strengthened the legal position of IPRs holders. The strengthening of IPRs under
TRIPs raises the price of technology transfer or access to new technologies and
further increases the risk of blocking developing countries, including Africa out of
the technology sector. This is because as a property right, IPRs holders can
dictate the terms on which third parties can access their technologies e.g. through
                                                
155 The IP standard laid down in TRIPs is very high than existing laws in most developing
countries, including those in Africa. Although developing and least-developed countries
have flexible schedules to implement TRIPs at the national level, the IP standard TRIPs
imposes often conflicts with these countries national interests and needs.
156 See Article 1 of TRIPs
157 See Article 65 of TRIPs. TRIPs came into force on 1 January 1995. Developed countries
had upto 1 January 1996, developing countries upto 1 January 2000, economies-in-transition
(from centrally-planned to market economies) had upto 1 January 2000 and least-developed
countries have upto 1 January 2006 to implement TRIPs. New WTO members do not benefit
from the transitional arrangements and thus have to comply with TRIPs immediately upon
joining WTO.
158 See Part V of TRIPs and Article 68 of TRIPs. The Council for TRIPs is required to monitor
members’ compliance with their obligations under TRIPs. IPRs disputes are subject to
WTO’s dispute settlement procedures. In the case of a dispute, a panel of specially
appointed trade experts hears the dispute. The decision of the panel may be subject to
appeal to the WTO’s Appellate Body. If a party to a dispute fails to abide by such a
decision, the other party can impose trade sanctions on the member in breach upon
authorization by the Dispute Settlement Body. See Audrey Chapman, op cit., p. 6 and
Report of the United Nations High Commissioner for Human Rights. The Impact of the
Agreement on Trade-Related Aspects of Intellectual Property Rights on Human Rights.
Sub-Commission on the Promotion and Protection of Human Rights. 52nd session.
E/CN.4/Sub.2/2001/13.  p. 3-4
159 Tansey, Geoff. Trade, Intellectual Property, Food and Biodiversity: Key issues and
options for the 1999 review of Article 27.3(b) of the TRIPS Agreement. A Discussion
Paper. 1999. Quaker Peace & Service. London. p. 6
160 Article 27(1) of TRIPs provides, inter alia, that patents shall be available for any
inventions, whether products or processes, in all fields of technology.
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the payment of royalties, and therefore the highest bidder gets the license to the
technology. This is particularly true with respect to modern technologies that have
been developed by MNCs where heavy investments have been put into their
R&D and therefore by obtaining IPRs, such MNCs would like to get a return for
their investment plus a profit.
3.3 TRIPs and Food & Agriculture
It is evident that TRIPs as adopted is as a result of intense negotiations and
comprise between different sets of interests. TRIPs covers, copyright and related
rights; trademarks; geographical indications; industrial designs; patents; plant
variety protection (PVP); layout-designs (topographies) of integrated circuits;
protection of undisclosed information/trade secrets and control of anti-competitive
practices in contractual licences.161 Of these, patents, PVP and trade secrets are
particularly relevant to food and agriculture and are studied herein below.
3.3.1 Patents
Section 5 of Part II of TRIPs on patents was the most politically and
economically controversial in the entire TRIPs negotiations.162
It is observed that articles 27(2) and 27(3)(b) of TRIPs draw from article 52 and
53 of the 1973 European Patent Convention (EPC).163 The latter entrenches a
morality criterion as part of the restrictions on patentability and the former
stipulates that European patents shall not be granted in respect of plant or animal
                                                
161 See Part II of TRIPs that deals with “Standards concerning the Availability, Scope and
Use of IPRs”.
162 During the negotiations, the USA and Japan pushed for patent law provisions that
recognized very few restrictions on the scope of patentability while in contradistinction, the
EU had another point of view, which prevailed at the end. In this respect, the USA was
following a long tradition of patent expansionism in biotechnology that had been part of its
domestic law since 19th century. For example, in 1873 the US Patent and Trademark Office
(USPTO) granted a patent to Louis Pasteur for yeast. IN 1930, the US passed the Plant
Patent Act that provides for the patenting of asexually propagated varieties. In 1970, the US
passed the Plant Variety Protection Act that provides for the protection of sexually
propagated plants. In ex parte Hibberd 227 USPQ 443 (1985), the PTO Boards of Appeal
reversed a decision of the USPTO that had precluded patent protection for plant-related
inventions that were covered, at least in theory, by the Plant Patent Act. Therefore, under
US IP law plants are patentable. In the landmark case of Diamond, Commissioner of Patents
and Trademarks vs. Chakrabarty, 447 US 303 (1980), the US Supreme Court was of the
view that it was the task of the courts to continue to adapt and expand the patent system
unless otherwise directed by US Congress and hence declared that inventions are
patentable in principle even if comprised of living matter. See paper presented by Peter
Drahos on The TRIPS Review found at www.acts.or.ke/drahos.doc and Li Westerlund.
Biotech Patents: Equivalency and Exclusions under European and US Patent Law. 2002.
Kluwer Law International. Hague. p. 1-2
163 The EPC is founded on the provisions of the 1963 Strasbourg Convention and also
UPOV. See Li Westerlund, op cit., p. 4-5
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varieties or essentially biological processes for the production of plants or animals
(with the exception of microbiological processes and the products thereof).164
The key element is the mandatory requirement for WTO members to make
patents available for any inventions, whether products or processes, in all fields of
technology without discrimination.165 It is said that one reason for the greater
interest in patents is the rapid development of biotechnology, especially in the
developed countries, and its application in agriculture.166
However, WTO members are allowed certain exceptions to the basic rule on
patentability:
Article 27(2) of TRIPs provides that members may, exclude from patentability
inventions, when they want to prevent the commercial exploitation of the invention
to protect ordre public167 or morality; including to protect human, animal or plant
life or health or to avoid serious prejudice to the environment. (emphasis mine)
Article 27(3)(a) of TRIPs provides that members may exclude from patentability
diagnostic, therapeutic and surgical methods for the treatment of humans or
animals (emphasis mine).
Article 30 of TRIPs provides members with limited exceptions to the exclusive
rights conferred by a patent, provided that such exceptions do not
unreasonably conflict with a normal exploitation of the patent and do not
                                                
164 Although the EPC provisions indicate restrictions to patentability, European Patent
Office (EPO) case law has been progressively narrowing the restrictions e.g. the
patentability of the Harvard “oncomouse” was initially rejected by the EPO on morality
grounds. The EPO Technical Board later reversed this decision. See paper presented by
Peter Drahos on The TRIPS Review, supra. Further, in light of recent developments in
biotechnology the protection of biotechnological inventions in the EU has expanded to now
include biological material and processes, isolated from their natural environment or
produced by means of a technical process as the subject of an invention even if it
previously occurred in nature, by the coming into force of the EC Directive on the Legal
Protection of Biotechnological Inventions.  See the EC Directive 98/44/EC of the European
Parliament and Council of the EU of 6.7.98 at http://www.wipo.int/WIPO/GRTKF/IC/1/8
165 Article 27 (1) of TRIPs. As a political matter in the negotiations, this was especially meant
to cover pharmaceuticals, which had been excluded from product patent coverage in many
developing countries. See Barton, J. Biotechnology and Trips: Issues and Options for
Developing Countries. 2000.  Graduate Institute of International Studies. PSIO Occasional
Paper. WTO Series Number 03. Geneva. p. 12
166 Biotechnology is not a new science. For example, methods of making bread, beer, wine or
cheese using yeast have been known and used since time immemorial. Article 2 of the CBD
defines “biotechnology” as  “any technological application that uses biological systems,
living organisms, or derivative thereof, to make or modify products or processes for specific
use.”
167 Ordre public concerns the fundaments from which one cannot derogate without
endangering the institutions of a given society. Morality is a different  concept. See Geoff
Tansey, op cit., p. 25
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unreasonably prejudice the legitimate interests of the patent owner, taking
account of the legitimate interests of third parties. (emphasis mine)
Article 27(3)(b) of TRIPs is of special interest. It states:
“Members may also exclude from patentability:
(b) plants and animals other than micro-organisms, and essentially
biological processes168 for the production of plants or animals other than
non-biological and microbiological processes. However, members
shall provide for the protection of plant varieties either by patents or by
an effective sui generis system or by any combination thereof. The
provisions of this subparagraph shall be reviewed four years after the date
of entry into force of the WTO Agreement.”(emphasis mine)
The key terms used in article 27(3)(b) are not defined in TRIPs i.e. plants,
animals, microorganisms, essentially biological processes, non-biological,
microbiological, plant varieties169, effective and sui generis170 system. It is noted
that these words are defined differently in different national and international laws.
This would mean that there is considerable scope for individual national
interpretations to be put onto them and protracted legal wrangles are likely to
determine which interpretation prevails.171
It is stated that in order to comply with article 27(3)(b) of TRIPs, four options are
available:
1. To allow patents on everything, and therefore not take up the option to
exclude plants, animals and essentially biological processes.
2. To exclude plants, animals and essentially biological processes from
patenting but not to exclude plant varieties from patentability.
3. To exclude plants, animals and essentially biological processes from
patenting and to introduce a sui generis system for the protection of plant
varieties.
                                                
168 In plant biotechnology, these can include multi-step processes consisting of the genetic
modification of plant cells, the subsequent regeneration of plants and the propagation of
these plants. The EU takes a more restrictive approach “any process which, taken as a
whole, exist in nature or is not more than a natural breeding process.” See Geoff Tansey, op
cit., p. 25
169 The question arises how a “plant variety” can be distinguished from a “plant” and
whether a transgenic/genetic engineered plant is a plant or a plant variety.
170 Sui generis is a Latin term meaning “one of its kind.” In this context, it could mean a
system of rights providing an alternative unique form of IP protection designed to fit a
country’s particular context and needs. It can have a wider meaning to cover IP not covered
under TRIPs or a system protecting community, farmers’ and indigenous peoples’ rights.
See Geoff Tansey, op cit., p. 25
171 Geoff Tansey, op cit., p. 7. It has also been said that this provision provides sufficient
flexibility for countries to design a system that best fits their circumstances and meet their
goals and objectives. See International Plant Genetic Resources Institute. Key Questions for
Decision-Makers: Protection of Plant Varieties under the WTO Agreement on Trade-
Related Aspects of Intellectual Property Rights. October 1999 at http://www.ipgri.org.
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4. To exclude plants, animals and essentially biological processes from
patenting but not plant varieties and to provide, in addition, for a sui
generis system (“combination thereof”).172
The bottom line is that plant varieties, at the very least, have to be protected.
Options 1 and 2 would not require members to establish a sui generis system to
protect plant varieties.
Our analysis will be limited to patents and PBRs on plant varieties because of the
requirement to provide some form of IPRs for plant varieties if WTO members
exempt plants and animals non-biological processes for their production from
patentability. It should be noted however, that there is biotech animal research
going on with many patents being taken out in this area e.g. Harvard “onco
mouse” or “Dolly” the sheep, which could have implications in animal research
and breeding.173
To be eligible for a patent an invention must be new, involve an inventive step
(non-obvious) and be capable of industrial application (useful).174
Traditionally, patent law has distinguished between “inventions”, which are
patentable, and “discoveries”, which are not. Life forms as products of nature,
laws of nature or scientific principles are not patentable as they are discoveries.
Before TRIPs, most countries in their domestic laws had excluded the patenting
of life forms, such as plants or plant varieties because as products of nature they
are not new but actually discoveries. Article 27(3)(b) of TRIPs has changed all
this as the distinction between “discovery” and “invention” has been blurred.
                                                
172 Geoff Tansey, op cit., p. 7-8
173 In 1984 research scientists at Harvard University, USA inserted a human cancer gene in a
mouse and obtained a US patent on the genetically engineered mouse “onco mouse” which
is said to be susceptible to cancers. The patent is for the biotech process used to "create"
the “onco mouse” or when used in other mammals and the mouse itself. Also, in 1995
research scientists at the Roslin Institute in Edinburgh, Scotland “created” “Dolly” a sheep,
by a genetically engineered process known as cloning.
174 Article 27(1) of TRIPs. The concept of “invention” as used in patent law means a
technical solution to a problem. Novelty is “the state of the art comprising everything made
available anywhere to the public by means of written or oral description, by use, or in any
other way, before the date of filing of the patent application”, Inventive step is “not
obvious, having regard to the state of the art, to a person skilled in the art.” See Geoff
Tansey, op cit., p. 25
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3.3.1.1 Modern agricultural biotechnology175
Agricultural biotechnology has been known and used for centuries. Over the
years, the improvements made in crops e.g. productivity, pest and disease
resistance have been achieved either through conventional plant breeding or
local/farmers selection using their traditional agricultural knowledge geared
towards maintaining agro-biodiversity in their ecosystems. In the 1960’s the
“green revolution” increased agricultural productivity in Asia and Latin America
through the introduction of high yielding rice and maize varieties (hybrids).
The work of Louis Pasteur on yeast fermentation and Gregor Mendel on genetics,
in the late 19th to early 20th century ushered in the current era of modern
biotechnology.  Modern biotechnology is characterised by a range of cutting-edge
techniques or applications that use living organisms or substances from those
organisms to make or modify a product, to change the characteristics of plants or
animals or to develop microorganisms for specific purposes. It includes cell
fusion, tissue culture, in-vitro fertilization, selection markers, gene transfer, cloning,
and promoter technology.176 It also includes genetic engineering - the process of
recombining/altering DNA.177 Genetic engineering involves the use of molecular
techniques both to identify and move genes from one cell to another (even across
species) - as opposed to reproductive/sexual means - to produce genetically
modified organisms (GMOs).
There have been substantial improvements in molecular science and reproductive
biology ushering in a new understanding of genetics. Modern science is now
unravelling the structure of genomes and discovering the characteristics and
functions of individual genes. Modern agricultural biotechnology is characterised
by the ability to manipulate genes and has brought to the fore the importance of
genetic resources. These new technologies have made a link between genes and
new plant varieties while sparking many debates about the limits of science and
the ethics of tampering with the essence of life.
                                                
175 Traditionally, biology was considered outside the scope of technology, as man could not
control it in a predictable way. Technology, strictly speaking, involves human control. Thus,
processes that may be entirely controlled by man in a scientific way, or products which are
made by man according to scientific principles, involve the use of technology. Recently, as
a result of scientific discoveries it has become possible to develop biological processes,
which manipulate living organisms. These processes may be entirely controlled by man e.g.
genetic engineering - the artificial modification of genes which changes the material
determining the hereditary characteristics of living organisms (DNA) and thus it is possible
to create modified organisms that have certain desirable features. See, New Developments in
Intellectual Property in Background Reading Material on Intellectual Property. 1988.
WIPO Publication. p. 375-376
176 ibid, p. 2-8
177 DNA is the molecule in chromosomes that is the repository of genetic information in all
living organisms, with the exception of a small number of viruses, in which the hereditary
material is ribonucleic acid, RNA. As its coded information determines the structure and
function of an organism, directly or indirectly the DNA controls the production and
reproduction of the cell, organ and plant or animal. See Li Westerlund, op cit., p. 7-8
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Life forms or products of nature are now patentable subject matter, when some
human intervention has been necessary to make them available or where man has
given that life form something it did not have naturally.178 Thus, if it is possible to
control a biotechnological product or process and to describe it in a way that
experts in the field can carry it out on the basis of the description made, then a
biotechnological invention has been made and can be the subject of a patent.
The advent of modern biotechnology, particularly genetic engineering is a major
driving force in the expansion of protectable subject matter, to now include life
forms. Big and powerful corporate interests are behind this expansion of
protectable subject matter to cover life forms.179
It is observed that plant biotechnology patents represent about 1% of the total
number of patents granted annually worldwide.180 In 1990-1995, the USA, EU
and Japan (combined) accounted for 93% of biotechnology patents while the
“rest of the world” where all developing countries fall only accounted for less than
7% of the total.181 Patents relating to agriculture represented only 11% of the total
for 1992-1995 while those specifically covering modified plants represented 6%
of the total.182At least five US MNCs accounted for 44% of the total plant
patents during this period.183
In plants, patents may apply to various biological materials and processes,
including:
                                                
178 The eligibility of life forms as patentable subject matter (as a point of law) is now settled
in light of the EC Directive, EPO case law and US case law. The US Supreme Court Decision
in Diamond, Commissioner of Patents and Trademarks vs. Chakrabarty, 447 US 303
(1980) addresses the scope of patentable subject matter by stating that “anything under the
sun that is made by man” is patentable. The respondent filed a patent application relating to
his invention of a human-made, genetically engineered bacterium capable of breaking down
crude oil (absorbs oil from oceans and rivers), a property not possessed by no naturally
occurring bacterium. Initially, the application was rejected because living things are not
patentable subject matter. On appeal, the Supreme Court stated that an artificially created life
form – the new form of bacterium obtained by genetic engineering – is patentable subject
matter. By virtue of this decision, the USPTO began to issue different types of patents
protecting biotechnological methods of breeding and biotechnologically produced plants.
In addition, USPTO has also interpreted this decision to mean that any plant can be
patented, provided it satisfies the conditions on patentability. However, the patenting of life
forms is still contested on ethical, cultural and religious grounds. See Frederick Abbott et al,
op cit., p. 28-42
179 One of the economic reasons for patenting life is that living organisms can reproduce
themselves after they have been sold. This limits the potential profitability of “biological
inventions” but patents on these inventions are an option for MNCs seeking to protect the
profits that these inventions promise.
180 Correa, Carlos M. Intellectual Property Rights, the WTO and Developing Countries:
The TRIPS Agreement and Policy Options. 2000. Zed Books Ltd. London & New York. p.
173
181 ibid, p. 173-174
182 ibid
183 ibid. In the order of those most active, they were Pioneer Hi-Bred International,
Monsanto, Calgene, Holden’s Foundation Seeds and Dupont de Nemours.
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· DNA sequences that code for a certain protein;
· Isolated or purified proteins;
· Seeds;
· Plant cells and plants;
· Plant varieties, including parent lines;
· Hybrids;
· Processes to genetically modify plants; and,
· Processes to obtain hybrids.184
Patents on plant genes are often claimed together with a purified protein, plasmids
& transforming vectors, plants or seeds.185 It has been said that patenting of genes
at the cell level extends the scope of protection to all plants, which include a cell
with the patented gene.186 However, patenting principles and practices on
biotechnological inventions are still in a state of flux, including in those countries
that have experience in the patenting of genes.187 It is not clear the extent to which
a patent on an isolated gene may extend to the same gene(s) existing in nature.
What is relatively clear is that biotech patents are being aggressively enforced and
are being used to establish a competitive advantage in the market place. The
threat of enforcement/litigation of biotech patents may deter production,
reproduction or research and breeding activities using patented plant material or
processes.
3.3.2 Plant breeders’ rights (PBRs)
As noted above, article 27(3)(b) of TRIPs states that plant varieties may be
protected under a sui generis system.188 A sui generis system likely to be
recognized (particularly by developed countries) as effective is the UPOV system
of PBRs.189 UPOV aims to encourage the development of plant varieties with the
promotion of an effective system of plant variety protection. This is a powerful
tool in an effort to enhance food production in a sustainable way.
The UPOV Convention, known after its French acronym, Union internationale
pour la protection des obtentions vegetales190 was initially developed in
                                                
184 Geoff Tansey, op cit., p. 8. For a more comprehensive analysis see Carlos Correa, op cit.,
p. 173-183
185 Carlos Correa, op cit., p. 179-180
186 Carlos Correa, op cit., p. 180
187 Carlos Correa, op cit., p. 182
188 TRIPs does not offer any definition as to what this system is. It is left to individual
countries to determine what an “effective sui generis system is to protect new plant
varieties with some form of IPRs.
189 Although not even mentioned in TRIPs, African countries are being pressurized or being
forced to join UPOV so as to meet their obligations. The lack of definitions in TRIPs is thus
leading to the manipulation of sovereign states. See Adede, op cit., p.17-18
190 UPOV establishes the International Union for the Protection of New Varieties of Plants,
an intergovernmental organisation with its headquarters in Geneva, Switzerland. UPOV was
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Europe and has now been adopted by industrialised countries and an increasing
number of developing countries. It ensures that its member states acknowledge
the achievements of breeders of new plant varieties, by making available to them
an exclusive property right on the basis of a set of uniform and clearly defined
standards. Most of UPOV contracting states account for the largest part of the
global seed trade.
PBRs were developed as an alternative to patents to grant plant varieties
protection because plant breeders found it impossible to meet the conditions for
patentability i.e. inventiveness (non-obvious) and the disclosure requirement of
how to make and use the invention. This was largely attributable to the fact that
life forms were excluded in their purely natural state from patent protection.
PBRs are exclusive property rights for a limited period of time at the end of which
the varieties protected by them pass to the public domain. The rights are also
subject to controls, in the public interest, against any possible abuse.191
PBRs are given by a state as an incentive to its breeders’ for continued or
increased investment to pursue innovation for the creation of new plant varieties.
This is because breeding is long term and expensive and once plant varieties are
released they are easily copied. PBRs also safeguard the interests of breeders’ by
recognizing their moral rights in innovation and their economic right to
remuneration.
To be eligible for protection, a plant variety has to be:192
1. Distinct (clearly distinguishable from existing commonly
known varieties);
2. Uniform (sufficiently uniform in its essential characteristics
with variation as limited as necessary to permit accurate
description and assessment of distinctness and to ensure
stability);
3. Stable (in its essential characteristics over time which remain
unchanged after repeated propagation) and;
4. New (it must not have been offered for sale or marketed
prior to certain dates established by reference to the date of
the application for protection).
                                                                                                                           
adopted in 1961, entered into force in 1968, and has subsequently been revised in 1972, 1978
and 1991. See http://www.upov.int for the role and functions of UPOV and other particulars.
191 Article 30 (1978 UPOV Act), Article 30 (1991 UPOV Act) allow for the restriction on the
free exercise of the exclusive rights “for reasons of public interest” and subject to ensuring
that the breeder receives equitable remuneration.
192 Article 6 (1978 UPOV Act), Article 5 (1991 UPOV Act). The 1991 Act also states that a
plant variety must have a denomination (i.e. scientific one) to enable it to be identified
specifically.
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The 1978 and 1991 UPOV Acts set out a minimum scope of protection and offer
member states the possibility of taking national circumstances into account. Under
the 1978 Act, the minimum scope of protection of PBRs requires that the right
holder’s prior authorization is necessary for production for purposes of
commercial marketing, the offering for sale and the marketing of propagating
material (e.g. seeds) of the protected variety. The 1991 Act contains more
detailed (and stronger) provisions as explained below.
The 1991 Act tilts PBRs more towards patents and is geared to institutional
breeding that may not suit all countries.193 This Act sought to maintain the
effectiveness of breeders’ rights in the face of new biotechnologies such as genetic
engineering. This led to the introduction of stronger terms, which are the only
terms under which new members may join.
A key addition in the 1991 Act was designed to prevent genetic engineers from
adding single genes to existing varieties and exploiting the modified variety with no
recognition of the contribution of the breeder of the existing variety. Such
modified varieties are now seen as “essentially derived” varieties and may not be
exploited without the consent of the original breeder.
Other notable changes are:194
1. It extends the subject matter of protection from plant varieties of
nationally defined species to all plant genera and species;
2. It has extended the scope of the breeders’ right by expanding the acts
subject to the breeder’s consent in respect to the propagating material of
the protected variety. This not only includes production, marketing and
final sale but also reproduction (multiplication), conditioning for the
purpose of propagation, exporting, importing and stocking for those
purposes;195
3. The “farmers’ privilege” in the 1978 Act is further limited in the 1991 Act.
It leaves member states to determine on an optional basis whether or not
to exempt from the breeders’ right any traditional form of saving seed, for
use as seed in subsequent planting seasons;
                                                
193 See Geoff Tansey, op cit., p. 8-11 e.g. the concept of “national treatment”; the provision
of appropriate legal remedies for the enforcement of rights.
194 See Girsberger, M.A. The Protection of Traditional Plant Genetic Resources for Food
and Agriculture and the Related Know-How by Intellectual Property Rights in
International Law – The Current Legal Environment . The Journal of WORLD
INTELLECTUAL PROPERTY. Vol. 1 No. 6. November 1998. Werner Publishing Co. Ltd.
Geneva. p. 1029-1032. See also Intellectual Property Rights and Foreign Direct
Investment, op cit., p. 18-19
195 Article 5 (1978 UPOV Act) lists down the acts that require the authorization of the
breeder. (1) the act of production for the purposes of commercial marketing; (2) the act of
offering for sale; and (3) the act of marketing. In addition to these acts, Article 14 (1991
UPOV Act), introduces (1) the act of reproduction or multiplication; (2) the act of
conditioning for the purpose of propagation; (3) the act of exporting; (4) the act of
importing; (5) the act of stocking for any of these purposes.
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4. Fourth, it provides that PBRs may be extended to the products made
directly from harvested materials in cases where the breeder did not have
reasonable opportunity to exercise his right on the propagating material of
the variety;
5. Fifth, the 1978 Act provides for the breeders’ exemption allowing
breeders’ to use a protected variety as an initial source to create their
own variety and then market them. The 1991 Act also includes this
exemption but adds that “essentially derived” varieties can only be
marketed with the consent of the original breeder;
6. Six, it removes the restriction of the 1978 Act, which prohibited the
accumulation of patents and PBRs;196
7. Seven, it extends the minimum period of protection from fifteen years to
twenty years and to twenty-five years for trees and vines.
3.3.3 The Combination Option
A mixed system of patents and a sui generis system is also envisaged under
TRIPs, which would provide the strongest IPRs regime as this allows both types
of IPRs to be used. It is also of the most advantage to developed countries with
modern biotechnological industries. It is unclear whether this provides for double
protection i.e. whether patents and a sui generis system can protect an object or
that every object must be covered by either system.
3.3.4 Undisclosed Information/Trade Secrets
TRIPs requires trade secrets to benefit from IP protection. Trade secrets are
protected against dishonest commercial practices e.g. unfair competition.
Article 39 of TRIPs provides that the protection applies to information that is:
1. Within the control of the holder;
2. The control must have been lawfully obtained;
3. The acts of disclosure, acquirement, and use of the information by others,
must take place without the consent of the holder of the information;
4. These acts must take place in a manner contrary to honest business
practices;
5. The information must be secret;
6. The information has commercial value because it is secret;
7. The person lawfully in control of the information must have taken the
steps reasonable under the circumstances to keep the information secret.
                                                
196 Under the 1978 UPOV Act, a member state whose national law allows protection under
both these forms may provide only one of them (and not both) for one and the same
species. It thus restricts the state to protect breeder’s rights either by patents or PBRs and
not both.
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TRIPs does not require trade secrets to be treated as a form of property but it
does require that a person lawfully in control of such information must have the
possibility of preventing it from being disclosed to, acquired by, or used by others
without his consent in a manner contrary to honest commercial practices.
“Manner contrary to honest commercial practices” includes breach of contract,
breach of confidence, as well as the acquisition of trade secrets by third parties
who knew, or were grossly negligent in failing to know, that such practices were
involved in the acquisition.
Thus, to benefit from trade secret protection, information (which can include
genetic material), must derive independent economic value from not being
generally known and must be the subject of efforts that are reasonable under the
circumstances to maintain its secrecy. The effective term of protection is as long
as the secret is valuable and secret and thus is not subject to a fixed term.
Trade secrets have been used to control inbred lines used as parents of a
hybrid.197As the inbred lines are kept secret this does not affect the marketing of
the hybrid. The lines can be protected through a combination of efforts such as:
the physical protection of the materials themselves and of the contracts with
employees and those involved in producing seeds.
However, this may not prevent a third party from attempting to reconstruct the
parental lines from the marketed hybrid, so called “reverse engineering.” Seed
companies (in order to supplement PBRs and patent protection) are also using
contractual provisions to prohibit reverse engineering of the material they sell to
farmers.198
                                                
197 Barton. J. Acquiring Protection for Improved Germplasm and Inbred Lines . CAB
INTERNATIONAL 1998. Intellectual Property Rights in Agricultural Biotechnology (eds
F.H. Erbisch and K.M. Maredia). p. 27. In the seed trade, the term hybrid refers to the first
generation of a cross between inbred lines. See also Pistorius, Robin and van Wijk, Jeroen.
The Exploitation of Plant Genetic Information – Political Strategies in Crop
Development. 1999. CAB International. New York.
198 Barton. J. op cit., p. 27-28
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4 TRIPs AND THE RIGHT TO
FOOD
4.1 Intellectual property rights in agricultural
biotechnology
Biotechnology is just one solution or a set of tools (and indeed not a panacea or
silver bullet) to solve food insecurity in Africa. No technology by itself can make a
country food secure but the appropriate use of biotechnology offers considerable
potential to boost food productivity. Most of the modern biotech benefits can be
packaged in seeds or other propagating material meaning that it is user friendly
than other methods that would require machines or other elaborate techniques.
Some of the biotech opportunities include possibilities to increase crop yields and
reduce production costs, provision of clean planting materials e.g. sweet potato,
potato, banana etc, increasing soil fertility, genetically engineered crops tolerant to
soil acidity/salinity and drought, genetically engineered crops resistant to pests and
diseases e.g. Bt maize,199 biotech research to increase nutritional value in food
e.g. “golden rice” fortified with Vitamin A & Iron,200 biotech can also find use in
solving post-harvest losses due to pests.
It is observed that the modern biotech products are a result of substantial
research and inventive effort and heavy investment in sophisticated laboratories of
universities or MNCs in industrialized countries.201 MNCs involved in
biotechnological inventions have allocated huge funds for research in genomics
and this has also resulted in the change of the structure of the global seed industry
                                                
199 Insect resistant maize (inserted with the gene Bacillus thuringiensis), also herbicide
resistant soybean (inserted with the gene Streptomyces spp.)
200 The gene Erwinia from the Daffodil is being inserted into rice to make it produce beta-
carotene, which the body converts into vitamin A. This experimental transgenic “golden
rice”, has the potential to reduce vitamin A deficiency, a leading cause of blindness and
child deaths in many developing countries. For full biotechnology information see,
http://www.fao.org/biotech/gloss.htm.
201 Developments in the seed industry in the USA give an indication of the recent interest in
biotech patents. As a result of the energy crisis in 1973 and the increased price of petroleum
products, US chemical companies were flush with funds and therefore looked for new
investment opportunities promising high returns. Developments in modern biotechnology
particularly genetic engineering were seen as a major opportunity for big business.
Consequently chemical, oil and pharmaceutical companies such as Ciba-Geigy, Monsanto,
ITT, Shell, Sandoz, Rhone-Poulenc, Pfizer, ICI, Upjohn and others entered the seed business
and over time various mergers and acquisitions have taken place creating a “life-sciences”
industry.  See Mishra, Jai Prakash. Intellectual Property Rights and Food Security – The
Efficacy of International Initiatives. The Journal of World Intellectual Property. Vol. 4. No.
1. January 2000. p. 12-14, and Geoff Tansey, op cit., p. 6
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resulting in mergers and acquisitions. For example, Monsanto Inc., a traditional
chemical company, reinvented itself as a life-sciences company and has invested
US $ 6.6 billion in biotech and genomics.202
The primary function of business like MNCs is to ensure maximum profits on
investments for their shareholders. Typically, businesses would only make
investments in R&D if legal protection were available for the results of research so
that in the final analysis they would recoup investment costs and also make a
profit. Thus, when MNCs are to make heavy investments in R&D the question of
legal protection of the results of their research plays an important role. As in all
other fields of technology, there is a need for the legal protection of
biotechnological inventions. MNCs have thus sought the protection of their
biotechnological inventions through IPRs, particularly patents.203
Patents as exclusive property rights provide MNCs with the requisite incentive to
innovate and invest because of the economic power of an exclusive right, even
though only for a limited period of time.204 The modern biotechnology industry
invests considerable time and money in order to come up with a biotech product.
Due to the complexity of biological phenomenon, a biotech product may present
risks not known until the later stages in R&D or until the product has been
launched into the market. Therefore, because of the considerable investment risk
in biotech R&D, the possibility of an economic reward for biotech inventions is
seen as vital.
Patents have served the biotechnology industry with the effective incentive to
promote innovation.205 Patents also provide the incentive for marketing new
biotech inventions in which the inventor holds the patent rights and have thus
promoted industrial competitiveness and continue to do so.206 Thus, MNCs view
patents as a tool to encourage or stimulate investment (also FDI) and innovation.
It is argued that if patent protection were not available, MNCs would invest less
                                                
202 ibid, p. 13
203 However, inventors of biotechnological inventions are faced with several obstacles in
seeking patents for their inventions e.g. whether their invention is not just a discovery and
the fact that few national IP laws recognize or allow biotechnological inventions. But for
inventions on microorganisms (either the process for obtaining a microorganism or the
microorganism itself or the particular use of a microorganism), they are governed by the
Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the
Purpose of Patent Procedure. As it is difficult, if not impossible, to sufficiently describe a
new microorganism, the Treaty provides a system for depositing microorganisms. Therefore,
applicants for those patents do not have to describe a new microorganism but only have to
refer to a deposit made with a recognized depositary authority.
204 See Li Westerlund, op cit., p. 9-13
205 ibid, p. 10
206 ibid
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in R&D or there would be a serious disincentive to publicise the results of
research.207
As a technology, the biotech products are not risk free.208 Concerns have been
raised due to inadequate controls, transfer of allergens, unpredictability, undesired
gene movement or other environmental consequences. The genes could escape in
pollen and create highly resilient weeds that could be resistant to herbicides or
that displace other wild plants and change the balance of the ecosystem. Similarly,
over time powerful new strains of insects resistant to insecticides could develop.
New toxins could have damaging effects in the food chain, and viruses could
escape from virus-containing crops.209
As a priority, modern agricultural biotechnology should be directed towards
human development such as food security and not just to establish a competitive
edge or maximise profits. Therefore all social, financial, ethical, environmental and
other concerns need to be taken into account while assessing the relevance or
appropriateness of these new biotechnologies, particularly GMOs whose social
and environmental implications are still largely unknown.
For Africa, which is at the centre of biodiversity the impact of these new
biotechnologies could be particularly serious. Conducting a risk assessment is
basic and essential for sustainable agriculture. Such an assessment would need to
identify who gains and who loses, and what are the benefits and what are the
costs of these new biotechnologies.210
Nevertheless, IPRs in agricultural biotechnology raise very heated debates at the
international, regional and national levels. The main legal and policy issues that
arise on the right to food relate to:
                                                
207 ibid, p. 11. The only remaining option would be for MNCs to keep the results of their
research secret. Biotechnological products or processes can be kept secret but as MNCs
would have to commercialise them (without revealing the invention), once a product reaches
the market, it is possible to work out how to copy it through e.g. by “reverse engineering.”
208 Agricultural biotechnology, particularly GMOs have been said to be risky for human
health and the environment and therefore the precautionary principle is applied in
introducing them. The opponents of biotechnology and GMOs mainly found in Europe,
have called for a total ban of planting GMOs and stringent regulations on biotechnology. In
Africa, the Governments of Zambia and Zimbabwe recently banned the import of genetically
modified maize offered as food aid by the US Government to alleviate the current famine in
those countries. However, the Government of Malawi accepted the import but on condition
that the same is only used as food and not for planting.
209 The growing of transgenic/genetically modified crops raises issues concerning the safety
of transferring organisms into new environments, questions of liability for damage that are
not covered under international law and the need for transparency in information.
210 The adoption of the Cartagena Protocol on Biosafety (CPB) in 2000 under the CBD is a
landmark in this regard as it introduces the precautionary approach (PA)  as a guiding
principle for the import of GMOs. CPB subjects the import of GMOs to an Advanced
Informed Agreement (AIA)  requiring the exports of GMOs to be approved in advance by the
importing country. Hartmut Meyer. The Cartagena Protocol on Biosafety. Biotechnology
and Development Monitor. No. 43, September 2000.
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· Ownership: Who has patent rights, for example, in instances where a
different person(s) than the one who has come up with the invention
nurtured the raw material?
·  Access: The grant of IPRs has implications on access as the right holder
usually has exclusive property rights.
· Benefit sharing: How can the benefits arising from innovations be
equitably shared?
Fundamental to the IPR system is the benefit to society. The purpose of the
patent system is to reward a contribution made to society. It is a contract or
bargain the public has with an inventor in the sense that the inventor gives the
public something new and useful, that it would not otherwise have had and in
return, the inventor is rewarded for a limited period of time by economically
exploiting these rights. Thus, the incentive to innovate that patents provide MNCs
should return to the society by either increasing the general knowledge base or the
creation of useful products for the benefit of the public.
It is fundamentally important that patents do not stop or block people from doing
what they have been doing before the patents were granted.211 During the term of
protection there is the possibility of conflict between the interests of the MNCs
(as right holders) and the public in a given invention. It is important to know as
exactly as possible the extent of the exclusive right for which an invention is
granted a patent; a broad patent can have sweeping claims that risk to block third
parties in various ways.
The actual scope of patent protection is thus a central issue for biotechnological
inventions. A perfect balance should be achieved so that as MNCs are given
exclusivity for their inventions as a sufficient financial reward to stimulate
innovation, the same should not deprive the public of what it already possesses or
stop/block people from doing what they have always done.
4.2 Issue One: Ownership
One major issue coming up as a result of IPRs in agricultural biotechnology and
creating new risks of marginalization, vulnerability and impoverishment of rural
farmers is the issue of ownership.
The immediate impact of patenting life forms is the appropriation of common
resources in the public domain into the private domain. The rise of  MNCs in the
life-sciences industry wielding enormous power and control in the food and
                                                
211 Li Westerlund, op cit., p. 13. That is why patents cannot be granted for inventions that
have been in widespread use as they are considered part of the public domain. Patents
should therefore not prevent the continuous use of genetic resources as found in nature.
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agricultural sector is worrying. Another worrying phenomenon is the biopiracy212
of the traditional knowledge (TK)213 of local and indigenous communities in
developing countries, including Africa.
4.2.1 Privatisation of Research and the Rise of
Oligopolies
In the previous chapter, we saw that TRIPs was conceived by major MNCs
based in developed countries and particularly, the USA.214 These MNCs claimed
they were losing profits in foreign countries because of the non-recognition of their
IPRs or inadequacy of foreign IP laws. Thus, they wanted an international system
for the effective enforcement of their IPRs. They also strengthened IP protection
by including new substantive IP standards in TRIPs. As a result, TRIPs is more
about the protection of IPRs for businesses in developed countries to ensure their
global trade than free trade.215
There is an increase in privatisation of research as the rising costs of innovation go
up.216 The 1990’s have seen a significant rise and trend in the number and value
                                                
212 Biopiracy refers to the process by which the rights of local and indigenous peoples in TK
and biodiversity is erased and replaced by IPRs by those who have exploited that
local/indigenous knowledge and biodiversity.
213 In this context, TK means knowledge, innovations and practices of indigenous and local
communities embodying traditional lifestyles relevant for the conservation and sustainable
use of agro-biodiversity. WIPO uses the term to refer to tradition-based literary, artistic or
scientific works; performances; inventions; scientific discoveries; designs; marks, names
and symbols; undisclosed information; and all other tradition-based innovations and
creations resulting from intellectual activity in the industrial, scientific, literary or artistic
fields. There are many categories of traditional knowledge such as e.g. agricultural
knowledge, ecological knowledge, technical knowledge, scientific knowledge or
biodiversity-related knowledge.  For a more comprehensive analysis see
http://www.wipo.int/eng/meetings/2002/igc/pdf/grtkfic3_9.pdf
214 See note 131, Supra .
215 As part of the WTO Agreement, TRIPs is essentially meant to ensure a multilateral
system to conduct free trade i.e. without any obstacles or barriers. The elimination of all
obstacles to international trade or trade liberalization, according to liberal economic theories,
is said to guarantee equal opportunity for all and would ensure the development of all
countries involved. However, in reality the international trade rules have favoured MNCs. In
this system, industrialized countries are at a distinct advantage over other countries
because of the level of their technological development. Where developing countries have a
competitive advantage, the industrialized countries have created barriers for market access
e.g. government subsidies on their agricultural products. Therefore, the notion of “free”
trade is a misnomer.
216 Many governments are facing a squeeze on budgets and thus the proportion of public
funding for R&D in science and technology has fallen around the world, to be replaced by
the private industry. There has also been a shift of R&D away from developing countries.
Their share in the global total dropped from 6% in the mid-1980’s to 4% in the mid-1990’s. In
the US, in the 1980’s crop and seed development was under public research, patents were
rarely sought and rarely enforced, saving and trading of seed was commonplace. The
passing of the Bayh-Dole Act in 1980 changed this as it allows universities and other public
funded institutes to license their technologies from research projects that are directly
62
of MNCs, triggered by mergers and acquisitions of MNCs in the seed, chemicals,
agro-chemicals and pharmaceuticals industries.217 The concept of IPRs on life
forms must be seen in this light. As a result of these mergers, a small number of
MNCs dominate and control the so-called life-sciences industry.218
MNCs from developed countries own most of the IPRs in agricultural
biotechnology.219 For example, in 1996, there were more than 400 patents
granted or pending worldwide, related to the gene of the soil bacterium, bacillus
thuringiensis (Bt), with 60% of these patents originating from just 10 companies
based in developed countries.220 Also, another MNC Agracetus was awarded a
very broad patent on transgenic soybeans covering all transgenic soybeans;
Monsanto later acquired Agracetus and thus, the ownership of the patent.221
The extension of very broad patents for specific plant varieties has meant that a
few MNCs in the life-sciences industry have virtual monopolies on the genome of
important global crops.
IPRs, particularly patents, are increasingly being used by MNCs to expand their
market share, to prevent competitors from becoming active, or as a bargaining
tool to negotiate favourable local agreements. The fundamental issue is control
                                                                                                                           
funded from federal sources. It provides the legal platform for universities to commercialise
the technologies they generate enabling private companies to profit from products
developed largely with public funds. The IP of public and university research has
increasingly passed over to private industry through licensing or other agreements. The
portion of public sector patents in biotechnology sold under exclusive licence to the private
sector rose from just 6% in 1981 to more than 40% by 1990. See UNDP Human Development
Report 1999. 1999. Oxford University Press. New York. p. 68
217 For example, Syngenta is a merger between AstraZeneca and Novartis to become the
world’s biggest agribusiness MNCs; Dupont de Nemours spent over US$ 9.4 billion to
acquire Pioneer Hi-Bred, the world’s largest seed company.
218 In biotechnology, genetic engineering underlies the new direction of pharmaceuticals,
food, chemicals, cosmetics, energy and seeds. This is blurring the distinctions among the
sectors, creating a large and powerful “life-sciences” industry.
219“Developed countries hold 97% of all patents worldwide. In 1995 more than half of global
royalties and licensing fees were paid to USA, mostly from Japan, UK, France, Germany and
the Netherlands…by contrast, more than 80% of the patents that have been granted in
developing countries belong to residents of developed countries.” See UNDP Human
Development Report 1999. p. 68
220 Bt gene is a soil bacterium that has pesticidal properties. It has been known by farmers
since the 1940s. When inserted in maize (Bt-maize) it produces corn resistant to the corn
stem borer. It has also been inserted in cotton (Bt-cotton) and potato (Bt-potato). Few
companies possess the technology in these specific or other crops. See Cecilia Oh. IPRs
and Biological Resources: Implications for Developing Countries.
http://www.twnside.org.sg/title/iprharare.htm. p. 9
See also, Electronic Forum on Biotechnology in Food and Agriculture. Conference 6. The
impact of IPRs on food and agriculture in developing countries. p. 6
http://www.fao.org/biotech/C6doc.htm
221 Such broad species patents are also being applied to cotton and rice so as to secure the
market for the patent holder and to prevent competition with the effect of stifling research.
See Cecilia Oh, op cit., p. 9
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and IPRs are being used as legal instruments to wield power and control. This
IPRs regime has enabled a select group of companies to gain control over ever-
growing shares of the global market.
In 1998, the top 10 corporations in the commercial seed industry; controlled 32%
of a $ 23 billion industry; in pharmaceuticals, 35% of the US$ 297 billion
industry; in veterinary medicine, 60% of the US$ 17 billion industry; and in
pesticides 85% of the US$ 31 billion industry. 222 It is also observed that the top
five biotechnology firms in the world are based in the United States and Europe
and control more than 95% of gene transfer patents.223  80% of patents on
genetically modified foods are owned by just 13 MNCs and the top five agro-
chemical corporations control “almost the entire global seed market.”224
Seed is the first link in the food chain. The control of seeds through patents largely
determines who controls the food system. Whoever controls the seed controls the
food supply. Such monopoly power means that the MNCs are able to control the
supply of seeds. By controlling the supply, they also have the means of controlling
the prices of seeds. To increase their profits, they can increase the prices.
More than just a pricing issue, patents are stifling rather than stimulating research.
MNCs now own multiple or overlapping patents required to develop a biotech
product. Patents have been obtained for enabling technologies – those
technologies that are essential for the practical implementation of a wide range of
biotech processes and products – which complicate the management of the
research agenda.225 This has a direct impact on access to technologies by
developing countries and the agricultural research system both in developed and
developing countries.
                                                
222 UNDP Human Development Report 1999.  p. 68
223ibid. Namely: Syngenta (AstraZeneca – UK/Sweden and Novartis (Sandoz and Ciba-
Geigy- Swizerland), E.I Dupont de Nemours (Pioneer Hi-Bred international -USA), Monsanto
(a component of Pharmacia and Upjohn, it acquired Agracetus, Asgrow Seed, Cargill,
Calgene, DeKalb Genetics, Holden’s Foundation Seeds - USA), Aventis (Hoechst Schering
AgrEvo, Plant Genetic Systems, Rhone-Poulenc - Germany/France), Dow Chemical
(Mycogen Seeds). See Barton, J.H.  The Impact of Contemporary Patent Law on Plant
Biotechnology Research in Intellectual Property Rights III Global Genetic Resources:
Access and Property Rights . 1998. Crop Science Society of America. American Society of
Agronomy. p. 94
224 van Dillen, Bob and Leen, Maura (eds.). Biopatenting and the Threat to Food Security:
A Christian and Development Perspective. CIDSE. February 2000.
http://www.cidse.org/pubs/tg1ppcon.htm
225 Modern biotechnology requires the use of several products and processes, which are
usually patented. For example, to produce a genetically modified food crop could entail the
use of individual genes that are patented, DNA sequences that control the expression of the
gene that are patented and the two methods used to transfer foreign DNA and identify plant
cells that are patented. MNCs have overcome this hurdle of access to patented products
and processes to conduct R&D by cross-licensing their patents among each other. In the
event that a competitor fails to license a technology, litigation usually ensues. This results
in acquisitions and mergers among MNCs as an out-of-court settlement.
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Due to patents, MNCs now have limited incentives to conduct research as the
industry leaders are in an oligopolistic (and potentially monopolistic) situation.
Smaller businesses are generally the source of innovation and are finding it
impossible to enter the biotech industry due to the many patents MNCs own.
With the advent of genetic engineering, seeds become the “operating system” that
MNCs use to deliver new technologies. MNCs are using genetically modified,
patented seeds to dictate how farmers will farm, and under what conditions, with
farmers, indigenous peoples and public sector researchers losing the right to use
and develop agro-biodiversity.226 This has potentially devastating consequences
for farmers, food security and the environment.
MNCs to maximise profits are also preventing the use of second-generation seed
produced from transgenic crops by using legal contracts or other mechanisms.227
This essentially constitutes a regulatory system that bypasses IPRs and
government authority. Hence, for example, farmers who purchase transgenic plant
seeds are often required to sign contracts that specifically prohibit the saving and
replanting of second-generation seed. These contracts also give the MNCs, or
their authorized agents, the right to inspect and test the farmer’s field and monitor
whether the farmer is reusing the patented seed or is otherwise complying with the
contract.228
Traditionally, farmers have had the right to save or replant seed from a harvest
and/or sell the seed. 1.4 billion rural people, primarily rural poor farmers in
developing countries rely on farm-saved seed as their primary seed source. By
subjecting farmers to sign contracts every time they buy seed is reducing farmers
to renters of seeds. This arrangement has also been described as a new kind of
“bioserfdom,” where the MNCs are the new feudal lords, wielding power and
wealth owning the information contained within the new seed varieties, rather than
the land.229
MNCs would go at any lengths to ensure profits. The latest development is the
creation of biotechnologies known as Genetic Use Restriction Technologies
(GURTs) (and obtaining patents on them) as a means of exerting control and
ownership rights over agro-biodiversity.230 GURTS are of two kinds; one is
                                                
226 MNCs such as Monsanto have sued farmers e.g. in Canada and USA for saving and
reusing genetically engineered seed patented by them. See other examples in Vandana
Shiva, op cit., p. 73-76
227 Intellectual Property. Transgenic Plants and World Agriculture. July 2000. National
Academy Press. Washington, D.C USA. p. 32. The validity of these contracts is an issue
because TRIPs controls anti-competitive practices in contractual licenses – See Part 8
TRIPs.
228 Audrey Chapman, op cit., p. 23
229 ibid
230 Monsanto has developed these technologies. Both AstraZeneca and Novartis have been
researching GURTs also.
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“terminator technology” which is a set of new genetic engineering techniques used
to create sterile plants with infertile seeds that cannot be replanted.231 The second
one is “traitor technology” which control other plant characteristics or traits.
These traits can be switched on or off by the application of inputs only available
from the MNCs.
These technologies are able to protect the interests of MNCs by killing the seed
after one generation. Farmers will then be forced to purchase seed every planting
season. Further, the seeds will only germinate and bear fruit only when used with
the MNCs inputs e.g. chemicals and thus increasing sales/profits through
increasing farmers’ dependency on inputs. In this case, patents are no longer
needed to protect MNCs interest, the technologies have in-built protection.
In the above scenario, farmers’ risk being caught up in a web of IPRs, biological
and licensing controls instigated by powerful MNCs.232 Their main source of
livelihood is jeopardized. The already poor rural farmers are further impoverished
as they are driven into cycles of debt from trying to adopt farming inputs, paying
royalties to the seed companies and buying seed each year. The cost of food
production just goes up threatening the livelihoods of millions of people in
developing countries.
It has been said that “the Third World farmer has a three-fold relationship with the
corporations that demand a monopoly of life forms and life processes: firstly, the
farmer is a supplier of germplasm to MNCs, secondly, the farmer is a competitor
in terms of innovation and rights to genetic resources, thirdly, the farmer is a
consumer of the technological and industrial products of MNCs. Patent
protection displaces farmers as competitors, transforms them into suppliers of free
raw materials, and makes them totally dependent on industrial suppliers for vital
inputs such as seeds.”233
The tighter control of research in the hands of private interests in developed
countries also ignores research needs of millions in the developing countries.234
                                                
231 Terminator technology involves the use of chemical treatments on seeds or plants that
either inhibits or activates specific genes involved in germination. It would involve a
complex three-gene system whereby one gene produces a protein that interferes with proper
plant embryo development preventing seed germination. The US Department of Agriculture
has recently announced its intention to commercialise this technology. See Audrey
Chapman, op cit., p. 24 and also Vandana Shiva, op cit., p. 80-85
232 Patents are also being used, not only against the farmers, but also against rival MNCs to
ensure corporate dominance in the market.
233 Carlos Correa, op cit., p. 171
234 Science and technology gives power to those who possess it, whatever the field
involved and such power tends to be wielded in the interests of those who command it. It
takes a lot of time and money (an estimate has been given of 10 years and US $300 million)
to create a new commercial product. MNCs have the money to protect their innovations and
thus to ensure profits and recoup investment costs they have been increasingly applying
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The best of the new biotechnologies are designed and priced for those who can
pay; they show a tendency of serving the needs of the rich industrialized
countries.235 The rest of the world is only a recipient of biotechnologies developed
in these countries. As a result, in general the developing world is the largest
eventual consumer of the new biotechnologies. This leads to an increased
dependency of developing countries on developed countries, as the newest
technologies are owned by MNCs based in developed countries.
The developed countries as generators of biotechnologies only produce that
which suits their own requirements or purposes rather than those of the poorer
nations or developing world. The conditions and needs of the developing world
are so different from the developed world, but the biotechnologies developed by
the industrialized world are often the only ones available irrespective of how
unsuitable they may be.236 There is thus a need of particularly considering the
needs of the developing world and the impediments to technological development
so as to derive the maximum benefit from biotechnology.237
With increasing control and homogenisation of the market by MNCs – with the
emphasis on the isolation of specific genes with beneficial characteristics - the
competitiveness of alternative plant varieties and the scope for producing
alternative crops will likely decline. Also, the commercialisation and farming of
monocultures/uniform plant varieties e.g. hybrids – which emphasize on
productivity and therefore are high yielding - leads to the loss of traditional plant
varieties/land races as the latter are pushed out of farming and the market as
farmers increasingly cultivate monocultures to increase farm productivity and
become more dependent on farm inputs e.g. fertilizers, herbicides and
pesticides.238
                                                                                                                           
for patent protection. Thus, in defining research agendas, money talks louder than need.
This approach focuses on the high-income markets only.
235 For example, research into tomatoes with longer shelf lives, yellow maize to be used
mainly for poultry feed or seed varieties that are engineered to be suitable for mechanized
mass production with labour-saving techniques are designed for industrial and intensive
farming conditions. However, over the last several years MNCs have also become interested
in developing world markets e.g. R&D in soybeans, maize, rice and wheat, which have large
markets in developing countries and where there is also major export potential.
236 Far less time and money is spent on research on the needs of farmers in developing
countries e.g. the development of drought-resistant crops for marginal lands or water-saving
plant varieties for small-scale farmers, development of disease-resistance and robustness of
crops, development of herbicide-resistant crops or increasing the nutritional value of crops.
For the rural farmers in Africa, the technological progress remains far out of reach.
237 The challenge is for developing countries and its scientists and researchers to gain
access to these biotechnologies on favourable terms and adapt them to suit the needs of
their rural farmers. Most of the agricultural research in developing countries is carried out by
the public sector. There is thus a need to foster public/private partnerships to effect transfer
of biotechnology to developing countries. In this way, biotechnology can be developed in
accordance with the needs and requirements of all humanity.
238 It is said local communities maintain a higher degree of genetic variety in the crops they
cultivate than does commercial agriculture, which relies on a very narrow genetic base using
only a few modern varieties. See Rohini Acharya, op cit., p. 6-7
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The tendency towards monocultures ignores locally adapted plant varieties (which
are more susceptible to certain diseases or ecological stresses) and ignores the
advantages of local planting techniques/traditional agricultural, ecological
knowledge geared towards maintaining agro-biodiversity and therefore leads to
the reduction or erosion of biological diversity.239As developing countries are
biorich, these trends threaten the depletion of their agro-biodiversity, as local
plant breeding is essential for adapting seeds to the ecosystem and maintaining
biodiversity.
Although supposed to increase farm productivity, monocultures do not ensure
food security because the varieties have similar characteristics, which are more
vulnerable to the same pressures, climatic, pests or disease and there are several
instances where an entire harvest has been lost as a result of either planting
monocultures or using a monoculture planting technique. This undermines small-
scale mixed subsistence and local market-based production systems and is a huge
threat to small-scale agriculture with its multiple roles as it could dramatically
reduce the food security of millions of people in developing countries.            
4.2.2 Biopiracy
It is observed that over 90% of the earth’s remaining biodiversity is in the tropical
and sub-tropical regions of the developing world i.e. Africa, Asia and South
America.240 As science and technology advance while biodiversity dwindles, there
is an increased interest in appropriating TK for scientific and commercial
purposes. Institutions and MNCs in the life sciences industry based in developed
countries engage in “bioprospecting” and “biopiracy” activities.241
                                                
239 Article 2 of CBD defines biological diversity as, “the variability among living organisms
from all sources including, inter alia, terrestrial, marine and other aquatic ecosystems and the
ecological complexes of which they are part, this includes diversity within species, between
species and of ecosystems.” Agriculture and biodiversity are inextricably linked. Biological
resources constitute a primary input for agricultural production; the erosion of biological
diversity directly affects agricultural production. Agro-biodiversity refers to that part of
biodiversity that is used for food and agriculture. Agro-biodiversity exists because of the
wide range of varying climates, habitats and farming practices found within the centres of
diversity and the natural selection caused by the presence of different pest and diseases.
See Patricia Kameri-Mbote and Philippe Cullet. Agro-biodiversity and International Law.
African Centre for Technology Studies (ACTS). ACTS Press. Biopolicy International Series
No. 22. Nairobi, Kenya. p. 3
240 UNDP Civil Society Organizations and Participation Programme: Conserving
Indigenous Knowledge
http://www.undp.org/csopp/CSO/NewFiles/dociknowledge.html
241 There are numerous examples. For e.g. University of Wisconsin has obtained a patent on
a plant that grows in Cameroon that produces Brazzein, a natural sweetener. The university
has also engineered a bacterium to produce brazzein. This means that Cameroon rural folk
who have nurtured the sweetener for generations will be excluded from commercialising it if
they so wished. See Vandana Shiva, op cit., p.49-57
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Bioprospecting is the exploration, extraction and screening of biodiversity and
indigenous knowledge for commercially viable genetic and biochemical resources.
Biopiracy involves the grant of patents to commercial interests such as MNCs
based in developed countries over biodiversity and indigenous knowledge used to
develop that biodiversity such as traditional methods of breeding or domestication
of local and indigenous peoples found in developing countries. Local or
indigenous peoples do not give their consent for the appropriation of these genetic
resources or their knowledge. The biodiversity and indigenous knowledge
appropriated is usually reduced to or isolated to specific genes, and this isolation
is treated as an “invention” warranting legal protection i.e. IPRs. Once a
product(s) is released to the market and becomes profitable, no benefit accrues
to the local or indigenous peoples where the product originated.
Bioprospecting and biopiracy usually go hand in hand.242 As a result, one finds a
growing number of MNCs in the life sciences industry (and their intermediaries,
usually universities and other research institutions) in the developing world in
search of biodiversity and TK.
Though bioprospecting does not always involve the use of TK, it is clear that
valuable genetic resources derived from plants, animals and microorganisms are
more easily identified and of greatest commercial value when collected with this
knowledge and/or found in territories traditionally inhabited by indigenous
peoples.243
The immediate impact of bioprospecting and biopiracy activities is that it reduces
the ability of local and indigenous peoples to meet, inter alia, their food and
health needs. Without their consent, it transfers their rights on their biodiversity
and indigenous knowledge to IPRs holders. The local communities then end up
paying high prices or royalties for products developed as a result of their own
resources and knowledge. This leads to the impoverishment of rural communities.
The patenting of life forms found in indigenous peoples lands or ecosystems raises
ethical, moral, religious and other concerns because for indigenous peoples they
have a spiritual and cultural connexion to their ecosystems. They are intimately
linked to a particular socio-ecological context by various economic, cultural and
                                                
242 RAFI, Bioprospecting/Biopiracy and Indigenous peoples. 2001.
http://www.latinsynergy.org/bioprospecting.htm. p. 1
243 Article 1(b) of the ILO Convention 169 Concerning Indigenous and Tribal Peoples in
Independent Countries states that indigenous peoples are: “Peoples in independent
countries who are regarded as indigenous on account of their descent from populations,
which inhabited the country, or a geographical region to which the country belongs, at the
time of
conquest or colonization or the establishment of present state boundaries and who
irrespective of their legal status, retain some or all of their own social, economic, cultural and
political institutions.”
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religious activities. TK is therefore deeply entrenched in the lives of indigenous
peoples. It is often difficult to isolate or distinguish TK from indigenous peoples.
Article 27(3)(b) of TRIPs allows for the exclusion from patentability only
traditional breeding methods, but not modern breeding methods (biological not
non-biological processes) such as genetic engineering. The contributions of
indigenous peoples to, inter alia, plant breeding, genetic enhancement,
biodiversity conservation, is not recognised or protected.  Indigenous peoples
have been the cultivators, breeders, researchers and protectors of biological
resources found in their lands. Indeed, it is their long acquired knowledge of their
biodiversity that is valuable to the biotech companies today.
RAFI estimates that “…possibly two thirds of the world’s people could not
survive without the foods provided through TK of plants, animals, insects,
microbes and farming systems.”244 Yet, indigenous peoples would not have
access to IPRs to protect their traditional breeding methods and as a result these
methods would remain in the public domain at the jeopardy of being freely used
and exploited by all, particularly by MNCs. If anything, the IP system is
predatory on the rights, knowledge and resources of indigenous peoples.
The use and improvement of farmers’ varieties has been a major source of food
security and vital to ensure food production for local and indigenous peoples. It is
estimated that nearly 2.5 billion people rely on wild and traditionally cultivated
plant species to meet their daily food needs.245 Seed supply relies on this
“informal” system. TK, combined with continued access to and the availability of
agro-biodiversity, is essential for the survival of many local and indigenous
peoples. Biopiracy threatens the very survival of many of these people.
As a result of bioprospecting and biopiracy activities, there has been increasing
recognition of the need to protect TK of local and indigenous peoples. TRIPs
does not provide any and/or adequate protection for TK. It does not specifically
protect TK. This knowledge is not treated as IP worth protection.
TRIPs ignores cultural diversity in creating and sharing innovations – and diversity
in views on what can and should be owned.246 As we have seen, the nature of
TRIPs is established on developed countries/western concepts of, inter alia,
individual ownership of rights and property and does not recognise the communal
ownership of rights and property, including TK of local and indigenous peoples.
Also, to the extent that patents are obtained on TK shows a weakness in the
system as such patents do not meet the criteria for patentability, particularly
novelty. To this extent therefore, TRIPs is discriminatory. It is an absurd
imposition of the western culture’s systems on other cultures and traditions.
                                                
244 RAFI, Bioprospecting/Biopiracy and Indigenous peoples, op cit., and also
UNDP/CSOPP Document, op cit., p. 2
245 Patricia Kameri-Mbote, Philippe Cullet, op cit., p. 4
246 UNDP Human Development Report 1999.  p. 68
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The very nature of the current IPRs system discriminates against developing
countries as it unfairly places a greater value on biotechnology outputs, generally
produced in developed countries, than on genetic resources (often used to create
the biotechnology products) and contributions from local/indigenous communities,
found in developing countries.
Further, what is also most disturbing today is the effort to bring germplasm held
by the International Agricultural Research Centres (IARCs) of the CGIAR.247 In
the 1950’s and 1960’s, indigenous and other rural people gave germplasm now
held by CGIAR for research use. CGIAR research efforts produced hybrid
varieties of especially maize and rice, which maximised and increased food
production, introducing the “green revolution”. The “green revolution” managed to
achieve food security and greatly reduced hunger for many countries in Asia and
Latin America. This was possible because the hybrid seeds were freely available,
CGIAR did not have IPRs over them and the developing countries were able to
buy the seeds at very low prices.
4.3. Issue Two: Access
The sustainable development of agriculture is strongly dependent on access to
plant genetic resources (PGRs).248 No country or region of the world is self-
sufficient in biological diversity. PGRs are unevenly distributed around the world.
Even the most biologically diverse countries look to other regions of the world for
a crucial share of their genetic stock.249 Humanity shares a common bowl
containing only 20 cultivated crops that sustain 90% of our calorie
                                                
247 For e.g. two agencies, Agriculture Western Australia and the Grains Research and
Development Corporation, had apparently applied for PBRs in relation to two species of
chicken pea, which had been bred from material provided by ICRISAT. See Michael
Blakeney. Intellectual Property Rights in the Genetic Resources of International
Agricultural Research Institutes-Some Recent Problems. 1 BioScience Law Review. 1998.
p. 2-3
248 PGR is a term generally used to refer to landraces, advanced cultivars, wild relatives of
domesticated plants and wild (non-domesticated) species used by man but which have
scientific and economic value. Conversely, the term “genetic resources” is said to be
“genetic material of actual or potential value while the term “genetic material” includes “any
material of plant, animal, microbial or other origin containing functional units of heredity.
Thus genetic resources are genetic material of actual or potential value of plant, animal,
microbial, or other origin. A South/North argument is used as to whether to use the term
“plant genetic resources” or “genetic resources”. See Robin Pistorius and Jeroen van Wijk,
op cit, and also Girsberger, op cit., p. 1020
249 For example, bananas and plantains are important cash crops in Central and South
America and the highest per capita consumption as a staple food is in East Africa; however
“home” for bananas and plantains is Southeast Asia. See The Crucible Group. People,
Plants and Patents: The impact of intellectual property on Biodiversity, Conservation,
Trade, and Rural Society. 1994. International Development Research Centre. Ottawa. p.4-7
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requirements.250 As far as the major crops are concerned, most regions of the
world mainly depend on resources originating from elsewhere. We need each
other.
In view of our interdependence, access to PGRs and processes is extremely
important as it directly affects food security. Access to, control over and
ownership of PGRs and processes has increasingly become a major issue
internationally especially as biological resources dwindle. This has led to increased
competition for these resources and an emphasis on their economic value.
Concern is also raised when equal partners have an unequal opportunity to benefit
from these resources or where it appears that IPRs are only available to a select
few like MNCs at the expense of farmers or other rural communities.
4.3.1 Do patents restrict access?
It is essential to establish the extent to which patents may affect access to agro-
biodiversity and processes because access is necessary for the continuous
adaptation and improvement of plants for food and agriculture.
A new plant variety cannot be “created” from scratch. The improvement of crops
can only take place on the basis of the use and modification of what nature has
created. Therefore, innovation in plant breeding activities is essentially of an
“incremental” nature, in the sense that it progresses on the basis of successive
changes on available varieties. However, the need for strong patent protection so
as to protect biotech inventions against copying is particularly important because
as biological material, they naturally (re)-produce themselves.
The minimum term of protection for patents is 20 years, after which the invention
falls into the public domain.251 During the term of protection a patentee has
exclusive property rights. The granting of a patent entails a prohibition, ius
excluendi, of use of the patented material in the countries where the rights have
been recognized.252
A product patent confers on its owner the exclusive right to prevent third parties
from “making, using, offering for sale or importing for those purposes the
product” without the patentee’s consent.253 In the case of a process patent, the
patentee may prevent the use of the process as well as the commercialisation of a
product “obtained directly by that process”.254 Thus, if a process (e.g. genetic
                                                
250 ibid, p. 4. Of these, rice, wheat and maize account for 60% of the calories and 56% of the
protein that people derive from plants. See Patricia Kameri-Mbote and Philippe Cullet, op
cit., p. 3
251 Article 33 of TRIPs
252 Carlos Correa, op cit., p. 176
253 Article 28(1)(a) of TRIPs
254 Article 28(1)(b) of TRIPs
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engineering) to produce a plant (e.g. transgenic plant) were patented, exclusive
rights would also extend to the plant obtained with the patented process.255
Patent rights are territorial therefore the right holder can only exercise his rights
within the jurisdiction of where his patent is recognised or registered. However,
outside the jurisdiction where his patent has been registered, the right holder can
prevent the importation of products made elsewhere containing his invention.256
In principle, patents are negative rights to the extent that they exclude or prevent
third parties from making, using or commercialising an invention without the
authorisation of the patent holder. A patent on either a biotech product or process
would exclude/prevent other parties from the production, reproduction
(multiplication), research, breeding and commercialisation of such biotech product
or process.
One of the negative implications of patents on agricultural biotechnology is its
impact on agricultural research. Patents have broken down the traditional access
and benefit-sharing system that previously existed between developed and
developing countries where on the one hand developing countries provided free
access to their genetic resources and developed countries freely received the
benefits of research that used those resources. Today developing countries still
provide access to genetic resources for free but the benefits of research that use
those resources are no longer free or as accessible as before.
Patents have hindered the traditional flow of knowledge and genetic material
among researchers. There is a lack of “freedom to operate” to conduct biotech
R&D activities because of the existence of many patents on biotech products and
processes held by MNCs. This has slowed down research partnerships and the
flow of knowledge between interested research parties and has led to a negative
impact on the quality of research carried out. The multiplicity of patents owned by
MNCs, especially where broad patents are granted on useful biotech information
and technology or fundamental research processes, have stifled research and
complicated or deterred useful and desirable follow-on research.
Access to patented biotech products or processes would be subject to terms set
by the patent holder such as the conclusion of licensing agreements with such
terms and conditions as the patent holder might see fit e.g. the payment of
royalties. This impedes and interferes with the exchange of plant materials and
knowledge among researchers, countries, universities and other stakeholders.
This could have dire consequences for public research in developing countries,
which normally have scarce financial resources.
                                                
255 Carlos Correa, op cit., p. 176. Article 34(1) of TRIPs places the burden of proof in process
patents on the producer, for him to show that he did not use the patented process to
produce his product.
256 Carlos Correa, op cit., p. 176
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A patentee may also prevent farmers from traditionally saving and reusing seeds
for use in subsequent planting seasons and/or commercially exploiting a harvest, if
the seeds thus used are patented. In addition, a patentee may prevent farmers
from breeding new varieties using patented seeds. It is evident that patents on
seeds (or other propagating material) can be used to protect against farmers seed
reuse (either for planting (production or reproduction) and commercialisation) and
against farmers or other breeders seeking to use the material for improving on the
variety. In practice, the patentee can find many ways to block access and
distribution of the patented biotech product or process and limit the uses made of
it while access to the patented products or processes would be subject to the
patent holder’s terms and conditions.
Similarly, as patents on isolated genes extend to GMOs into which the genes are
inserted hence bringing the entire organism under patent protection, when such
genes are inserted into plant varieties there is a failure of recognizing the
contribution of breeders’ of the original plant variety while this also has an
implication on access to any plant variety inserted with the patented gene.
4.3.2 Do PBRs restrict access?
The criteria used to grant PBRs – plant varieties that are distinct, uniform and
stable – leads to genetic erosion. As farmers opt to farm and sell such varieties
instead of land races/traditional plant varieties – which are genetically diverse and
do not meet the criteria for the grant of PBRs – this leads to genetic erosion. As
PBRs are only granted for a variety that is genetically uniform they automatically
limit both what kind of seeds can be marketed and who can market them thereby
keeping genetically diverse and locally adapted seeds from the market and from
the farms.
PBRs promote commercially bred varieties geared for industrialized agriculture in
which local or rural farmers have to pay royalties on such seed. The seed sector
thus becomes an investment opportunity for MNCs. Such varieties only breed or
grow successfully when farm inputs are applied to them e.g. fertilizers, herbicides,
pesticides which are available only from the MNCs, at the expense of more
sustainable biologically diverse systems.
Traditionally PBRs do not restrict access to plant varieties due to the availability
of the breeders’ exemption and farmers’ privilege. However, the stronger levels
of protection introduced under the 1991 UPOV Act ensures a restriction of
access.
The 1991 Act does not require countries to protect the rights of farmers to freely
use their harvest as further planting material  (so-called farmers’ privilege). It
leaves it optional for member states to define a farmer’s privilege – as an
exemption from the breeders’ right – which then potentially restricts farmers’
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access to propagating materials e.g. seeds in those member states that choose not
to grant this privilege.257
Thus, under the 1991 Act, unless the national law provides otherwise, a farmer
who produces or reproduces a protected variety from farm-saved seed is guilty
of infringement. This weakens the economic position of rural farmers because they
traditionally rely on farm-saved seed for use as seed in subsequent planting
seasons and also to sell in their local markets.
Under article 13(2) of the 1991 Act, a breeder may have some rights in relation
to a farmer’s harvest. For instance, if a farmer plants in his farm seed from a
protected variety on which royalty had not been paid, the breeder could sue the
farmer for infringement. The breeder has no rights in relation to the harvest when a
farmer resows his own seed exercising the farmers’ privilege.
It would also be an infringement to produce or reproduce and perform related
acts with respect to “essentially derived” varieties. This may limit the diffusion of
varieties improved by farmers, though (if the farmers’ privilege is recognized) it
would not prevent them from using the essentially derived varieties in their own
local and traditional innovations.
The 1991 Act also restricts breeding in that anyone using a protected variety in
research has to make significant changes to the variety or else the “new” variety
will not be considered as “new” but as an “essentially derived” variety, which as
we have seen, cannot be exploited without the permission of the original breeder.
In addition, the 1991 Act is silent on the double protection of plant varieties i.e.
under patents and PBRs hence leaving it free for member states to decide
whether or not to provide plant varieties double protection. In the event that a
member state provides double protection, this will strengthen the position of the
right holder at the expense of the public, particularly researchers, breeders and
farmers.
4.3.3 Do trade secrets restrict access?
A trade secret held by its possessor is not accessible to third parties, unless with
the possessor’s consent. Trade secrets are not exclusive rights; the protection
accorded is against using the secret information in dishonest commercial practices.
Thus, information protected because it is secret may be used and reproduced by
a third party, if such acts do not constitute unfair commercial practice. In addition,
trade secrets do not protect against discovery, or accidental or wilful disclosure.
                                                
257 It is observed that the 1991 UPOV Act expressly allows countries to permit seed saving
by farmers and, in practice, virtually all countries make special provision for the right to
reuse seed in their national laws although this is usually restricted to small-scale or
subsistence farmers. See Geoff Tansey, op cit., p.10
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It is observed that hybrid seeds need to be replaced for each cycle of production
(planting season) because they do not breed true. They are therefore protected
by their very nature against unauthorized reproduction. However, in the case of
their parent/inbred lines, when used to produce hybrids, if the said lines are not
commercialised or made public, the lines would be protected as a trade secret,
creating a barrier for third parties against unauthorized access to and use of the
said lines for research and breeding activities.
Under Article 39(2)(b) of TRIPs reverse engineering (e.g. of hybrids so as to
know what constitutes the parent/inbred lines) appears to be legitimate because in
order to be protected, the “undisclosed information” must be “secret in the sense
that it is not…readily accessible to persons within the circles that normally deal
with the kind of information in question.” Hence, to the extent that the secret can
be discerned through evaluation of a product that “incorporates” it, no protection
would be available.
The extent to which trade secrets may restrict access to information will depend
on the rights the possessor has in respect of acts of reverse engineering when the
secret information is “embodied” in and obtainable from the products and
possibly, on the terms and conditions of the particular sales contract.
The use of conditions of sale, label licences on bags of seeds (“shrink wrap”) and
contractual clauses by MNCs can also be restrictive on the use of seeds imposing
restrictions beyond those determined by IP or other substantive laws.
4.4 Issue Three: Access and Benefit
Sharing
Access and benefit sharing have often been raised together as a result of
biopiracy. Benefit sharing constitutes a useful strategy to reduce the impact of
patents on farmers and local communities and to eliminate biopiracy, which fails to
acknowledge or compensate local or indigenous communities for appropriating
their knowledge.
MNCs engaged in biopiracy activities have made enormous profits as a result of
using TK and PGRs developed and bred by local and indigenous peoples. It is
estimated, for example, that the economy of the USA alone has annual sales of at
least US$ 50 million from genes of 15 major crops that were first cultivated and
enhanced by indigenous peoples.258
                                                
258 Mugabe, John. Intellectual Property Protection and Traditional Knowledge: An
Exploration in International Policy Discourse. 1999. African Centre for Technology
Studies (ACTS). ACTS Press. Biopolicy International Series no. 21. Nairobi, Kenya. p. 5
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The IP system has contributed to the biopiracy of TK posing issues of
compensation and benefit sharing to the local and indigenous peoples where the
knowledge originated from and the need for protection against future such-like
activities.
Though the definition of benefit sharing is often broad, in practice it is often limited
to monetary compensation. In effect, this kind of benefit sharing legalizes and
legitimises the dispossession of local and indigenous peoples rights over PGRs
and TK and to avoid biopiracy, it sacrifices their rights.259
In this light therefore, there have been efforts both at the international and regional
level to address access and benefit sharing issues. These are presented herein
below so as to analyse the efficacy of the TRIPs regime.
4.4.1 The Convention on Biological Diversity (CBD)
The CBD was adopted at the 1992 United Nations Conference on the
Environment and Development (UNCED) dubbed “Earth Summit” and came into
force in December 1993.260
The negotiations leading to the conclusion of the CBD were characterised by
major ideological differences between developing and developed countries
(particularly the USA).261 The issue of IPRs was very prominent in the
negotiations. The main issues of concern pertained to the ownership of biological
resources both within (in situ) and without (ex situ) national boundaries and in
gene banks (e.g. CGIAR) and biotechnological innovations ensuing from those
resources.262
                                                
259 Cullet, Philippe. Plant Variety Protection in Africa: Towards Compliance with the
TRIPS Agreement. 2001. African Centre for Technology Studies (ACTS). ACTS Press.
Biopolicy International Series No. 3. Nairobi, Kenya. p. 22
260 See Johnson, Stanley P. The Earth Summit: The United Nations Conference on
Environment and Development (UNCED). 1993. International Environmental Law and
Policy Series. Graham & Trotman/Martinus Nijhoff. London. p. 81-102. See text at
http://www.biodiv.org/default.asp
261 The USA was the most prominent objector to the CBD and is still not a party to the CBD.
Her main reasons were: firstly, the fact that the CBD dealt with biotechnology and provided
that developing countries should have access to biotechnology on preferential terms;
secondly, the provisions allowing for countries to patent genetic material and charge
royalties for its use, thus presumably reducing the profits of MNCs that develop such
material to marketable products; thirdly, the financial provisions requiring developed
countries to provide financial resources to developing countries so that they can implement
the CBD which provisions were seen to provide a wide leeway with the developed countries
being legally bound to provide whatever the developing countries decide. See Stanley
Johnson, op cit., p. 81-82 and Malanczuk, P. Akehurst’s Modern Introduction to
International Law. 1997. 7th revised edition. Routledge. London & New York. p. 249
262 The CBD does not apply to ex situ collections such as those held by gene banks like
CGIAR centres collected prior to the date when the CBD came into force. These ex situ
collections are dealt with in the FAO Treaty (mentioned below).
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In its preamble, the CBD recognizes that conservation and sustainable use of
biodiversity is of crucial importance for meeting the food, health and other needs
of a growing world population, for which purpose access to and sharing of both
genetic resources and technologies are essential. It also recognizes the vital role
that women play in the conservation and sustainable use of biological diversity and
affirms the need to include women in all decision-making processes for
biodiversity conservation.
The main aims of the CBD are “the conservation of biological diversity, the
sustainable use of its components and the fair and equitable sharing of benefits
arising out of the use of genetic resources, including by appropriate access to
genetic resources and by appropriate transfer of relevant technologies, taking into
account all rights over those resources and to technologies, and by appropriate
funding.”263
The preamble of the CBD recognises that the conservation of biodiversity is now
a “common concern of humankind”. In spite of the international trend towards the
conservation of biodiversity as a common concern, states generally are
responsible for the sustainable conservation of the biodiversity within their
boundaries. Therefore, the CBD recognises the sovereign rights of states over
their biological and genetic resources.264
State sovereignty remains an important basis for regulating access to biological
resources. The CBD states that the authority to determine access rests with
national governments and is subject to national legislation.265 States are to
endeavour to facilitate access by other state parties for environmentally sound
use.266 Further, access to these resources can only occur on mutually agreed
terms and with the “prior and informed consent” of states, unless states have
otherwise determined.267
                                                
263 Article1 of CBD
264 Article 3, 15(1) of CBD. State sovereignty over natural resources is reaffirmed in many
international conventions.  Permanent sovereignty over natural resources is a facet of state
sovereignty and refers to the right to exploit and develop natural resources, including agro-
biodiversity, according to a state’s own policies. This right is also found in both article 1 of
the ICCPR and ICESCR, and is a component of the right to self-determination. It states “All
peoples may, for their own ends, freely dispose of their natural wealth and resources
without prejudice to any obligations arising out of international economic co-operation,
based upon the principle of mutual benefit, and international law. In no case may a
people be deprived of its own means of subsistence.”
265 Article 15(1) of CBD
266 Article 15(2) of CBD
267 Article 15 (4), 15(5) of CBD “Prior Informed Consent” from states and/or local
communities means that agreement has been obtained by those taking genetic resources
from the providers of the resources about the destination of those resources, what they may
be used for and, usually, a commitment to share any benefits derived from the enhanced use
of those resources. See Geoff Tansey, op cit., p. 25
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Further, the CBD requires the equitable sharing of benefits – on mutually agreed
terms - arising from the results of R&D and commercial use of genetic resources
with the state providing the resources.268 It particularly states that countries are to
provide for the effective participation in biotech R&D and particularly in
developing countries who provide the genetic resources and also countries are to
promote and advance priority access to developing countries - on mutually
agreed, fair and equitable terms - results and benefits from biotechnologies based
on genetic resources provided.269
Biotechnology has enormous potential to meet food and other needs, but biotech
R&D is dependent on genetic resources. There is thus a need to conserve
biodiversity and its components. Paradoxically, while new biotech R&D poses a
threat to biodiversity e.g. GMOs, it is the conservation of biodiversity that will
enable advances in biotech R&D.
The CBD recognizes IPRs to biotechnological inventions and asserts that IPRs
must be supportive of and not run counter to the objectives of the CBD.270 The
CBD recognizes that access to and transfer of technology, including
biotechnology is essential for the attainment of its aims. It requires the transfer of
technologies to developing countries who provide genetic resources (including
those technologies protected by patents and IPRs) to be on – mutually agreed,
fair and most favourable terms and in accordance with the financial mechanism
established thereby - recognising and consistent with the adequate and effective
protection of IPRs.271
Due to the current trends in IPRs protection, particularly patents on PGRs e.g.
biopiracy, broad bio-patents, ethical or cultural issues as regards patenting of life
forms etc, concerns have been growing with regard to the extent IPRs may
jeopardize the exercise of sovereign rights over PGRs and make illusory the
implementation of a balanced multilateral system based on shared-access.272
The CBD does not deal specifically with the issue of PVP but is of direct
relevance because it covers all biological resources, whether plant varieties or not.
Thus, the introduction of PVP in the context of TRIPs cannot be separated from
                                                
268 Article 15(7) of CBD
269 Article 19(1)(2) of CBD
270 Article 15(6), 16, 19 of CBD
271 Article 16(2), 16(3) of CBD It is said that the emphasis on acquiring new and patented
biotechnologies designed for the needs of developed countries that will attract royalties
denies the importance of biotechnological information that is already in the public domain
and adapted to the environment and development needs of developing countries.
Developing countries are therefore urged to concentrate their efforts on informing
themselves about the existence of such knowledge than on gaining access to
biotechnologies found in developed countries. See Rohini Acharya, op cit., p. 17-22
272 Carlos Correa, op cit., p. 168-169
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the CBD. Indeed, the CBD provides the broad framework within which IPRs
over plant varieties must fit.
The CBD recognizes the close and traditional dependence of many indigenous
and local communities on biological resources and deals with TK in the context of
conservation and sustainable use of biodiversity.273 Although, articles 8(j) and 10
do not use the word “protect”, they create legal obligations for states to respect,
preserve, promote and maintain the knowledge, innovations, practices of
indigenous peoples and local communities. Article 8(j) also provides for the
equitable sharing of the benefits arising from the use of TK, innovations and
practices with indigenous peoples and local communities.
In the CBD, TK is limited in the context of conservation of biodiversity. It also
relates to the “old” rather than “modern” or “future” manifestations of TK. The
CBD is also subject to national laws for its implementation. Therefore, at the
subsequent Conferences of Parties (CoP) to the CBD, concerns on IP protection
of TK has occupied the agenda due to the acknowledgement of the fact that the
CBD does not provide an adequate legal basis for its protection.274
4.4.2 The International Treaty on Plant Genetic Resources
for Food and Agriculture
On 3rd November 2001, the FAO Conference adopted the International Treaty
on Plant Genetic Resources for Food and Agriculture.275 It covers all PGRs
relevant to food and agriculture276 and will come into force three months after it
has been ratified by 40 states.277
Once in force, the Treaty will succeed the IU, a non-binding agreement adopted
by the FAO Conference in 1983.278 The Treaty as a legally binding instrument
                                                
273 Mugabe, J, op cit., p. 21
274 ibid
275 It was adopted by Resolution 3/2001 with only two countries abstaining, notably the
USA and Japan. See Mekoaur, Ali. A Global Instrument on Agro-biodiversity: The
International Treaty on Plant Genetic Resources for Food and Agriculture. January 2002.
FAO Legal Papers Online #24 at http://www.fao.org/Legal/pub-e.htm. For a more
comprehensive analysis on its implications see Helfer, Laurence R. Intellectual Property
Rights in Plant Varieties: An Overview with Options for National Governments. July 2002.
FAO Legal Papers Online #31 at http://www.fao.org/Legal/pub-e.htm. See also “A Treaty on
agro-biodiversity” at http://www.fao.org/ag/magazine/0112sp3.htm. See text at ftp://ext-
ftp.fao.org/ag/cgrfa/iu/ITPGRe.pdf
276 Article 3 of Treaty
277 Article 28 of Treaty
278 The IU was adopted by Resolution 8/83 and was the first international agreement to deal
with the sustainable management of PGRs for food and agriculture. It formalized the de facto
status of PGRs as a “common heritage of mankind” that should be “available without
restriction”. Subsequently, three other interpretive FAO resolutions were adopted and
annexed to the IU, namely: Resolution 4/89 with recognized farmers’ rights and UPOV-based
80
goes much further than the IU as it represents a legally binding international
commitment to the improvement of the world’s key food and feed crops.
From its preamble, the Treaty recognises the “special nature of PGRs for food
and agriculture, their distinctive features and problems needing distinctive
solutions.” It recognises that PGRs for food and agriculture “are a common
concern of all countries, in that all countries depend very largely on PGRs for
food and agriculture that originated elsewhere.” This notion of  “common concern
of all countries” is also found in the CBD although, as in the CBD, the Treaty
affirms the sovereign rights of states over their PGRs for food and agriculture.279
The preamble further states that “the conservation, exploration, collection,
characterization, evaluation and documentation of PGRs for food and agriculture
are essential in meeting the goals of the Rome Declaration on World Food
Security and the World Food Summit Plan of Action and for sustainable
agricultural development for this and future generations…”
It also states that PGRs for food and agriculture “are the raw material
indispensable for crop genetic improvement, whether by means of farmers’
selection, classical plant breeding or modern biotechnologies, and are essential in
adapting to unpredictable environmental changes and future human needs...”
The Treaty also acknowledges that PGRs for food and agriculture raise a synergy
of issues in agriculture, commerce and the environment. It states that the Treaty
and other international agreements relevant to it should be mutually supportive
with a view to sustainable agriculture and food security. It also explicitly makes
references to the CBD while stating that its aims “will be attained by closely
linking it to the CBD.”
The aims of the Treaty are stated as “the conservation and sustainable use of
PGRs for food and agriculture and the fair and equitable sharing of benefits
derived from their use, in harmony with the CBD, for sustainable agriculture and
food security.” 280 The Treaty states that PGRs should be conserved and used in a
sustainable way and spells out the type of actions to be taken to achieve this
end.281 It calls for the participation of interested stakeholders in decisions
regarding PGRs.282
                                                                                                                           
PBRs as compatible with the IU; Resolution 5/89 which conceptualised the notion of
farmers’ rights; Resolution 3/91 which recognized the sovereign rights of nations over their
PGRs and set out the farmers’ rights that could be implemented through a fund for PGRs.
FAO’s Commission on Genetic Resources for Food and Agriculture served as the secretariat
of the IU. See Ali Mekoaur, op cit., p. 2
279 See preamble, Article 10 of Treaty
280 Article 1 of Treaty
281 Article 6 of Treaty: These include: (i) encouraging farming systems that enhance the
sustainable use of agro-biodiversity and other natural resources; (ii) maximizing intra and
inter specific variation for the benefit of farmers, especially those who apply ecological
principles in maintaining soil fertility and combating diseases, weeds and pests; (iii)
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An important landmark of the Treaty is its formal recognition of Farmers’ rights.
Its Article 9 states “the contracting parties recognize the enormous contribution
that the local and indigenous communities and farmers of all regions of the world,
particularly those in the centres of origin and crop diversity, have made and will
continue to make for the conservation and development of PGRs which constitute
the basis of food and agriculture production throughout the world.”
It further states “that the responsibility for realizing Farmers’ rights…rests with
national governments…and …should take measures to protect and promote
Farmers’ rights, including: protection of TK relevant to PGRs for food and
agriculture; the right to equitably participate in sharing benefits arising
from the use of PGRs for food and agriculture; and the right to
participate in decision-making, at the national level, on matters related to
the conservation and sustainable use of PGRs for food and agriculture. It
also states “nothing in this article should be interpreted to limit any rights
that farmers have to save, use, exchange and sell farm-saved
seed/propagating material, subject to national law and as appropriate.”
This is a major step because it acknowledges and provides for the implementation
of the rights of informal innovators (“traditional farmers”) on equal footing with the
rights already granted to formal innovators (“modern breeders”) by existing
treaties.
Another key element of the Treaty is the provision of a Multilateral System of
Facilitated Access and Benefit-Sharing for PGRs.283 The system aims to provide
facilitated access to an agreed list of over 60 plant genera, including 35 crops and
29 forages, established on the basis of interdependence and their importance for
food security.284 Recipient countries of these PGRs agree to provide facilitated
access to other countries by, inter alia, not claiming any IPRs or other rights that
limit the facilitated access to PGRs for food and agriculture, or their genetic
components.285
The Treaty also provides that the benefits accruing from the use – including
commercial - of the material accessed under the Multilateral System should be
                                                                                                                           
broadening the genetic base of crops and increasing the range of genetic diversity available
to farmers; and (iv) promoting increased world food production compatible with sustainable
development.
282 See preamble, Article 6(2)©, 9(2)© of FAO treaty
283 For example, access to information related to PGRs is a principle that is found throughout
the Treaty e.g. Article 13(2)(a) where non-confidential information regarding technologies,
results of research etc on PGRs is to be made available to countries. This facilitates the
exchange of information “on scientific, technical and environmental matters related to PGRs
for food and agriculture”, with a view to contributing to the sharing of benefits there from.
284 Article 11, Annex I of Treaty
285 Article 12(3) of Treaty
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shared fairly and equitably.286 Its provision on the sharing of monetary benefits
arising from the commercial use is also a landmark in that someone who obtains a
commercial profit from the use of PGRs administered multilaterally will be obliged
- by a standard Material Transfer Agreement - to share these profits fairly and
equitably, and pay a royalty to the multilateral mechanism, to be used by the
Governing Body of the Treaty as part of its funding strategy for benefit-sharing.287
The monetary benefit sharing is part of a larger whole as the Treaty establishes a
funding strategy that will mobilise funds for priority activities particularly in
developing countries and economies in transition countries.288
The Treaty for the first time also provides an agreed international framework for
the ex situ collections of PGRs held in trust by, among others, the IARCs of the
CGIAR. Such collections will now be available within the context of the
Multilateral System and under the terms and conditions set out in Article 15.
The Treaty does set out a clear and predictable framework for access to PGRs
and a greater balance of the relevant interest groups. It ensures that both formal
and informal plant breeders (e.g. rural farmers) have access to PGRs they need
and prevents their monopolization, through IPRs, by third parties e.g. MNCs.
                                                
286 Article 13 of Treaty: Notably, the benefits do not return to the country of origin, but are
to be shared in a fair and equitable manner through multilateral mechanisms e.g.
partnerships and collaboration with the private and public sectors of countries in
development and in transition. Such benefits should flow primarily to all farmers, especially
farmers in developing countries and countries with economies in transition, who conserve
and sustainably use PGRs for food and agriculture. There will be increased opportunities for
developing joint strategies for the conservation and sustainable use of PGRs, the facilitation
of research partnerships and the pooling of resources to exploit PGRs, and access to
relevant research and technologies. See Ali Mekour, op cit., p. 7
287 Article 13(2)(d) of Treaty: the Treaty distinguishes between mandatory and voluntary
payment. Payment is mandatory on the commercialisation of a product that is a PGRs and
that incorporates material accessed from the Multilateral System, when this product is not
available without restriction to others for further R&D. Payment is voluntary when this
product is available. See Ali Mekour, op cit., p. 7
288 Article 18 of Treaty: countries are also to take into account the priorities established in
the rolling Global Plan of Action for the Conservation and Sustainable Use of Plant Genetic
Resources for Food and Agriculture. 150 countries at the Leipzig International Technical
Conference on Plant Genetic Resources for Food and Agriculture adopted this plan in 1996.
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4.4.3 The African Model Legislation for the Protection of
the Rights of Local Communities, Farmers and
Breeders and for the Regulation of Access to
Biological Resources289
In June 1998, at the 68th Ordinary Session of the Council of Ministers of the
OAU held in Ouagadougou Burkina Faso, Ethiopia sponsored a draft Model
Law that was tabled for discussion. The Council of Ministers, adopted the Model
Law and expressed concern that the western patent system was laying a claim, in
a massive way, to the biological diversity, knowledge and technologies of local
and indigenous people of the South, including Africa and made various
recommendations.290 The Model Law is the only regional effort at attempting to
come up with a regime on access to biological resources in Africa.
Of the two regional IP organisations, only the French-speaking OAPI has dealt
with PVP directly. In 1999, OAPI member states revised the Bangui Convention,
which now commits them to UPOV 1991 version. This is an unexpected choice
because there is no obligation to join UPOV so as to fulfil the requirements of
Article 27(3)(b) of TRIPs. The other organisation, ARIPO has not dealt with the
issue specifically following the adoption of TRIPs. It appears as though ARIPO
leaves its members free to reject patents granted on grounds found in domestic
law but does not itself provide any framework within which patentability must
fall.291
The main aim of the Model Law is stated as “to ensure the conservation,
evaluation and sustainable use of biological resources, including agricultural
                                                
289  The development of the OAU Model Law is the result of initiatives from the Scientific,
Technical and Research Commission (STRC) of the then OAU (which has since been
preceded by the African Union), the Ethiopian Environmental Protection Authority and the
Institute of Sustainable Development in Ethiopia. They found common ground in response
to the mounting pressure on developing countries in general, and Africa in particular, to
comply with the CBD and TRIPS. See Prof J.A Ekpere - Project Coordinator, OAU/STRC. An
Explanatory Booklet on the OAU Model Law.  p. 8. See also The Model Law of the OAU
on Community Rights and on the Control of Access to Biological Resources at
http://www.twnside.org.sg/title/oau-cn.htm. See text at http://www.blauen-
institut.ch/Tx?+T/ttOauModelLaw.html
290 First, that member states should give attention, as a matter of priority, the need to
regulate access to biological resources, community knowledge and technologies and their
implication for IPRs as found in TRIPS; Second, member states should enact the Draft
Model Law into national law and involve all stakeholders in accordance with national
interest; Third, member states should initiate a process of negotiation for an African
Convention on Biological Diversity with emphasis on conditions for access to biological
resources and protection of community rights; Fourth, member states should develop an
African Common Position and forge an alliance with like-minded countries of the South in
the 1999 revision of TRIPS so as to safeguard their sovereign rights and the interests of
local communities. Fifth, that the OAU/STRC be designated as the focal point for
coordination and follow up activities. See Ekpere, op cit., p. 10
291 Philippe Cullet, op cit., p.
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genetic resources, and knowledge and technologies in order to maintain and
improve their diversity as a means of sustaining all life support systems.”292
It focuses on the definition of the rights of local communities, farmers and
breeders over biological resources and establishes them as a priori rights that
take precedence over rights based on private interests.
Its core principles and provisions are state sovereignty and the inalienable rights of
its people over biological resources,293 food sovereignty and security including the
right and responsibility of all stakeholders to keep seed free from private rights.294
It also provides for the full participation of all stakeholders in decisions over
biological resources.295
The Model Law provides for community rights and responsibilities over biological
resources.296 These include: inalienable rights over biological resources and the
right to collectively benefit from its use; rights to their innovations, practices,
knowledge and technology; the right to collectively benefit from their use; the right
to prohibit access to their biological resources and TK (but only in cases where
access would be detrimental to the integrity of their natural or cultural heritage).
The state is also required to ensure that at least 50% of the benefits derived from
the use of their biological resources or TK are channelled back to the local
communities.
It recognises the importance of TK in the conservation and sustainable use of
biological resources and provides for its protection.297 It recognises the vital role
played by women in the conservation of biodiversity.298 It also provides for
farmers’ rights.299 These include: the protection of their TK relevant to plant and
animal genetic resources; the right to an equitable share of benefits arising from
the use of plant and animal genetic resources; the right to participate in making
decisions on matters related to the conservation and sustainable use of plant and
animal genetic resources; the right to save, use, exchange and sell farm-saved
seed or propagating material; and the right to use a commercial breeder’s variety
to develop other varieties.
It provides for a mechanism to regulate access to biological resources and TK
based on the prior informed consent of states and local communities, mutually
                                                
292 See Part I
293 See preamble-1st paragraph, Part I (a), Part IV-Article 21(1)
294 See Part I (k), Part VI – Article 26(3), Article 33(1)(b)
295 See preamble-6th paragraph, Part I (e), Part V – Article 26 (1)©
296 See preamble-2nd, 6th paragraph, Part I (g), Part IV-Article 16
297 See preamble-3rd paragraph, Part I (e)(h), Part III-Article 5(1)(ii), Part IV-Articles 18, 22,
Part V-Article 24(1), Part VII –Article 66(4)
298 See preamble-4th paragraph, Part I (a), Part II-Article 1, 2(2), Part IV-Article 16, 21, 23, Part
V - Article 24, 25, 26, Part VI – Article 31, Part VII – Article 60 (ii)
299 See Part V
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agreed terms and the fair and equitable sharing of benefits arising from their use,
and establishes a community fund for this purpose.300 Access by the formal sector
is made subject to the conditions agreed to in the CBD while the traditional
access by local communities and indigenous peoples is maintained.
The conditions of access include: R&D to be carried out in the country giving
access; prior informed consent of both the state and the local communities;
commitments for the conservation of biodiversity; commitment to provide
information and duplicate specimens to the country giving access; commitment not
to transfer to third parties without authorization; commitment not to apply any
other IPRs; payment for the communal labour that has gone into creating or
knowing the specific characteristics of the biodiversity, TK or technology
accessed and the work done by the state in doing this; commitment to abide by
certain procedures aimed at ensuring the implementation of the mutually agreed
terms.
It provides for a sui generis system for the protection of plant varieties and
clearly stipulates a no patents on life forms policy.301 Generally, the PBRs rights
follow those defined under UPOV.302 What is noteworthy is the fact that PBRs
under the OAU Model Law are subject to very broad exemptions such as
breeders’ exemptions to have the right to use a protected variety for purposes
other than commerce, the right to sell plant or propagating material such as seed
as food, the right to sell within the place where the variety is grown and the use of
the variety as an initial source of variation for developing another variety.303
                                                
300 See preamble-5th, 6th paragraph, Part I ©(d), Part II – Article 1, 2(2)(ii), Part III, Part IV –
Article 18, 19, 20, 21, 22, Part V – Article 26(1)(b), Part VIII – Article 66, 67(2)(iii)(iv), 68.
301 See preamble–9th paragraph, Part II –Article 2(1)(v), Part III – Article 9, Part VI
302 Philippe Cullet, op cit., p. 9
303 ibid
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5 RECONCILING THE
ACCESS ISSUE
5.1 Status of Food Security in Africa
Agriculture in Africa is an activity of primary importance. It holds a key place in
the national economies because it provides for most of the food needs of most
people in Africa. The majority of African people are involved in agricultural
activities as their main economic activity.304 Agriculture’s contribution to the GDP
is also very substantial.305 Agriculture is, for instance, the most important
economic sector in Kenya.306 The importance of this sector is reinforced by the
fact that a majority of the population in sub-Saharan African countries lives in
rural areas.307
Although today about 70% of Africans are farmers i.e. subsistence or small-scale
farmers while the agricultural sector is the main economic activity for over 80% of
Africans, the agricultural performance is persistently poor or even dismal.308 The
per capita food production, availability and access are steadily declining. For
instance, if you compare with other regions of the world, Western Europe: 3500
Kcal/person/day, North America: 3600 Kcal/person/day while in Africa it is
2100 Kcal/person/day.309 Africa is characterised by food shortages, food
insecurity, chronic hunger and malnutrition. Food insecurity in Africa is directly
                                                
304 This is particularly true for sub-Saharan countries where more than two-thirds of the
population is engaged in agriculture e.g. 92% in Burkina Faso, 76% in Kenya, and 74% in
Senegal. See Philippe Cullet, op cit., p. 11
305 GDP’s contribution is 26% in Kenya, 32 % in Nigeria, 42% in Cameroon, and 50% in
Ethiopia. See Philippe Cullet, op cit., p. 11
306 ibid
307 ibid. Rural population accounts for 54% in Senegal, 58% in Nigeria, 74% in Tanzania, and
86% in Uganda.
308 Kiome, Romano (Dr), Director, KARI. Potential Contribution of Biotechnology to
Sustainable Development of Kenyan Agriculture. Biotechnology and Food Security
Workshop, KARI hqs. 9.8. 2002. See also Prof. Reuben Olembo. Role of Biotechnology in
African Development . BiotekAfrika. Biotechnology for Sustainable Development. Vol. 005-
2001. Jan-March. See also Prof. James Ochanda. Agricultural Biotechnology: Policy and
Institutional Implications for Africa. ABSF. Nairobi, Kenya.
http://www.worldbank.org/wbi/attacking poverty/rural/ochanda-presentation.ppt
309 ibid. Profits from farming are too small because of low levels of productivity to allow
farmers to reinvest in their land and maintain sustainable agricultural production. In
contrast, farmers in Western Europe and North America have seen a steady increase in
agricultural productivity increasingly facilitated by biotechnology and the constant
payments of massive agricultural subsidies by their governments. As a result world grain
prices have continued to fall rendering it increasingly difficult for the African small-scale
farmer to operate profitably. See J. De Vries and G. Toenniessen. Securing the Harvest:
Biotechnology, Breeding and Seed Systems for African Crops. 2001. CABI Publishing. p.
29-30
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tied to the collapse of rural or small-scale/subsistence farming. It is estimated that
200 million Africans, most of them women and children, suffer chronic
malnutrition, especially Vitamin A and other micronutrient deficiencies.310
Agricultural development is thus critical to Africa’s economic growth and
improving the standard of living of its people.
It is said that one of the main reasons for rising hunger in Africa is the high rate of
population growth311 combined with low or negative economic growth which
growth has exerted more demand for improved agricultural output and has
resulted in increasing poverty.312 It is observed that a high population growth rate
is especially injurious in countries with low or negative economic growth, where
the number of lives to support simply outstrips the rate of appearance of new
opportunities for adding value within households.313 Nevertheless, it is debateable
to what extent this population growth rate has exerted pressure on agricultural
outputs due to factors such as endemic diseases e.g. HIV/AIDS and malaria, civil
wars, natural disasters & calamities e.g. floods which claim millions of lives on the
continent.
Of the 48 low-income countries in the world today, 32 are in sub-Saharan
Africa.314 Africa experiences poverty in absolute terms. It is indisputable that
Africa has the highest incidence of poverty, hunger and malnutrition globally. It is
estimated that about 70% of the rural population in Africa is absolutely poor.315
The poverty levels are rising because of the high levels of population growth
combined with a poorly performing agricultural sector and generally bad
governance.
There has been a significant decline in crop yields to match the population growth.
Some of the most severe constraints to food production are poor soils, brought
about by population increases, the encroachment on forests, drought and even
                                                
310 Within Africa, eastern and southern Africa account for the greatest number of
undernourished people. Currently, Angola, Ethiopia, Eritrea, Mauritania, Mozambique,
Lesotho, Swaziland, Zambia and Zimbabwe are experiencing massive famine. At least 15
million in Ethiopia and another 15 million in the southern African countries are in urgent
need of food aid. Also, FAO estimates that Kenya has 13.2 million undernourished people
(out of a total population of about 30 million). See FAO State of Food and Agriculture, 2002,
op cit., p. 1. WHO also estimates that 54% of child mortality in Africa is associated with
malnutrition and as many as 1/3 of children in sub-Saharan Africa are said to be stunted
because of poor diet. See J. De Vries and G. Toenniessen, op cit., p.  29-30
311 See J. De Vries and G. Toenniessen, op cit., p.  29-30. It is estimated that today there are
more than 650 million Africans and it is projected that in 25 years to come there will be 1.3
billion Africans (a growth rate of 3.1% annually).
312 It is estimated that although Asia, with 70% of the developing world’s total population,
has far greater numbers of people who are undernourished; sub-Saharan Africa has almost
double the percentage (33% compared with 17% in Asia) of hungry people. See J. De Vries
and G. Toenniessen, op cit., p. 30
313 See J. De Vries and G. Toenniessen, op cit., p.29
314 See note 245
315 See note 301
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floods. The arable land is limited with little scope for expansion. Kenya for
instance may have the capacity to produce sufficient food for her people and even
for export, but about 70% of the land is arid or semi-arid. In addition, a high
incidence of crop pests and diseases account for over 40% of pre and post
harvest losses. Costly farm inputs e.g. fertilizers, herbicides and pesticides, which
most rural farmers can barely afford and the low technology base has also
contributed to this dire situation. There is also low livestock production arising
from diseases and lack of vaccines to treat those diseases.
5.2 A further look at the implications
In Africa, farmers largely carry out seed management; indeed farm-saved seeds
account for about 80% of farmers’ total seed requirements.316 These proportions
are even higher in some countries e.g. in Ethiopia, farmers contribute about 96%
of the annual seed requirements while in Tanzania, only 2% of the maize crop is
planted with purchased certified seeds.317 Even when farmers buy seeds for the
crops they market, they usually continue to cultivate local food crops.
Traditionally, agriculture has been built around significant sharing of knowledge
and resources at all levels. No specific farmer becomes a seed producer for the
community. Instead, each year farmers share their seeds with each other,
identifying those that perform well and conduct their own experiments with a
variety of seeds.
This is also reflected in the fact that Africa, and indeed every region in the world is
dependent on genetic material, which originated in another region for over 50% of
its basic food production, and for several regions of the world, such dependency
is close to 100%.318 The global interdependency that prevails in respect of PGRs
for sustainable agriculture explains why access to PGRs is key to food security,
an issue that has been addressed in the CBD, the FAO Treaty and the African
Model Law.
Although a few African countries, namely Kenya, Zimbabwe and South Africa,
had introduced PVP regimes even before TRIPs (akin to UPOV type laws) very
limited lessons can be learnt from these countries in terms of the impact of TRIPs
in its introduction of IPRs on plant materials because in all these countries, PVP
has not substantially fostered the development of new food crops; rather PVP has
fostered the development of cash crops.319
                                                
316 Philippe Cullet, op cit., p. 12
317 ibid
318 Carlos Correa, op cit., p. 168
319 In Kenya, out of the 136 applications filed and tested in 1997, only one was for a food
crop, most were for cash crops and more than half concerned Rose Varieties. In Zimbabwe,
for the same period of time, less than 40% of the applications were for food crops. In
addition, the introduction of PBRs does not seem to promote the development of
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Although biotechnology promises a lot for farmers in Africa, particularly with
improved varieties accustomed to the ecological realities in Africa such as
drought, comparisons with the “green revolution” of the 1960’s, which Africa did
not benefit from, indicates that increasing yields alone through biotechnology may
not address the complex issue of food insecurity and alleviation of hunger in
Africa.
When assessing the relevance or appropriateness of agricultural biotechnology in
addressing food security in Africa, it emerges that what is fundamentally at stake
is the ownership of IPRs on biotech products and processes (and the related
access problems) rather than the benefit/risk analysis of these new
biotechnologies.320 The introduction of IPRs in the management of biodiversity
would have serious repercussions if it were not done with the aim of ensuring the
realization of basic food needs.
TRIPs has extended and emphasised on private property rights over agro-
biodiversity. We have seen that this could adversely impact on the individual’s
right to food (and food security) directly and is bound to affect agricultural
practices and the lives of rural farmers.
TRIPs favours corporate/commercial interests. IPRs as exclusive property rights
are an incentive for private sector R&D in agriculture. This then tends to promote
commercial breeding activities and high-technology agriculture. Businesses are not
directly concerned with ensuring food security but mainly with the maximization of
profits in any venture they enter into. Businesses focus on the commercial
potential of agro-biodiversity and neglect its use in meeting basic subsistence
needs while completely overlooking the contribution of local communities or
groups e.g. farmers in the management of these resources.
In addition, MNCs based in developed countries, dominate and control the global
seed industry. They hold the majority of patents relating to biotech products and
processes. As we have seen, this restricts the accessibility of such knowledge or
technologies.
TRIPs is also set to potentially conflict with established agricultural management
practices of small-scale rural farmers. This is due to the fact that the two systems
                                                                                                                           
indigenous research capacity because most of the applications e.g. in Kenya between 1997-
1999, 91% came from foreign institutions while in South Africa, 72% were also foreign in
1997. See Philippe Cullet, op cit., p. 12
320 Increasing food production alone will not solve food insecurity in Africa. It is appreciated
that the causes of food insecurity in Africa are complex e.g. access to land, land rights and
poverty. Nevertheless, access to existing and new technologies in agriculture is clearly a
high priority. Africa needs to adopt and adapt appropriate technologies already developed
elsewhere while at the same time she needs to develop her own capacity for designing new
technologies, building on her own experience and traditional and indigenous knowledge.
90
rely on and promote different knowledge systems, identify innovations differently
and reward inventors in different ways.
Further, under TRIPs, TK is not recognized as knowledge worth IP protection.
Consequently, it is assumed that TK is in the public domain and thus freely
available. It gives the impression that TK is not valuable while scientific research
work carried on in laboratories is more valuable (and also adds value to TK).
With the current TRIPs regime, farmers and other local innovators contribute to
the research efforts of others, principally those based in developed countries,
without being attributed any right to their work.
As farmers TK is not recognised and also because the majority of farmers mainly
operate on the basis of sharing of knowledge, the gap between countries –
developed and developing – and individuals who can compete in international
agricultural trade will eventually widen.
IPRs as exclusive rights are inadequate to protect farmers’ TK, which is often less
individualistic and involves the collective work of local communities and farmers.
IPRs as private rights marginalize, negate and completely ignore the rights and
contribution of different actors involved in the improvement of agro-biodiversity.
Usually more than one farmer is involved in the development of a variety (similar
or close varieties could even have been developed in different areas or countries
by different communities) and it is almost virtually impossible to attribute an
improvement of a variety to one person.
It is clear that there is a need to recognise the immense contribution of the various
actors involved in the conservation and development of biodiversity, particularly
local communities, indigenous peoples and farmers. TRIPs while emphasising on
private rights channels all benefits to an individual person and lacks a framework
for the equitable sharing of benefits and compensation to those actors who have
played a role in the management of biodiversity. There is thus a need to create
alternative systems that reward farmers, indigenous peoples, local communities
and other groups.
IPRs also generally foster the commercialisation of agricultural inputs. One of the
most direct impacts of patents is to raise the price of patented seeds compared to
other seeds. In addition, farmers become dependent on private firms for their
seeds and also for farming inputs such as fertilizers and pesticides.321 Further, and
perhaps most crucial in Africa, farmers’ will be unable to save and replant seeds
of patented varieties exacerbating the food insecurity situation and worsening an
already desperate situation.322
                                                
321 Especially as regards GURTs where seeds will only germinate on the application of inputs
available from the same MNCs.
322 In practice, I think that most small-scale farmers in Africa would be able to carry on the
practice of saving seeds because litigation of millions of small farmers by seed companies is
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In addition, IPRs such as PBRs encourage the breeding of new varieties which lay
an emphasis on genetic uniformity and stability (thereby fostering monocultures)
geared for industrialized agriculture which often have the tendency to displace
local or traditional plant varieties. This leads to homogenisation and the erosion of
agro-biodiversity or the genetic base on which continuous R&D activities are
based as farmers stop maintaining existing local varieties and opt for high yielding
varieties. This trend is not sustainable in the long run as local varieties provide the
genetic base for most high yielding varieties.
Although IPRs may entail restrictions on access to biotech products and
processes that could generally adversely impact on R&D activities in Africa, it is
unlikely that local/domestic breeding would substantially benefit from the
introduction of IPRs on plant varieties. The fact that an overwhelming majority of
applications for PBRs in both Kenya and South Africa are foreign is a case in
point. The correlation between R&D and IPRs has not been established in Africa
as opposed to the obvious linkages the same has in developed countries.
Access to food still remains the main food security concern in Africa. Concerted
efforts are needed to address access related problems such as those arising from
IPRs on biotech products and processes while also addressing poverty
alleviation, land rights and land redistribution.
For Africa, TRIPs, UPOV, CBD, FAO Treaty and the African Model Law are
the key instruments that will govern and influence a system of access for PGRs for
food and agriculture.323 At least, at the international and regional level, there is a
basic agreement of ensuring that for the key food and feed crops, there should
exist a system that facilitates access to and exchange of PGRs for food and
agriculture and the equitable sharing of benefits arising from their use. Access to
PGRs for food and agriculture - either for production, reproduction, research or
breeding - is essential in any system that seeks the conservation, sustainable use,
exchange and equitable sharing of benefits of those resources.
Indeed IPRs are meant to serve a societal function, their grant should serve the
wider public. The challenge is for national, regional and international policy
makers to ensure that a balance is struck between the interests of IPRs holders
                                                                                                                           
simply not feasible, unless seed companies produce seeds for staple foods with in-built
protection such as ”terminator technology” or ”traitor technology.”
323 Carlos Correa, op cit., p. 171. The notion of access has shifted from a concept of
“unrestricted” or “free” access to one of “shared-access”.  It is observed that some
countries may find it difficult to agree on a system of  “shared-access” if the genetic
resources maintained and developed by their farmers and local communities may be
appropriated under IPRs by foreign MNCs, especially if such IPRs create barriers to access
to and use of the protected materials.
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and those of the public so as to maximize and not block or restrict access to
agro-biodiversity and biotech products or processes.
5.3 Towards Compliance with TRIPs
Up and above the food security implications brought about by TRIPs, it is
necessary for African countries to fulfil their obligations under this legally binding
treaty. African states should take advantage of the flexibility provisions under
article 27(3)(b) of TRIPs to devise an IPRs system adapted to their own needs
and conditions (sui generis system) and should avoid any system that involves
private exclusionary rights such as patents or PBRs.
As we have seen, such private exclusionary rights are ill suited to provide the
conditions necessary to ensure the fulfilment of basic food needs of individuals,
households and nations in Africa and also the sustainable management of
biological resources. An optimal balance could be achieved by determining the
scope of protectable subject matter, the scope of rights, the permissible limitations
or exceptions and the term of protection.
5.3.1 Exclusions from patentability
Nothing in TRIPs obliges members to follow an expansive approach regarding the
patenting of life forms.324 What article 27(1) of TRIPs does is that it specifies the
requirements that an invention must meet for patentability, but does not define
what an invention is. This leaves members with the freedom to determine what
should be deemed an invention.
Access-related problems in relation to patents on plant varieties or processes
would partly be solved if countries formulated in their domestic laws, exclusions
banning the total patenting of substances existing in nature, such as genes, cells or
entire plant varieties. Many developing countries in their laws do exclude the
patenting of life forms as found in nature, even if purified/isolated. Patenting of life
forms raises serious ethical, religious and cultural questions and therefore total
exclusion of patenting life forms would be an option.
Article 27(2) and 27(3) of TRIPs also specify exclusions that a member country
can establish in its domestic law e.g. based on morality, protection of human,
animal or plant life or health or to protect the environment.
Article 27(3)(b) of TRIPs specifically provides for the exclusion of patentability of
plants but without defining what “plants” are. Member states can thus exclude the
patentability of plant species, plant varieties, including hybrids and transgenic
plants, as well as their cells and seeds under this rubric. It should be borne in mind
                                                
324 Carlos Correa, op cit., p. 186
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that if patents are granted on “plants”, the protection might extend to plant
varieties, because no definitions are afforded as to the difference between a
“plant” and a “plant variety.” It is clear that TRIPs requires that plant varieties be
protected by IPRs but there is no obligation to implement such protection under
patents.
Another possible exclusion from patenting would relate to “essentially biological
processes for the production of plants or animals.” Classic breeding methods are
not patentable e.g. traditional breeding practices but biotechnological methods
such as genetic engineering, where the degree of human intervention is significant,
would be patentable (as a non-biological process).
TRIPs requires microorganisms and microbiological processes to be patented but
the term “micro-organism” is not defined, in some countries “micro-organisms”
can be classified as animals. This leaves member states with the freedom to apply
a narrow scientific definition than an expansive one.
Article 30 of TRIPs provides for limited exemptions to the exclusive rights
conferred by a patent. Developing countries should take advantage of this by
providing research exemptions in their domestic laws to enable their public sector
agricultural research to continue without the threat of infringing on patents.
5.3.2 If patents are granted:
5.3.2.1 Conditions for patentability
Article 27(1) of TRIPs states that inventions shall be patentable as long as they
are new, involve an inventive step (non-obvious) and are capable of industrial
application (useful).  There are different national interpretations on these
conditions for patentability. There is some scope to tighten the criterion for
patentability e.g. “novelty” would require that knowledge already in the public
domain or in use for many years should not be the subject of a patent (e.g.
biopiracy claims and revocation of such patents). An “inventive step” should be
significant not just the mere identification of biomaterials or their function. The
difference between one plant variety and another might also not be non-obvious
to warrant patentability. Further, “usefulness” could include the public benefit of a
biotech invention e.g. food security.
5.3.2.2 Scope and Interpretation of claims
We have seen that broad patents mainly based on functional claims vis-à-vis
structural claims, widens the scope of protection to any means that performs the
claimed function. Therefore, if patents on biotech products or processes are
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allowed caution should be exercised to ensure that such broad claims are not
accepted.
In practice, the scope of the rights can also be determined in the event of an
infringement. Under patents unlike PBRs, it is sometimes difficult to establish an
infringement because of problems distinguishing between a new plant variety and
the patented one; one would need to prove that the “accused” plant has been
derived from the patented one, that it is a copy of the patented one.325
5.3.2.3 Access to samples of patented materials
TRIPs requires that an invention must be disclosed.326 The description of a
biotechnological invention may need to be supported by the deposit of samples
that contains the invention. National laws would need to determine how to deal
with the conditions of access to deposited samples, particularly when and under
what circumstances may third parties e.g. farmers, breeders etc obtain such
samples.327Access to the samples may be an incentive for innovation based on the
protected invention.
5.3.2.4 Compulsory Licenses
Article 31 of TRIPs explicitly allows for compulsory licenses. A compulsory
license is an authorization conferred by a government or third parties authorized
by the government, to use a patent without the consent of the patent owner.
Access to patented biotech products or processes may be obtained by means of
compulsory licenses so long as it is provided for under domestic law.
TRIPs does not limit the grounds for the grant of compulsory licences, but
establishes the conditions under which the grant may take place.328 Therefore,
compulsory licenses may be granted on grounds related to public interest, to
attain specific agricultural objectives like availability of high-tech seeds for farmers
or food security, or the lack of exploitation of the invention, anti-competitive
practices of the patentee (i.e. monopolistic practices), emergency, including
conservation or protection of the environment.
Compulsory licenses can also be available if the patentee has not voluntarily
assented to a request to grant a license on reasonable commercial terms for the
                                                
325 Carlos Correa, op cit., p. 191
326 Article 29 of TRIPs states “…in a manner sufficiently clear and complete for the invention
to be carried out by a person skilled in the art …”
327 The 1977 Budapest Treaty on the International Recognition of the Deposit of Micro-
organisms for the Purposes of Patent Procedure, is an international system for the deposit of
microorganisms and provides for conditions for access to samples deposited under it e.g.
they will only be granted after publication of the relevant patent application.
328 Carlos Correa, op cit., p. 191
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use of the patented biotech product or process. It should be borne in mind that
Agenda 21, concluded at the UNCED, also recommended the provision of
compulsory licenses to facilitate access to and use of environmentally sound
technologies.
5.3.2.5 Revocation of patents
TRIPs cannot be viewed in isolation from the rest of the international legal system
and therefore, in this regard, it would be best to articulate its provisions in light
with the CBD, the FAO Treaty etc. If this is the case, then patent applicants
would be required to declare the country of origin of biological materials related
to a patent application so as to identify the country of origin of given material and
also to ascertain whether prior and informed consent has been obtained. This will
also facilitate access and the sharing of benefits. Where these conditions have not
been met a patent application or patent may be revoked. TRIPs does not indicate
the grounds on which such a decision may be adopted but obliges members to
ensure the availability of a judicial review of a decision to revoke a patent.329
5.3.3 Sui generis protection for plant varieties
A sui generis system for the protection of plant varieties would allow African
countries to develop IPRs over plant varieties, which are suited to their needs and
conditions.
It is observed that very little conceptual work has gone into defining such a
system, thus posing a challenge to African countries members of WTO.330 This
could be attributable to the fact that the pre-TRIPs era was characterised by the
free sharing of biodiversity and knowledge and thus African states did not have
much time to devise entirely new systems, which had not been experimented
elsewhere.
African countries have been experiencing pressure from developed countries to
join UPOV to fulfil their obligations under Article 27(3)(b) of TRIPs. This could
also be another reason as to why they have not as yet developed a sui generis
system.331African countries should use this opportunity to rethink their needs,
instead of succumbing to pressure with regard to UPOV and adopt regimes that
will actually benefit the majority in the long term.
                                                
329 Article 32 of TRIPs
330 Philippe Cullet, op cit., p. 24
331 The deadline for compliance with TRIPs for “developing countries” was I January 2000,
for most African countries classified as “developing” the deadline has since passed and
most have not as yet adopted PVP regimes. African countries categorised as least-
developing have up to I January 2006.
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The sui generis PVP system envisaged should first seek to foster food security
for all and not contribute to food insecurity. It should also lead to sustainable
agriculture that does not lead to the erosion of biodiversity. It should also lead
more generally to the development of food crops that do not harm the
environment and thus biosafety provisions should be part and parcel of this
regime.
A sui generis system should also be all encompassing taking into account other
international obligations that African states could be party to, such as the CBD
and FAO Treaty. In addition, such a system should provide rights to all relevant
actors in agricultural management, focusing on broadening the range of rights
holders and not excluding any specific actors.
Although TRIPs does provide that member states can protect plant varieties
through an alternative sui generis system, it does not define what such a system
is. However, it can be implied that it should allocate IPRs, an alternative to
patents.332
In devising such a system, African countries can recognise concurrently and
equally farmers rights, rights of local communities and indigenous peoples, rights
of commercial breeders and rights of national agricultural research institutes. Such
rights should be clearly spelt out and should not be exclusive; in this way none of
the actors can stop others from carrying out their activities. In this regard
therefore, the African Model Law appears to be in the right direction.
The sui generis system can also for instance, limit the number of varieties that can
be protected for commercial use. Thus, to foster food security, it would be
possible to prohibit the registration of commercial breeders of any food crops
used to meet basic food needs or reduce the duration of commercial breeders’
rights as much as possible and extend farmers’ rights as far as possible.333
A sui generis system will remain valid even if TRIPs is not reviewed or modified
in the years to come. Indeed, in the context of the CBD and the FAO Treaty all
developing countries will have to consider ways to regulate the management of
biological resources and associated knowledge within their countries. Further, the
calls for a sui generis system to protect TK constitutes another part of the
challenge that developing countries, including Africa have to tackle.
                                                
332 Financial compensation under benefit sharing arrangements e.g. under CBD, FAO Treaty
or African Model Law instead of property rights cannot constitute a sui generis system. See
Philippe Cullet, op cit., p. 25-26
333 Another proposal would be to provide that the burden of proof should be on the
defendant. See Philippe Cullet, op cit., p. 26-27
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5.4 Issues for the TRIPs review
In 1999 the Council for TRIPs began its review of article 27(3)(b) of TRIPs while
in 2000 the review of the entire TRIPs agreement began. As yet both reviews
have not been concluded. It appears that there is no consensus about what the
scope of the review of article 27(3)(b) of TRIPs should be.  Developed countries
insist that the review is about the extent to which the provision has been
implemented while developing countries see it as a review of the substantive
provisions themselves that could lead to the revision of the text.334
African countries have raised various issues in the review of article 27(3)(b) of
TRIPs.335 The African Group has called for the link between article 27(3)(b) and
development. They have asserted that they are yet to enjoy the benefits from
globalisation or benefits in their joining WTO or benefits arising from the
biotechnology revolution or the mutuality of benefits under TRIPs. They have
called for the extension of the review with an additional five-year transition
thereafter. This would save African countries from being rushed into accepting
UPOV as a sui generis system.
The African Group (and SADC) have also stated that the review should clarify
that plants, animals, micro-organisms, their parts and natural processes cannot be
patented as the distinction made in article 27(3)(b) of TRIPs is artificial and
violates the basic principles of IP law that products of nature such as life forms
are discoveries and therefore not patentable. African countries have maintained
that the patenting of life forms raises serious ethical, religious, and cultural
questions and therefore reject in toto their patentability. They have also stated
that the co-modification and marketing of life forms violates the cultural practices
of most societies.
The African Group (and SADC) have stated that the sui generis system
envisaged, although not defined, should be retained and allow for protection of
community rights, continuation of farmers’ practices and prevention of anti-
competitive practices, which threaten food sovereignty. They have also called for
                                                
334 The USA basically favours extending patent protection and in the long term, the removal
of all exemptions from patenting. This is also the position favoured by the MNCs in the life
sciences industry. Other OECD countries would prefer that UPOV 1991 be the sole sui
generis option available. In the review and ensuing negotiations, developing countries have
a wide range of interests to consider, such as whether they are net food importers or
exporters, the nature of farming etc. See Geoff Tansey, op cit., p. 14 and Peter Drahos on the
TRIPs review, op cit., p. 8-13
335 See WTO, The TRIPs Agreement: Communication from Kenya on behalf of the African
Group, WTO Doc. WT/GC/W/302 dated 6.08.99; Southern Africa Development Cooperation
(SADC) – WTO Doc. WT/L/317 of I.10.99. See also Adede, op cit., p. 16-20; Correa,
Correa. M. Options for the Implementation of Farmers’ Rights at the National Level.
Trade-Related Agenda, Development and Equity (T.R.A.D.E.) Working Papers. December
2000. South Centre. p. 17-19
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the harmonisation of TRIPs with CBD and the IU. They have called for the
relationship of TRIPs to the concepts of TK and farmers’ rights and have
observed that TRIPs is based on “formal” and western concepts of knowledge
and property rights and does not recognize “informal” knowledge and the
communal ownership of rights such as TK and farmers’ rights.
Kenya, on her own behalf, has cited the need for a five-year extension as a
transition period.336 She has also called for the harmonisation of TRIPs with CBD
and an increase of the scope of protection to include the protection of indigenous
knowledge and farmers’ rights. Tanzania, Uganda and Zambia have also called
for a “no patenting of plants” policy without the prior informed consent of
government and communities in the country of origin.337
It is evident that African negotiators are not in the same position of influence in the
WTO as their counterparts from USA, Europe and Japan. If the latter three unite
and adopt a common position on both reviews, they will likely determine the
outcome of the process. The challenge therefore is for African countries to
present alternative frameworks that will address their interests. There is a need for
sui generis legislation to protect farmers’ rights and TK. These issues should be
looked into so as to guarantee a multilateral system of access to PGRs for food
and agriculture as provided for, inter alia, in the CBD, FAO Treaty and the
African Model Law.
In the just concluded UN Conference on Sustainable Development held in
Johannesburg, South Africa calls were made for, inter alia, the sustainable use of
our natural resources.338 The persistent call for sustainability is based on the
recognition that, inter alia, our natural resources be they arable land, water
resources, wildlife or even the atmosphere, are finite resources that are fast
diminishing in quantity and quality. It is thus imperative that the relationship of
TRIPs, to the extent that it relates to life forms, should be linked to the
conservation and sustainable use of natural resources as detailed out in the CBD,
the FAO Treaty and the OAU Model Law.
The need to establish the relationship between TRIPs and CBD has also been
realized by WTO itself.339 In November 2001, at the WTO’s 4th Ministerial
Conference in Doha, Qatar, which ushered a new trade Round dubbed “the
Development Round”, the Council for TRIPs was instructed in pursuing its work
programme including under the review of article 27(3)(b) and the review of the
implementation of TRIPs under article 71(1), to examine, inter alia, the
                                                
336 WTO Doc. WT/GC/W/23 of 5.07.99
337 http://www.foe.org/international/wto/govt.html. Of 2.09.1999
338 Sustainable Development is development, which meets the needs of the present
generation while not compromising the ability of future generations to meet their needs.
339 It has been discussed in the WTO Committee on Trade and Development; see
“Environment and TRIPS” Doc. WT/CTE/W/8
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relationship between TRIPs and CBD; the protection of TK and folklore; and
other relevant developments raised by member states pursuant to article 71(1). It
was stated that the TRIPs Council’s work on these issues is to be guided by the
TRIPs agreement’s objectives (article 7) and its principles (article 8) and must
take development fully into account.340The debate and political appeal of the
primacy of CBD over TRIPs on biodiversity issues is ongoing and also needs to
be looked into.
In addition, as the UN Special Rapporteur on the right to food has noted, the new
trade Round must address the impact on human rights and the right to food.341
Other wider issues such as the moral and ethical concerns of IPRs over life forms
or equity in international negotiations, economic issues e.g. technology transfer or
priorities in R&D, environmental effects of GMOs should be addressed so as to
create a global system that serves everyone.
5.5 Conclusion
Generally, there is a need to build human rights safeguards into TRIPs and its
implementation so as to forestall the potential negative implications on human
rights, such as the right to food as shown in this thesis. At a time of such dramatic
breakthroughs in new technologies, it is indefensible that hunger, malnutrition and
poverty still persist and yet the same technologies can have a huge impact on
poverty eradication and generally improve the standard of living of many poor
people in developing countries, including Africa.
As we have seen, the current technology path will lead to greater marginalization,
vulnerability and impoverishment of Africans. The gap between the poorest and
richest countries will widen. TRIPs strengthens IPRs and favours those who
develop and market modern forms of technology than the majority of the end
users of such technology, who are usually informal innovators.
There is a need to strengthen global ethics and responsibility, which values are
enshrined in, inter alia, international human rights treaties. Article 28 of UDHR
states that everyone is entitled to a social order in which all the rights guaranteed
therein can be realized. As MNCs are now very dominant in the global scene
shaping the path of globalization, there is a need to develop a legally binding
global code of conduct to regulate them and a global forum to monitor their
activities to ensure compliance with human rights.342
                                                
340 See paragraph 19 of the Doha Ministerial Declaration and also WTO Annual Report 2002.
p. 79 at http://www.wto.org
341 See his report to the UN Commission for Human Rights. UN Doc. E/CN.4/2002/58
342 A notable effort is the UN Global Compact that now brings companies from (all over the
world) together with UN agencies (particularly UNEP, UNDP, OHCHR, ILO), Governments,
NGOs and civil society to foster action and partnerships in the pursuit of good corporate
citizenship. The Global Compact is a voluntary initiative and not intended to be regulatory
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There is a need to put human concerns and rights at the centre of global
governance of technology, which must respect and include diverse needs and
cultures. The MNCs need to put precaution before profits and reshape
technologies path to benefit all humanity.
In addition, developments in “terminator and traitor technologies” are running far
ahead of ethical, legal, regulatory and policy limits needed to govern their use. The
technology path needs to be reshaped and redirected so that it benefits rural
farmers and so that it promotes innovation and sharing of knowledge, respects
diverse systems of property ownership, restores social balance, brings its benefits
to the majority, empowers people, and makes it accessible to those who need it.
                                                                                                                           
and is based on nine internationally accepted principles in human rights (i.e. UDHR), labour
and the environment. Principle 1 states “Businesses should support and respect the
protection of internationally proclaimed human rights within their sphere of influence”;
Principle 2 states “Businesses should make sure that they are not complicit in human
rights abuses.”  See http://www.unglobalcompact.org/Portal/
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